Publikationen seit 2006

1. Hoffmann T, Gassler N, Teichgräber U, Sandhaus T, Oelzner P, Wolf G, Pfeil A. Clinical Images: Severe interstitial lung disease in Sjögren disease - What happens in the lungs? Inflammation or fibrosis? ACR Open Rheumatol. 2023; Feb;5(2):61-62
2. Roth M, Lehmann T, Kloos C, Schmidt S, Kellner C, Wolf G, Müller N. Metabolic Control, Diabetic Complications and Drug Therapy in a Cohort of Patients with Type 1 and Type 2 Diabetes in Secondary and Tertiary Care between 2004 and 2019. Int. J. Environ. Res. Public Health 2023;20, 2631. https://doi.org/10.3390/ijerph20032631 
3. Schachtl-Riess JF, Schoenherr S, Lamina C, Forer L, Coassin S, Streiter G, Kheirkhah A, Li Y, Meiselbach H, Di Maio S, Eckardt KU, Köttgen A, Kronenberg F, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Alberth-Schmidt U, Weigel A, Marschall S, Schefler E, Walz G, Schultheiss UT, Kotsis F, Meder S, Mitsch E, Reinhard U,  Floege J, Saritas T, Gross A, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Zeier M, Sommerer C, Aykac M, Wolf G, Busch M,  Paul R, Sitter T,  Wanner C, Krane V, Börner-Klein A, Bauer B, Raschenberger J, Kollerits B,  Weißensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J. KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study. Atherosclerosis 2023;368, 1-11
4. Steinbrenner I, Sekula P, Kotsis F, von Cube M, Cheng Y, Nadal J, Schmid M, Schneider MP, Krane V, Nauck M, Eckardt KU, Schultheiss UT, GCKD investigators, Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmid M, Nadal J. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrol Dial Transplant. 2023;38:1430-1438
5. Dorenkamp M, Nasiry M, Semo D, Koch S, Loeffler I, Wolf G, Reinecke H, Godfrey R. Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function. Cells. 2023 Feb 3;12(3):513. doi: 10.3390/cells12030513. PMID: 36766855; PMCID: PMC9914555
6. Wolf G, Heemann U, Schulte K. Einführung zum Thema: Ethik in der Nephrologie. Die Nephrologie 2023;18:63-64
7. Wolf G, Knoepfller N. Philosophische Begründung einer Medizinethik. Eine kurze Einführung. Die Nephrologie 2023;18:65-71
8. Herfurth K, Busch M, Wolf G. Beendigung der Dialyse und Palliativnephrologie. Die Nephrologie 2023;18:78-85
9. Bajwa S, Luebbe A, Vo NDH, Piskor EV, Kosan C, Wolf G, Loeffler I (geteilte Letztautorenschaft): RAGE is a critical factor of sex-based differences in age-induced kidney damage. Front Physiol. 2023 Mar 29;14:1154551. doi: 10.3389/fphys.2023.1154551. PMID: 37064891; PMCID: PMC10090518
10. Heerspink H, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J,  Komers R, Mercer A, Noronha  IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V, Alarmartine E, Chae DW, Del Vecchio L, Floege J, Hwang S, Jelakovic B, Maes B, Malecki R, Miglinas M, Nolasco F, Praga M, Rabindranath K, Rosenberg M, Tang S, Tesar V, Bose B, Gangadharan M, McDonald S, Peh C, Jahan S, Yeap C, Clayton P, Irish G,Thyagarajan N, Hollett P, Krishnasamy R, Carroll R, Jesudason S, Crail S, Coates T, Waugh J, Noble E, Mahadevan E, Campbell V, Salehi T, Lim W,  Boudville N, Chakera A,Chan D, Krishnan A, Eqbal Y, Gillies A, Vilayur E, Myint T, Gray N, Waugh J, Noble E, Cheetham M, Eqbal Y, Hollett P, Krishnasamy R, Mahadevan K, Campbell V, Pollock C, Cooper B, Mather A, Roxburgh S, Shen Y, Stangenberg S, Siriwardana A, O'Lone E, Wan S,  Neuen B, Ha J, Kim D, Heath L, Jain A, Phua E, Li Y, Gallagher M, Jardine M,  Ritchie A, Razavian M, Foote C, Wyndham R, Sen S, Endre Z, Erlich J,  Fernando M, Yong K, Luxton G, Kotwal S, Roger S, Wijeratne V, Packham D, Fraser I, Vandewiele B, Laute M, Lemahieu W, Jamar S, Ombelet S, Meeus G, Decupere M, Schockaert O, Doubel P, Viaene L, Radermacher L, Masset C, Moonen M, Firre E, Milicevic M, Warling X, Vanacker A, Malfait T, Durlen I,  Horvatic I, Savuk A, Gellineo L, Karanovic S, Dika Z, Plavljanic D, Mikacic I,  Kentric D, Barisic D, Stankovic M, Barac K, Kruljac I,Pavlovic D, Drinkovic M,  Prkacin I,  Barbic J, Sitas Z, Vujcic D, Rychlik I, Benesova A, Drinovska K,  Kratka K, Maixnerova D, Ilmoja M, Unt K, Lilienthal K, Auerbach A, Leis L, Piel J, Adoberg A, Kolvald K, Veermae K, Telling K, Seppet E, Uhlinova J, Zaoui P, Carron PL, Masson I, Dinic M, Thibaudin D, Broyet C, Maillard N, Mohey H,  Mariat C, Claisse G, Alamartine E, Dussol B, Burtey S, Chiche-Jourde N,  Serre JE, Jeantet G, Chenine L, Blanchard A, Roueff S, Thervet E, Fouassier F, Buffet A, Livrozet M, Gaisset R, Karras A, Heng AE, Garrouste C, Philipponnet C, Nicolo C, Atenza A, Lanaret C, Greze C, Mayet V, Dumond C, Delmas Y, Combe C, Rigothier C, Burguet L, Labat A, Mucha S, de Précigout V, Weinreich T, Reichel H, Draganova D, Wolf L, Hohenstein B,  Heinrichs S, Kulka S, Sat S, Weiland L, Krueger T, Wolf G, Kettner C, Schlosser M,  Herfurth JK, Koch A, Busch M, Werth S, Nitschke M, Cakiroglu F, Sarnow F, Schulz L, Weiner S, Wirtz N, Koester E, Moeller M, Stamellou E,  Sanden S, Schmidt-Guertler H, Bernhardt W,  Patecki M, Schlieper G, Schulte K, Girardet A, Kunzendorf U, Pui L, Kwan Y, Mok M, Chan G, Ma M, Lie DE, Chan A, Szeto CC, Ng K, Cheung SF, Yue T, Fung K, Tang H, Yim, Wai KY, Law P,  Wong YH, Lam C, Wong S, Marcantoni C, Aliotta R, Deodato F, Patella G, Comi N, Vita C, Carullo N, Bolignano D, Musolino M, Trillini M, Perico N, Remuzzi G, Daina E, Biancone L, Colla L, Burdese M, Cogno C, Boaglio E,  Abbasciano I, Zizzi CF, Randone P, Napodano P, Ricchiuto A, Cassia M, Accarino S, Cozzolino M, Baccaro R, Costanzi S, Maio FD, Arena M, Urciuolo F, Vigano S, Cavalli A,  Limardo M, Bordoli M, Ponti S, Longhi S, Solazzo A, Giaroni F, Donati G, Torreggiani M,Catucci D, Colucci M,  Esposito V, Esposito C, Gesualdo L, Capaccio F, Stea E, Sivo C, Annese F, Papadia F, Messa P, Belingheri M, Passerini P, Malvica S, Vickiene A, Zakauskienen M ,  Asakiene E, Bumblyte' I, Stankuviene A, Santockiene L, Hayat A, Williams A, Sizeland P, Tan E, Waters G, Chan LW, Henderson A, Turnbull A, McNally A,  Reynolds A, Pilmore H, Dittmer I, Manley P, Stallworthy E, Goh M, Semple D,  Collins M, Curry E, Ahmed J, Nguyen T, Winiarska A, Zbrzezniak J, Stompor T, Krajewska M, Augustyniak-Bartosik H, Zielinska D, Jander A, Stanczyk M, Tkaczyk M, Miarka P, Aksamit D, Jaskowski P, Sulowicz W, Cieniawski D,  Gontarek-Kacprzak J, Felicjanczuk E, Kwella N, Kwella B, Satora E, Fernandes JC, Gomes AM, Reis M, Lopes D, Almeida C, Sá H, Figueiredo A, Pardinhas C, Almeida E, Raimundo M, Costa A, Goncalves F,  Fernandes S,  Silva S, Teixeira C, Fernandes A, Nolasco F, Alves P, Gois M, Fonseca N, Messias A, Menezes M, Cardoso F, Sousa H, Marques J, Barata R, Lopes JA,  Jorge S,  Gameiro J, Fonseca J, Goncalves S, Farinha A, Santos J, Natario A,  de Jesus Barreto J, Abrantes C, Soares ESQ, Felgueiras J, Cunha L, Parreira L, Furtado T, Vaz A, Oh KH, Lee H, Kim J, Jeong JC, Kim YH, Kim Y, Park HC, Choi H, Kim H, Lee MH, Yoon S, Lee KB, Hyun YY, Yoo TH, Han SH, Park JT, Kim S, Song YR, Kim JK, Lee H, Joo N, Lee JE, Jang HR, Jeon J, Chung W, Lee HH, Chang JH, Chun KY, Jung JY, Ro H, Kim A, Jo SK, Yang J, Kim MG, Oh S, Villanueva C, Gimeno AV, Bonilla G, Tamarit E, Serrano A,  Moreno E, Fernandez JL, Diezhandino M, Guzman UV, de Jose A, Ortiz A,  Pérez Gómez U, Cleary C, Prado R, Goma E, Encarnacion B, Iara Da Silva Santos M, Marco H, Rusinol J, Furlano M, Arias C, Barrios C, Garcia ER,  Ochoa A, Castillo B, Perez JP, Moya M, Sargsyan M, Aristoy E, Bernabeu A,  Lluna LP, Marin TM, Vila MAM, Rico IMB, Burgos N, Martinez G, Gutierrez Solis E, Sevillano A, Herrero EM, Pelicano J, Marin L, Quintana LF, Rivero M,  Terrades NR, Caro CG,  Pamplona I, Lazo MS,  Alvarez F, Garcia F, Morales WA,  Heres SVP, Forcen A, Moncasi EP, Villarroya M, Villen AS, Garcia O,  Plaza MV, Sánchez de la Nieta M, Arevalo MC, Moreno A, Guldris SC, de Vicente M, Vila AM, Maritza I, Rico B, Burgos NA, Hsu BG, Wang CH, Chen CH, Yu TM, Wu MJ, Tsai SF, Hsu CT, Chiu HF, Chou KJ, Fang HC, Lee PT,  Chen HY, Chen CL, Huang CH, Ou SH, Ho TY, Hsu CY, Chang MS, Chiu YL,  Peng YS, Shu KH, Pan SY, Hsu SP, Yang JY, Pai MF, Tseng PY, Wu HY,  Tsai WC, Tung KT, Chen HY, Chen HC, Kuo MC, Daw-Yang H, Chiu YW,  Hung CC, Kuo HT, Tsai JC, McCafferty K, Forbes S, Dasgupta I, Thomas M,  Mahdi A, Ajayi B, Chowdhury P,  Kasimatis T, Moutzouris D, Dudreuilh C,  Pruthi R, Mansfield N,  Doctor G,  Shah S, Kon S, Smith P, Hamilton P, Kanigicherla D, Ragy O, Alchi B, Flossmann O, Ghalli F,  Lawman S, Sinha S,  Chrysochou C, Chukwu C,  De Bhailis AM,  Chalabi SA, Hudson A, Gopu A,  Wickens O, Storrar J,  Wahba M, Lorde N, Rony M,  Griffin S, Latif F, Mohammad Ali M, DaSilva L, Ayling-Smith J, Mahdi E, Willcocks L, Jones R, Cheung CK, Selvaskandan H, Pugh D, Sayer M, Dhaun N, Chapman F, Mark P,  Geddes C, McQuarrie E, Patel  R, Solomon L, Ponnusamy A, Morrism A, Okoh P, Floyd L, Dhaygude A, Leung J, Goldsmith C, Pandya B, Tez D,  Mikhail A, Brown K, Bucknall T, Lambie M, Comunale R, Brandon D, Martinez S, Hall A, Henderson A, Fearday A, Douthit N, Snow B, Silva A, Sly C, Keller C,  Davidson R, Meng J, Haws R,  Kattamanchi S, Mojarrab J, Pillai U, Lafayette R, O'Shaughnessy M, Kamal F, Mehta K, Baker B, Ruiz M, Jyothinagaram P, Peri U, Paxton K, Tumlin J, McGreal K, McCarthy E, Kimber C, Gautam A, Khalil K, Nguyen V, Minasian R, Arfaania D, Daneshvari S, Zakari M, atrikyan A, Afsari R, Ayvazyan C, Fakih F, Lagatta M, Rodriguez A,  Enrique J,  Avella M,  Patak R, Kadakian J, Radhakrishnan J, Appel G, Ahn W, Nelson B, Medina A, Ahmad S, Peleg Y, Clement N, Hendren E, Bomback A, Canetta P, Spinowitz B, Charytan C, Parikh N, Kuo S, Raichoudhury R,  Dobre M, Negrea L, Padiyar A, Jittirat A, Pradhan N,  Dhelaria R, Balamuthusamy S, Madhrira M, Powell T, Lifland H, Bailey A, Ashley S,  Sightler F, Suthar, Heather Green, Samir Parikh, Isabelle Ayoub, Salem Almaani, Gabriel Contreras MP, Fornoni A, Drexler Y, Geara A, Sheridan B, Coppock G, Hogan J, Gonzalez C, Bhadra S,  Chowdhury P, Kyaw K, Tan M,  Raakesh L, Mendoza E, Viramontes V,  Chaudhry A, Carbonell J, Gadh R,  Fernandez V, Kassem M, Jacob R, Wilder K, Newsome B, Klamm K, Suyumova I, Kooienga LA,Janko C, Rizk D, Julian B, Caster D, Perez E, Garg G,  Gowda N, Udani S, Mandayam S, Workeneh B, Comunale R, Brandon D, Pillai U, Assefi A, Greco B, Germain M, Patel J, Quinn S, Sullivan J, Glaze J, Madonia P, McMahon K, Giles H,  Adler S, Dai T: Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. The Lancet 2023;401:1584-1594
11. Ruhe J, Giszas B, Schlosser M, Reuken P, Wolf G, Stallmach A: Immunadsorption zur Therapie des Fatigue-dominanten Long-/Post-COVID-Syndroms. Fallserie eines standardisierten individuellen Heilversuchs. Dtsch Arztebl 2023;120:499-500
12. Busch M, Wanner C, Wolf G: KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung – Update 2022. Die Nephrologie 2023;18:160–170
13. Cejka V, Störk S,  Nadal J, Schmid M, Sommerer C, Sitter T, Meiselbach H, Busch M, Schneider MP, Saritas T, Schultheiss UT, Kotsis F, Wanner C,  Eckardt KU,  Krane V,  Schiffer M, Prokosch HU, Bärthlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D,  Alberth-Schmidt U, Hausknecht B,  Weigel A, Walz G, Köttgen A, Kotsis F, Meder S, Mitsch E, Reinhard U,  Floege J, Schaeffner E, Baid-Agrawal S,  Theisen K, Haller H,  Zeier M, Theilinger J, Wolf G, Paul R, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W: Differential prognostic utility of adiposity measures in chronic kidney disease. J Ren Nutr. S1051-2276(23)00066-3. doi: 10.1053/j.jrn.2023.04.006
14. Wulf S, Mizko L, Herrmann KH, Sánchez-Carbonell M, Urbach A, Lemke C, Berndt A, Loeffler I, Wolf G: Targeted disruption of the MORG1 gene in mice causes embryonic resorption in early phase of development. Biomolecules 2023; 13(7):1037. doi: 10.3390/biom13071037
15. Jankowski E, Schlosser M, Wiech T, Wolf G, Busch M: SARS‑CoV‑2 infection: a possible trigger for the recurrence of IgA nephropathy after kidney transplantation? Journal of Nephrology 2023, https://doi.org/10.1007/s40620-023-01684-y
16. Wolf, G: Diabetes und Niere. Nephrologie aktuell 2023;27:251
17. Wolf G: Empagliflozin für alle? Die Wunderpille schlägt erneut zu. Nephrologie aktuell 2023;27:249-250
18. Ruhe J, Nadal J, Bärthlein B, Meiselbach H, Schultheiss UT, Kotsis F, Stockmann H, Krane V, Sommerer C, Loeffler I, Saritas T, Kielstein JT, Sitter T, Schneider MP, Schmid M, Wanner C, Eckardt KU, Wolf G, Busch M: Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease - Prospective data from the German Chronic Kidney Disease cohort. Clin. Kidney J 2023;16(11):2032-2040
19. Barth J, Loeffler I, Bondeva T, Liebisch M, Wolf G: The role of hypoxia on the trimethylation of H3K27 in podocytes. Biomedicines 2023 Sep 7;11(9):2475. doi: 10.3390/biomedicines11092475. PMID: 37760919; PMCID: PMC10525388
20. Reindl J, Busch M, Wolf G: Secondary thrombotioc microangiopathy following CNI and mTOR toxicity after COVID-19 therapy with nirmaltrevir/ritonavor in a kidney transplant patient. Clin Nehrol 2023;100:143-144
21. Neubig M, Wolf G: Lautstärke in der Krankenhausdialyse des Uniklinikums Jena. Gibt es eine Beeinflussung der Lebensqualität? Nephrologie aktuell 2023;27:436-441
22. Canney M, Induruwage D, Tang M,  Alencar de Pinho N, Er L, Zhao Y, Djurdjev O,  Ahn Y, Behnisch R, Calice-Silva V, C Chesnaye N,  de Borst MH,  Dember LM,  Dionne J,  Ebert N, Eder S,  Fenton A,  Fukagawa M,  Furth SL,  Hoy WE,  Imaizumi T,  Jager KJ, Jha V,  Kang HG, Kitiyakara C, Mayer G,  Oh KH, Onu U,  Pecoits-Filho R,  Reichel H, Richards A, Schaefer F, Schaeffner E,  Scheppach JB,  Sola L, UlasiI I,  Wang J,  Yadav AK, Zhang J,  Feldman HI,  Taal MW,  Stengel B,  Levin A,  Ahn C, Berger SP,  Caskey FJ,  Cho MH,  Cho H, Dekker FW,  Diwan V, Drechsler C, Eckardt KU, Evans M, Ferreiro M,  Floege J, GadolaL, Haller H, Han KH, Healy HG, Heerspink HL, Hemmelder M,  Hiemstra T,  Hilbrands L,  Kim SH,  Klyprayong P, Köttgen A,  Kronenberg F, Lamadrid V,  Lee JH,  Mark P,  Matheson M, Mi E, Noppakun K, Oefner P,  Panaput T, Park YS,  Prokosch HU, Reis A,  Rios P, Rosivall L,  Rotmans JI,  Sackeyfio A, Sangthawan P, Schmid M,  Shin JI, Silavarino R, Sitter T, Sommerer C, Szymczak M, Torino C, Toth J, van Ittersum FJ,  Venuthurupalli KS,  Verhaar MC,  Wang Z, Wanner C, Wiecek A, Wolf G, de Zeeuw D, Zhang L, Zheng Y,  Zhao MH,  Zietse R: Regional variation in hemoglobin distribution among individuals with CKD: the ISN international network of CKD cohorts. Kidney Int. Rep. 2023;12;8(10):2056-2067
23. Gerdes C, Müller N, Wolf G, Busch M: Nephroprotective properties of antidiabetic drugs. J.Clin. Med. 2023;2:3377. https://doi.org/10.3390/jcm12103377
24. Loeffler I, Wolf G: Diabetische Nephropathie. Geschlechtspezifische Aspekte bei der Genese. Nephrologie aktuell 2023;27:252-260
25. Müller N, Busch M, Gerdes C, Wolf G: Effektive antidiabetische Therapie zur Vorbeugung einer diabetischen Nephropathie. Antidiabetika als Teil eines multimodalen Therapiekonzeptes bei Typ-2- diabetes und CKD. Nephrologie aktuell 2023;27:261-270
26. Hoffmann T, Oelzner P, Wolf G, Pfeil A: Entzündlich-rheumatische Erkrankung - Diagnostik über die Gelenke hinaus. Kompendium Rheumatologie 2023;46-52
27. Oelzner P, Wolf G: Lupusnephritis: Epidemiologie, Pathogenese, Therapie und Diagnostik. Kompendium Nephrologie 2023;50-59
28. Busch M, Pfeil A, Wolf G: Nierenbeteiligung bei Vaskulitis. Nieren- und Hochdruckkrankheiten 2023;52:345-356
29. Hoffmann T, Wolf G, Pfeil A: Systemische Sklerose und die Niere. Nieren- und Hochdruckkrankheiten 2023;52:357-363
30. Pfeil A, Oelzner P, Wolf G: Rheumatoide Arthritis und Niere. Nieren- und Hochdruckkrankheiten 2023;52:364-369
31. Pfeil A, Oelzner P, Wolf G: Die Behandlung der Osteoporose bei chronischer Niereninsuffizienz: Herausforderungen und Strategien 2023. Nieren- und Hochdruckkrankheiten 2023;52:370-376
32. Eidner T, Wolf G: Nephrologische Nebenwirkungen der antirheumatischen Therapie. Nieren- und Hochdruckkrankheiten 2023;52:377-385
33. Wolf G: Are Richard Wagner’s operas a potential tool to teach medical students and young doctors humanities? Postgraduate Medical Journal,1–5 Postgraduate Medical Journal 2023;99:1120–1124
34. Mrowka R: An update on hypertension; Acta Physiol (Oxf). 2023 Mar;237(3):e13942. doi: 10.1111/apha.13942. Epub 2023 Feb 5.PMID: 36709490
35. Kang H, Hasselbeck S, Taškova K, Wang N, Oosten LNV, Mrowka R, Utikal J, Andrade-Navarro MA, Wang J, Wölfl S, Cheng X: Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo; Eur J Med Chem. 2023 Sep 5;257:115513. doi: 10.1016/j.ejmech.2023.115513. Epub 2023 May 24. PMID: 37253308
36. Mrowka R: An Artificial Intelligence Algorithm that may blow your mind; Acta Physiol (Oxf). 2023 Apr;237(4):e13923. doi: 10.1111/apha.13923. Epub 2023 Feb 15. PMID: 36606501
37. Dilz J, Auge I, Groeneveld K, Reuter S, Mrowka R: A proof-of-concept assay for quantitative and optical assessment of drug-induced toxicity in renal organoids; Sci Rep. 2023 Apr 15;13(1):6167. doi: 10.1038/s41598-023-33110-5. PMID: 37061575
38. Herold K: Hormones-Modulators of metabolism; Acta Physiol (Oxf). 2023 Jul;238(3):e14003. doi: 10.1111/apha.14003. Epub 2023 Jun 8. PMID: 37223989
39. Loeffler I, Ziller N: Sex-Related Aspects in Diabetic Kidney Disease-An Update. J Clin Med. 2023 Apr 12;12(8):2834. doi: 10.3390/jcm12082834. PMID: 37109170; PMCID: PMC10145498.
40. Winter S, Heiling B, Eckardt N, Kloos C, Axer H: Hoffmann's syndrome in the differential work-up of myopathic complaints: a case report. J Med Case Rep. 2023 Oct 31;17(1):473. doi: 10.1186/s13256-023-04184-6.
41. Mertes B, Gödde S, Kloos C, Kuniß N: Choosing an insulin injector by a structured, pharmaceutical-neutral curriculum via an informed shared decision-making process in 349 insulin-naive patients with diabetes mellitus. Acta Diabetol. 2023 Aug;60(8):1109-1112. doi: 10.1007/s00592-023-02069-0. Epub 2023 Apr 2.
42. Heiling B, Karl A, Fedtke N, Müller N, Kloos C, Grimm A, Axer H: Evaluating Diagnostic Ultrasound of the Vagus Nerve as a Surrogate Marker for Autonomic Neuropathy in Diabetic Patients. Medicina (Kaunas). 2023 Mar 8;59(3):525. doi: 10.3390/medicina59030525.
43. Schmitt A, Ehrmann D, Kuniss N, Müller N, Kulzer B, Hermanns N: Assessing fear of complications in people with type 1 and type 2 diabetes with the Fear of Diabetes Complications Questionnaire. Health Psychol. 2023 Sep;42(9):674-685. doi: 10.1037/hea0001304. Epub 2023 Jul 27.
44. Schulze PC, Bogoviku J, Westphal J, Aftanski P, Haertel F, Grund S, von Haehling S, Schumacher U, Möbius-Winkler S, Busch M: Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients with acute Decompensated Heart Failure (EMPAG-HF)". Circulation 2023;147:e75. DOI: 10.1161
45. Semo D, Obergassel J, Dorenkamp M, Hemling P, Strutz J, Hiden U, Müller N, Müller UA, Zulfikar SA, Godfrey R, Waltenberger J: The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms. J Clin Med. 2023 Feb 8;12(4):1356. doi: 10.3390/jcm12041356.
46. Mertes B, Kuniss N, Piorkowski M,  Mertes LP, Hammes HP: Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center. Exp Clin Endocrinol Diabetes 2023; 131: 182–186. doi: 10.1055/a-2002-5116
47. Pleus S, Tytko A, Landgraf R, Heinemann L, Werner C, Müller-Wieland D, Ziegler AG, Müller UA, Freckmann G, Kleinwechter H, Schleicher E, Nauck M, Petersmann A: Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2023. Diabetol Stoffwechs 2023; 18 (Suppl 2): S100-S113. DOI 10.1055/a-2075-9943
48. Tam FWK, Tumlin K, Barratt J, Rovin BH, Roberts ISD, Roufosse C, Cook HT, Bhangal G, Brown AL, Busch M, Dudhiya F, Duliege AM, Fraser DJ, Gale DP, Huang CC, Lai PC, Lee M, Masuda ES, McAdoo SP, Rosenkranz AR, Sommerer C, Sunder-Plassmann G, Szeto CC, Tang SCW, Williamson DE, Willcocks L, Vielhauer V, Kim MJ, Todd L, Zayed H, Tong-Starksen S, Lafayette R: Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy. Kidney International Reports 2023; 8, 2546-2556
49. Keyßer G, Michalsen A, Reuß-Borst M, Frohne I, Gläß M, Pfeil A, Schultz O, Seifert O, Sander O: Empfehlungen der Kommission Komplementäre Heilverfahren und Ernährung zu ayurvedischer Medizin, Homöopathie, Ernährung und mediterraner Kost. Zeitschrift für Rheumatologie 82(6): 517-531.
50. Hoffmann T, Oelzner P, Teichgräber U, Franz M, Gaßler N, Kroegel C, Wolf G, Pfeil A: Diagnosing lung involvement in inflammatory rheumatic diseases-Where do we currently stand? Frontiers in Medicine (Lausanne) 9: 1101448.
51. Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH: Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the Rheumatic Disease 82: 698-709.
52. Pfeil A, Krusche M, Proft F, Vossen D, Braun J, Baraliakos X, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Fleck M: Rheumatologische Weiterbildungsstellen in Deutschland. Zeitschrift für Rheumatologie 82: 539-551.
53. Vo Chieu VD, Vo Chieu V, Dressler F, Kornemann N, Pfeil A, Böttcher J, Streitparth F, Berthold LD, Dohna M, Renz DM, Hellms S: Juvenile idiopathic arthritis of the knee: is contrast needed to score disease activity when using an augmented MRI protocol comprising PD-weighted sequences? European Radiology 33: 3775-3784.
54. Hasseli R, Richter JG, Hoyer BF, Lorenz HM, Pfeil A, Regierer AC, Schmeiser T, Strangfeld A, Voll RE, Krause A, Reckert S, Gräßler A, Saar P, Kapelle A, Backhaus M, Blank N, Henes J, Osiek S, Knothe A, Hoese G, Brandt-Jürgens J, Maltzahn A, Specker C, Müller-Ladner U, Schulze-Koops H, COVID-19 task force of the German Society of Rheumatology collaborators; COVID19-Rheuma.de collaborators: Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases. RMD Open 9: e002998.
55. Frohne I, Keyßer G, Pfeil A: Traditionelle chinesische Medizin – Relevant für die Behandlung der rheumatoiden Arthritis? Aktuelle Rheumatologie 48: 339-348.
56. Eckstein J, Skeries V, Pöhler G, Babazade N, Kaireit T, Gutberlet M, Kornemann N, Hellms S, Pfeil A, Bucher AM, Hansmann G, Beerbaum P, Hansen G, Wacker F, Vogel-Claussen J, Wetzke M, Renz DM: Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals. Investigative Radiology, Online ahead of print.
57. Proft F, Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Raspe M, Krusche M, Pfeil A: Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST. Zeitschrift für Rheumatologie: Online ahead of print.
58. Pfeil A, Busch M, Wiech T, Oelzner P, Wolf G: Psoriasisarthritis und IgA-Nephritis – ein Patient zwei Erkrankungsbilder? Die Nephrologie 2023, https://link.springer.com/article/10.1007/s11560-023-00650-w. Online ahead of print
59. Pfeil A, Klemm P, Hueber AJ, Hoffmann T, Weise T, Oelzner P, Knop S, Müller-Ladner U, Lange U, Wolf G, Schett G, Simon D, Kleyer A: Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. Rheumatology (Oxford) 2023;Sep 22:kead508. doi: 10.1093/rheumatology/kead508. Online ahead of print
60. Pfeil A, Hoffmann T, Freesmeyer M, Oelzner P, Wolf G: Zungennekrose als klinische Manifestation einer Riesenzellarteriitis. Innere Medizin: Online ahead of print.
61. Hoffmann T, Teichgräber U, Lassen-Schmidt B, Kroegel C, Krämer M, Förster M, Renz D, Oelzner P, Böttcher J, Franz M, Wolf G, Güttler F, Pfeil A: Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis? Z Rheumatol. 2023 Oct 17. doi: 10.1007/s00393-023-01434-2. Online ahead of print.
62. Krämer S, Rauen T, Pruin K, Anslinger T, Busch M, Schmitt T, Bergner R, Mosberger S, Neumann T: POS1162 EVALUATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GPA AND MPA IN A EUROPEAN ANCA-ASSOCIATED VASCULITIS (AAV) COHORT. Annals of the Rheumatic Diseases, 82(Suppl 1), 913–913. https://doi.org/10.1136/ANNRHEUMDIS-2023-EULAR.3899 https://ard.bmj.com/content/82/Suppl_1/913.1
63. Krämer S, Rauen T, Pruin K, Anslinger T, Busch M, Schmitt T, Bergner R, Mosberger S, Neumann T: POS1173 LONG-TERM ANALYSIS OF RELAPSE RATES IN A EUROPEAN ANCA-ASSOCIATED VASCULITIS (AAV) COHORT FOR GPA AND MPA. Annals of the Rheumatic Diseases, 82(Suppl 1), 919–919. https://doi.org/10.1136/ANNRHEUMDIS-2023-EULAR.3973 https://ard.bmj.com/content/82/Suppl_1/919.1

1. Reindl J, Ludewig S, Wolf G. Typ-B-Aortendissektion mit komprimierender Raumforderung der linken Niere. Der Nephrologe 2022;17:51-54
2. Ruhe J, Schnetzke U, Kentouche K, Prims F, Baier M, Herfurth K, Schlosser M, Busch M, Hochhaus A, Wolf G. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine. Ann Hematol 2022;101:717-719
3. Bondeva T, Wolf G. Cloning of the human MORG1 promoter: Differential  regulation by hypoxia and prolyl‐hydroxylase inhibitors. Genes 2022;13,427. https://doi.org/10.3390/genes13030427
4. Schmidt S, Werner C, Goetze S, Kloos C, Wolf G. Case Report of a Rapidly progressing thyroiditis following immune checkpoint inhibitor therapy with pembrolizumab and accidential exposure to Iodine in a 30-year-old male patient with metastatic melanoma. J Case Rep Clin Images 2022,5(1): 1108
5. Winitzki D, Zacharias HU, Nadal J, Baid-Agrawal S, Schaeffner E, Schmid M, Busch M, Bergmann MM, Schultheiss U, Kotsis F, Stockmann H, Meiselbach H, Wolf G, Krane V, Sommerer C, Eckardt KU, Schneider MP, Schlieper G, Floege J, Saritas T. Educational Attainment is Associated with kidney and cardiovascular outcomes in the German CKD (GCKD) cohort. Kidney Int Rep 2022;7:1004-1015
6. Hoffmann T, Oelzner P, Franz M, Teichgräber U, Renz D, Förster M, Böttcher J, Kroegel C, Schulze PC, Wolf G, Pfeil A. Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of infammatory rheumatic disease. Arthritis Research & Therapy 2022;24:107. https://doi.org/10.1186/s13075-022-02786-x
7. Hauptmann L, von Saß N, Neuwirth T, Wiech T, Wolf G, Busch M. Therapierefraktäre arterielle Hypertonie. Die Nephrologie 2022;17:255–258
8. Schneider MP, Schmid M, Nadal J, Wanner C, Krane V, Floege J, Saritas T, Busch M, Sitter T, Friedrich N, Stockmann H, Meiselbach H, Nauck M, Kronenberg F, Eckardt KU, on behalf of the GCKD Study Investigators. Heart-type fatty acid binding protein, cardiovascular outcomes, and death: Findings from the German CKD cohort study. Am J Kidney Dis 2022;80:483-494
9. Malich L, Gühne F, Hoffmann T, Malich A, Weise T, Oelzner P, Wolf G, Freesmeyer M, Pfeil A. Distribution patterns of arterial affection and the influence of glucocorticoids on 18F-fluorodeoxyglucose positron emission tomography/CT in patients with giant cell arteritis. RMD Open 2022;8:e002464. doi:10.1136/rmdopen-2022-002464
10. Cleemen C, Müller N, Lehmann T, Voigt UA, Meller D, Kloos C, Wolf G, Müller UA, Voigt M. Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2022;130:652-659
11. Eiermann F, Schlosser M, Möbius-Winkler S, Schulze CP, Wolf G. Kontrastmittelinduzierte akute Nierenschädigung nach Koronarangiographie am Universitätsklinikum Jena. Nieren- und Hochdruckkrankheiten 2022;51:412-418
12. Herfurth K, Ruhe J, Kentouche K, Günther A, Brämer D, Eckardt  N, Busch M,  Wolf G. Refractory thrombotic thrombocytopenic purpura. Die Innere Medizin Med 2022;63:1307-1311
13. Pfeil A,  Heinz M, Hoffmann T, Weisen T, Renz DM, Franz M,  Malich A,  Driesch D, Oelzner P, Wolf G, Böttcher J. The relationship between structural analysis of the hand and clinical characteristics in psoriatic arthritis. Scientific Reports 2022;12:18913, https://doi.org/10.1038/s41598-022-23555-5
14. Wolf G. Salzkonsum und Verlust der Nierenfunktion: Effekte unabhängig vom Blutdruck? Dialyse aktuell 2022;26:403
15. Wolf G. Arterielle Hypertonie. Dialyse aktuell 2022;26:404
16. Wolf G, Amann K. Nephropathologie. Die Nephrologie 2022;6:357
17. Busch M, Wolf G. Warum ist die Nierenbiopsie bei Nierenerkrankungen das zentrale diagnostische Instrument? Fallbeispiele aus der Praxis. Die Nephrologie 2022;6:359-367
18. Hoffmann T, Gassler N, Teichgräber U, Sandhaus T, Oelzner P, Wolf G, Pfeil A. Clinical Images: Severe interstitial lung disease in Sjögren disease — What happens in the lungs? Inflammation or fibrosis? ACR Open Rheumatology 2022; V0, No. 0, pp 1–2
19. Müller N, Busch M, Wolf G. Antidiabetika zur Progressionshemmung der Nephropathie. Der Nephrologe 2022;17:34-43
20. Pfeil A, Hoffmann T, Freesmeyer M, Wolf G, Oelzner P. Entzündlich-rheumatische Erkrankungsbilder der Schulter. Thüringer Ärzteblatt 2022;2:10-12
21. Oelzner P, Wolf G, Pfeil A. Osteoporose: Differenzialindikation für antiresorptive und osteoanabole Therapie. Kompendium Rheumatologie 2022;1–8
22. Schmidt S, Kloos C, Busch M, Wolf G. Sinnvolle Diagnose und Therapie von hormonabhängigen Hypertonusformen. Dialyse aktuell 2022;26:416-423
23. Schulze PC, Bogoviku J, Westphal J, Aftanski P, Haertel F, Grund S, von Haehling S, Schumacher U, Möbius-Winkler S, Busch M. Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients with Acute Decompensated Heart Failure (EMPA-HF). Circulation 2022;146:289-298
24. Gwinner W, Karch A, Braesen JH, Abedalrazag AK, Metzger J, Naesens M, Van Loon E, Anglicheau D, Marquet P, Budde K, Matz M, Arns W, Fischereder M, Habicht A, Eisenberger U, Mühlfeld A, Busch M, Wiesener M, Scheffner I, Koch A. Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial. Transplantation Direct 2022;8:e1316
25. Busch M. Kommentar zu "IgA-Nephritis: Methylprednisolon effektiv". Dtsch Med Wochenschr 2022;147:1165-1166
26. Giszas B, Ruhe J, Schlosser M, Reuken PA, John-Kroegel U, Stallmach A, Wolf G. Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series. J Nephrol 2022;Sep 5:1-3
27. Jankowski E, Wulf S, Ziller N, Wolf G, Löffler I. MORG1—A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes. Biomedicines 2022; 10:30 https://doi.org/10.3390/biomedicines10010030
28. Heiling B, Wiedfeld LIEE, Müller N, Kobler NJ, Grimm A, Kloos C, Axer H. Electrodiagnostic Testing and Nerve Ultrasound of the Carpal Tunnel in Patients with Type 2 Diabetes. J Clin Med. 2022 Jun 13;11(12):3374. doi: 10.3390/jcm11123374.
29. Weschenfelder F, Herrmann E, Lehmann T, Schleußner E, Kloos C, Battfeld W, Groten T. Predictors of a successful vaginal delivery in women with type 1 diabetes: a retrospective analysis of 20 years. Arch Gynecol Obstet. 2022 Jun;305(6):1445-1452. doi: 10.1007/s00404-021-06255-9. Epub 2021 Sep 24
30. Gerdes C, Werner C, Kloos C, Lehmann T, Wolf G, Müller UA, Müller N. Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course. Exp Clin Endocrinol Diabetes. 2022 Feb;130(2):101-109. doi: 10.1055/a-1192-3761. Epub 2020 Aug 10.
31. Jacob VYP, Felber J, Müller N, Kloos C, Müller UA, Stallmach A. The High-Resolution Three-Dimensional Magnetic Detector System 3D-Magma Accurately Measures Gastric and Small Bowel Motility in People with Type 2 Diabetes with Neuropathy.Exp Clin Endocrinol Diabetes. 2022 Feb;130(2):94-100. doi: 10.1055/a-1163-7230. Epub 2020 Jun 18.
32. Bernard M, Lehmann T, Hecht L, Fabisch G, Harder A, Müller N, Luck-Sikorski C. Efficacy of DiaLife, an Education Program for Relatives of Adults with Diabetes - A Cluster Randomized Controlled Trial. Patient Educ Couns. 2022 Jul;105(7):2158-2165. doi: 10.1016/j.pec.2021.11.013. Epub 2021 Nov 16.
33. Müller N, Lehmann T, Müller UA, Kloos C. Is there an HbA1c Threshold for Symptoms of Chronic Hyperglycemia? Exp Clin Endocrinol Diabetes. 2022 Jun;130(6):386-392. doi: 10.1055/a-1493-0683. Epub 2021 Jun 7.
34. Keinki C, Meyer H, Bozkurt G, Müller N, Römelt J, Müller UA, Hübner J. Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion. J Relig Health. 2022 Feb;61(1):601-615. doi: 10.1007/s10943-020-01074-9.
35. Horvath LB, Böhm M, Kuniss N, Bleidorn J, Schulz S. Participation rate of diabetes patients in structured education programs and reasons for non-participation: A cross-sectional survey among patients with diabetes mellitus in Thuringia. Z Evid Fortbild Qual Gesundhwes. 2022 Sep;173:49-55. doi: 10.1016/j.zefq.2022.04.004. Epub 2022 Jun 14
36. Oelzner P, Eidner T, Pfeil A. Glukokortikoid-induzierte Osteoporose - Fokus Therapie (Teil 1). Z Rheumatol 2022;81:57-66
37. Oelzner P, Eidner T, Pfeil A. Glukokortikoid-induzierte Osteoporose - Fokus Therapie (Teil 2). Z Rheumatol 2022;81:125-133  
38. Oelzner P. Kap. "Osteoporose" in: Therapie-Handbuch Rheumatologie und Immunologie, Hrsg.: Jörg H.W. Distler, Elsevier, Urban & Fischer 2022
39. Pfeil A, Heinz M, Hoffmann T, Weise T, Renz DM, Franz M, Malisch A, Driesch D, Oelzner P, Wolf G, Böttcher J. The relationship between structural analysis of the hand and clinical characteristics in psoriatic arthritis. Sci Rep 2022:12(1):18913. doi: 10.1038/s41598-022-23555-5
40. Oelzner P, Wolf G, Pfeil A. Osteoporose: Differenzialindikation für antiresorptive und osteo-anabole Therapie. Kompendium Rheuma 2022;37-44, Georg Thieme Verlag Stuttgart 2022
41. Mrowka R. Recent advances in kidney research. Acta Physiol (Oxf). 2022 Jun;235(2):e13820. doi: 10.1111/apha.13820. Epub 2022 Apr 22.
42. Richter JF, Hildner M, Mrowka R, Schmauder R. Probing the leak pathway: Live-cell imaging of macromolecule passage through epithelia. Ann N Y Acad Sci. 2022 Oct;1516(1):151-161. doi: 10.1111/nyas.14847. Epub 2022 Jun 29.
43. Zuieva A, Can S, Boelke F, Reuter S, Schattscheider S, Töpfer E, Westphal A, Mrowka R, Wölfl S. Real-time monitoring of immediate drug response and adaptation upon repeated treatment in a microfluidic chip system Arch Toxicol. 2022 May;96(5):1483-1487. doi: 10.1007/s00204-022-03272-8. Epub 2022 Mar 19.
44. Labes R, Dong L, Mrowka R, Bachmann S, von Vietinghoff S, Paliege A. Annexin A1 exerts renoprotective effects in experimental crescentic glomerulonephritis Front Physiol. 2022 Oct 12;13:984362. doi: 10.3389/fphys.2022.984362. eCollection 2022.
45. Keymling M, Schlemmer HP, Kratz C, Pfeil A, Bickelhaupt S, Alsady TM, Renz DM. Li-Fraumeni syndrome. Radiologie (Heidelb). 2022;62(12):1026-1032
46. Izadi Z, Gianfrancesco MA, Aguirre A, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Seet AM, Schmajuk G, Jacobsohn L, Katz P, Rush S, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ribeiro SLE, de Oliveira Marinho A, de Azevedo Valadares LD, Giuseppe DD, Hasseli R, Richter JG, Pfeil A, Schmeiser T, Isnardi CA, Reyes Torres AA, Alle G, Saurit V, Zanetti A, Carrara G, Labreuche J, Barnetche T, Herasse M, Plassart S, Santos MJ, Rodrigues AM, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Yazdany J, Global Rheumatology Alliance Registry. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. ACR Open Rheumatol 2022;4(10):872-882
47. Pfeil A, Schuch F, Fleck M. Weiterbildung in der Rheumatologie – Stand 2022. Zeitschrift für Rheumatologie 2022;81(6):482-486
48. Pfeil A. Editorial: Calcium Pyrophosphate Crystal Deposition in Gitelman Syndrome: Which joint is affected? Rheumatology (Oxford) 2022;61(6):2211-2212
49. McInnes IB, Szekanecz Z, McGonagle D, Maksymowych WP, Pfeil A, Lippe R, Song IH, Lertratanakul A, Sornasse T, Biljan A, Deodhar A. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology (Oxford) 2022;61(5):1783-1794
50. Leipe J, Holle JU, Weseloh C, Pfeil A, Krüger K; die Kommission Pharmakotherapie der Deutschen Gesellschaft für Rheumatologie e. V. (DGRh). Erratum to: German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version]. Zeitschrift für Rheumatologie; 81(3):263
51. Bäz L, Grün K, Diab M, Pfeil A, Jung C, Möbius-Winkler S, Schulze PC, Franz M. Prediction of one- and two-year mortality after transcatheter aortic valve implantation: proposal of a fast sum-score system integrating a novel biomarker of cardiac extracellular matrix accumulation and fibrosis. Reviews in Cardiovascular Medicine 2022;23(2): 62
52. Renz DM, Huisinga C, Pfeil A, Böttcher J, Schwerk N, Streitparth F, Weidemann J. Röntgenuntersuchungen des Thorax bei Kindern und Jugendlichen. Radiologe 2022;62(2):140-148
53. Buxha F, Pfeil A. Interstitielle Lungenerkrankungen – Neue Ansätze und Perspektiven. Thüringer Ärzteblatt 2022;33: 29-32
54. Renz DM, Herrmann KH, Kraemer M, Boettcher J, Waginger M, Krueger PC, Pfeil A, Streitparth F, Kentouche K, Gruhn B, Mainz JG, Stenzel M, Teichgraeber UK, Reichenbach JR, Mentzel HJ. Ultrashort echo time MRI of the lung in children and adolescents: comparsion with non-enhanced computed tomography and standard post-contrast T1w MRI sequences. European Radiology 2022;32:1833-1842
55. Vo Chieu VD, Vo Chieu V, Dressler F, Kornemann N, Pfeil A, Böttcher J, Streitparth F, Berthold LD, Dohna M, Renz DM, Hellms S. Juvenile idiopathic arthritis of the knee: is contrast needed to score disease activity when using an augmented MRI protocol comprising PD-weighted sequences? Eur Radiol 2022; DOI: 10.1007/s00330-022-09292-3
56. Pfeil A, Krusche M, Proft F, Vossen D, Braun J, Baraliakos X, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Fleck M. Rheumatologische Weiterbildungsstellen in Deutschland. Z Rheumatol 2022;https://doi.org/10.1007/s00393-022-01284-4
57. Kheirkhah A, Lamina C, Kollerits B, Schachtl-Riess JF, Schultheiss UT, Forer L, Sekula P, Kotsis F, Eckardt KU, Kronenberg F, for the GCKD Investigators, GCKD Investigators (Eckardt KU, Meiselbach H, Schneider MP, Schiffer M, Prokosch HU, Bährtlein B, Beck A, Reis A, Ekici AB, Becker S, Becker-Grosspitsch D, Alberth-Schmidt U, Hausknecht B, Weigel A, Walz G, Köttgen A, Schultheiß UT, Kotsis F, Meder S, Mitsch E, Reinhard U, Floege J, Saritas T, Schaeffner E, Baid-Agrawal S, Theisen K, Haller H, Menne J, Zeier M, Sommerer C, Theilinger J, Wolf G, Busch M, Paul R, Sitter T, Wanner C, Krane V, Börner-Klein A, Bauer B, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weissensteiner H, Oefner P, Gronwald W, Schmidt M, Nadal J). PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function. Clin J Am Soc Nephrol 2022;17:809-818

1   Hoffmann T, Oelzner P, Busch M, Franz M, Teichgräber U, Kroegel C, Schulze PC, Wolf G, Pfeil A. Organ Manifestation and             Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases. Diagnostics (Basel). 2021 Dec 29;12(1):67.           doi: 10.3390/diagnostics12010067. PMID: 35054234

2   Jankowski E, Wulf S, Ziller N, Wolf G, Loeffler I. MORG1-A Negative Modulator of Renal Lipid Metabolism in Murine Diabe           tes. Biomedicines. 2021 Dec 23;10(1):30. doi: 10.3390/biomedicines10010030.

3   Jahn L, Rüster C, Schlosser M, Winkler Y, Foller S, Grimm MO, Wolf G, Busch M. Rate, Factors and Outcome of Delayed Graft      Function After Kidney Transplantation of Deceased Donors. Transplant Proc 2021;53:1454-1461

4   Ruhe J, Gröne HJ, Schlosser M, Kroegel C, Wolf G, Busch M. IgM-MGUS and associated membranoproliferative glomerulone       phritis during IVIG administration. Ann Hematol 2021;100:1087-1088

5   Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Gale         sic K, Griffin S, von den Hoogen MWF, Hrušková Z, Jeyabalan A, Karra A, King C, Kohli HS, Mayer G, Maas R, Muto M, Moiseev       S, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Schönermarck U, Segelmark M, Smith L,       Tesař V, Wetzels J, Willcocks M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Rituximab in Membranous Nephropa       thy. Kidney Int Rep 2021;6:881-893

6   Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, Lipovsek J, Meiselbach H, Busch M, Eckardt KU,         Kronenberg F; GCKD Investigators.  Association of the metabolic syndrome with mortality and major adverse cardiac               events: A large chronic kidney disease cohort. J Intern Med 2021;290:1219-1232.

7    Busch M. Harnwegsinfektionen nach Nierentransplantation. Nieren- und Hochdruckkrankheiten 2021;50(4):135-145

8   Busch M, Mann J, Wolf G. KDIGO-Leitlinie zur Behandlung des Diabetes mellitus bei chronischer Nierenerkrankung - Deut         sche Übersetzung und Kurzfassung. Nephrologe 2021;16:169-176

9   Busch M, Wolf G. Arterielle Hypertonie: Kompendium Nephrologie 2021;13:64-71

10 Eidner T, Wolf G, Oelzner P. Risikostratifizierung in der Rheumatologie: Analgetika-Therapie. Akt Rheumatol 2021; 46: 179-        186. doi 10.1055/a-1373-3883

11 Gühmann M, Reuter S, Hartung J, Mrowka R. Preselector.uni-jena.de: optimize your cloning-a resource for identifying               restriction enzymes for preselection reactions. Nucleic Acids Res. 2021 Jul 2;49(W1):W541-W543. doi: 10.1093/nar/gkab406.         PMID: 34037777; PMCID: MC8262699.

12 Mrowka R. From small molecules to dinosaurs - Recent advances in blood pressure research. Acta Physiol (Oxf). 2021               Jul;232(3):e13677. doi: 10.1111/apha.13677. Epub 2021 May 27. PMID: 33998149.

13 Hassan MIA, Keller M, Hillger M, Binder U, Reuter S, Herold K, Telagathoti A,  Dahse HM, Wicht S, Trinks N, Nietzsche S, De         ckert-Gaudig T, Deckert V, Mrowka R, Terpitz U, Peter Saluz H, Voigt K.  The impact of episporic modification of Lichtheimia       corymbifera on virulence and interaction with phagocytes. Comput Struct Biotechnol J. 2021 Jan 20;19:880-896. doi:                   10.1016/j.csbj.2021.01.023. PMID: 33598103; PMCID: PMC7851798.

14 Auge I. Renal failure in focus, Acta Physiol (Oxf) . 2021 May;232(1):e13645.doi: 10.1111/apha.13645.

15 Oelzner P, Wolf G. Lupusnephritis. Kompendium Nephrologie 2021:26-34

16 Oelzner P, Wolf G. Risikostratifizierung bei ANCA-assoziierten Vaskulitiden. Akt Rheumatol 2021;46:155-167

17 Oelzner P, Wolf G. Risikostratifizierung ausgewählter schwerer Organbeteiligungen bei systemischer Sklerose und bei Lu          pus-Nephritis. Akt Rheumatol 2021;46:168-178

18 Pfeil A, Oelzner P, Renz D, Wolf G, Böttcher J. Sind röntgenologische Scoring-Methoden als Parameter zur Verlaufsbeurtei         lung der rheumatoiden Arthritis noch zeitgemäß ? Akt Rheumatol 2021;46:149-154

19 Pfeil A, Franz M, Hoffmann T, Klemm P, Oelzner P, Müller-Ladner U, Hueber AJ, Lange U, Wolf G, Schett G, Simon D, Kleyer        A. Virtual teaching for medical students during SARS-CoV-2 pandemic. Clin Exp Rheumatol 2021;39:1447-1448

20 Hoffmann T, Mawrin C, Oelzner P, Wolf G, Pfeil A. Musculoskeletal ultrasound can aid in diagnosis and follow-up of a pati         ent with eosinophilic fasciitis. J Clin Rheumatol 2021;27:784-785

21 Müller N, Lehmann T, Müller UA, Kloos C. Is there an HbA1c Threshold for Symptoms of Chronic Hyperglycemia? Exp Clin           Endocrinol Diabetes. 2021 Jun 7. doi: 10.1055/a-1493-0683. Online ahead of print.

22 Kuniss N, Kramer G, Müller UA, Wolf G, Kloos C. Diabetes related distress is high in inpatients with diabetes. Diabetol               Metab Syndr. 2021 Apr 9;13(1):40. doi: 10.1186/s13098-021-00659-y.

23 Kloos C, Burghardt K, Müller UA, Kramer G, Müller N, Wolf G, Kuniss N. Reduction of Severe Hypoglycaemia in People with        Type 2 Diabetes after a Structured Inpatient Intervention. Exp Clin Endocrinol Diabetes. 2021 Aug;129(8):587-592. doi:                10.1055/a-0983-1559. Epub 2019 Sep 5.

24 Hopf M, Kloos C, Wolf G, Müller UA, Müller N.  Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of       Patients with Diabetes Mellitus Type 2. J Clin Med. 2021 Feb 3;10(4):571. doi: 10.3390/jcm10040571.

25 Weschenfelder F, Herrmann E, Lehmann T, Schleußner E, Kloos C, Battefeld W, Groten T. Predictors of a successful vaginal       delivery in women with type 1 diabetes: a retrospective analysis of 20 years. Arch Gynecol Obstet. 2021 Sep 24. doi:                   10.1007/s00404-021-06255-9.. Online ahead of print.

26 Kramer G, Michalak L, Müller UA, Kloos C, Werner C, Kuniss N. Association between Flash Glucose Monitoring and Metabo         lic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1. Exp Clin Endocrinol Diabetes. 2021                 Mar;129(4):303-308. doi: 10.1055/a-0875-3988. Epub 2019 Jun 11.

27 Kramer G, Kloos C, Müller UA, Wolf G, Kuniss N. Metabolic control and hypoglycaemia in people with type 1 diabetes: insu         lin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care. Diabetol Metab Syndr. 2021 Jul           23;13(1):80. doi: 10.1186/s13098-021-00700-0.

28 Dargel S, Schleußner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during                   pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy       Childbirth. 2021 Aug 12;21(1):552. doi: 10.1186/s12884-021-04035-6.

29 Roth J, Müller N, Kuniss N, Wolf G, Müller UA. Association Between Glycaemic Control and the Intake of Thiazide Diuretics,         Beta Blockers and Levothyroxine in People Without Diabetes. Exp Clin Endocrinol Diabetes. 2021 Jun;129(6):443-448. doi:          10.1055/a-0919-4525. Epub 2019 Jul 1.

30 Bernard M, Lehmann T, Hecht L, Fabisch G, Harder A, Müller N*, Luck-Sikorski C. Efficacy of DiaLife, an Education Program         for Relatives of Adults with Diabetes - A Cluster Randomized Controlled Trial. Patient Educ Couns. 2021 Nov 16:S0738-               3991(21)00734-5. doi: 10.1016/j.pec.2021.11.013. Online ahead of print.

31 Busch M, Lehmann T, Wolf G, Günster C, Müller UA, Müller N. Antidiabetic Therapy and Rate of Severe Hypoglycaemia in Pa       tients with Type 2 Diabetes and Chronic Kidney Disease of Different Stages - A Follow-up Analysis of Health Insurance             Data from Germany. Exp Clin Endocrinol Diabetes. 2021 Nov;129(11):821-830. doi: 10.1055/a-1129-6699. Epub 2020 Apr 14.

32 Spraul AMS, Schönbach AM, Müller N, Müller UA, Koller A, Spraul M. Long-term outcome of persons with diabetic and non-       diabetic neuro-osteoarthropathy after foot correction using external fixation. Diabet Med. 2021 Apr;38(4):e14404. doi:               10.1111/dme.14404.

33 Horvath LB, Müller N, Kuniß N, Bleidorn J, Schulz S. Gründe für die Nicht-Teilnahme von Diabetespatient*innen an einer           strukturierten Schulung: ein narrativer Review. Z Allg Med. 2021;97:26-31

34 Voigt M, Sinn K, Malouhi A, Gecks T, Zinke J, Hilgendorf I, Scholl S, Hochhaus A, Schnetzke U. HHV-6 encephalitis in a non-         transplanted adult acute myeloid leukemia patient. Ann Hematol2021 Jul;100(7):1895-1897. doi: 10.1007/s00277-021-04409-y.

35 Wolf G. Buchrezension-Pommer/Thumfart: Palliative Nephrologie. Der Nephrologe 2021;16:414

36 Eisfeld H, Kircher S, Rosenwald A, Anagnostopoulos I, Werner M, Gaßler N, Wolf G, Lehmkuhl L, Teichgräber U, Gühne F,             Darr A, Freesmeyer M, Weschenfelder W, Hofmann G, Kalkilic R, Kalff R, Hochhaus A, Schreink KG. Revealing the true face         behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL). Ann Hematol 2021;100:1107-1109

37  Renz DM, Herrmann KH, Kraemer M, Boettcher J, Waginger M, Krueger PC, Pfeil A, Streitparth F, Kentouche K, Gruhn B,                Mainz JG, Stenzel M, Teichgraeber UK, Reichenbach JR, Mentzel HJ      Ultrashort echo time MRI of the lung in children and        adolescents: comparison with non-enhanced computed tomography and standard post-contrast T1w MRI sequences. Eu          ropean Radiology 2021; Online ahead of print.

38  Hasseli R, Pfeil A, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C. A survey to evaluate knowledge, perceptions            and attitudes toward COVID‑19 vaccinations among rheumatologists in Germany. Rheumatology International 2021;41:              1949-1956

39  Regierer AC, Hasseli R, Schäfer M, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schmeiser T, Schulze-Koops H, Strang          feld A, Voll RE, Specker C, Mueller-Ladner U. TNFi is associated with positive outcome, but JAKi and rituximab are associa        ted with negative outcome of SARS-CoV-2 infection in patients with RMD. RMD Open 2021;7: e001896.

40  Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hy        rich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda        Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S,        Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks        JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S,        Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN,                Smith CH, Yazdany J, Kappelman MD. Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 In            fection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease          (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epi          demiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for In            flammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Alliance (GRA) (2021) Association Bet            ween Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated          Inflammatory Disease and COVID-19. JAMA 2021;Netw Open 4: e2129639.

41  Klemm P, Kleyer A, Tascilar K, Schuster L, Meinderink T, Steiger F, Lange U, Müller-Ladner U, Knitza J, Sewerin P, Mucke J,            Pfeil A, Schett G, Hartmann F, Hueber AJ, Simon D   A virtual reality based educational application for knowledge transfer        on rheumatic and musculoskeletal diseases. JMIR Serious Games 2021;9: e23835.

42  Hasseli R, Pfeil A, Hoyer BF, Krause A, Lorenz HM, Richter JG, Schmeiser T, Voll RE, Schulze-Koops H, Specker C, Müller-Lad        ner U. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloar          thritis? Clin Exp Rheumatology 2021;39: 639-647.

43  Gouyou B, Grün K, Kerschenmeyer A, Villa A, Matasci M, Schrepper A, Pfeil A, Bäz L, Jung C, Schulze PC, Neri D, Franz M.              Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension.             Int J Mol Sci 2021;22:3460.

44   Radeva M, Predel D, Winzer S, Teichgräber U, Pfeil A, Malich A, Papageorgiou I Reliability of a Risk-Factor Questionnaire           for Osteoporosis: A Primary Care Survey Study with Dual Energy X-ray Absorptiometry Ground Truth. Int J Env Res Pub               Health 2021;18:1136.

45   Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter JG, Schmeiser T, Strangfeld A, Schulze-Koops         H, Voll RE, Specker C, Regierer AC. Older age, comorbidity and glucocorticoid use are risk factors for COVID-19 hospitali             sation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD open 2021;7:e001464

46   Teichgräber U, Ingwersen M, Mentzel HJ, Aschenbach R, Neumann R, Franiel T, Herzog A, Böttcher J, Pfeil A, Mensel B,                 Freesmeyer M, Fischer MR, Zottmann JM. Wirkung eines Heutagogischen, Multimedialen Lehrkonzepts zur Förderung des         Selbstbestimmten und Kooperativen Lernens von Medizinstudierenden in der klinischen Radiologie. RöFo 2021;193:701-           711.

47   McInnes IB, Szekanecz Z, McGonagle D, Maksymowych WP, Pfeil A, Lippe R, Song IH, Lertratanakul A, Sornasse T, Biljan A,          Deodhar A.    A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheu        matology 2021; online ahead of print.

48  Hasseli R, Pfeil A, Hoyer BF, Lorenz HM, Regierer AC, Richter JG, Schmeiser T, Strangfeld A, Voll RE, Krause A, Schulze-Ko            ops H, Müller-Ladner U, Specker C. Deutsches Register www.Covid19-Rheuma.de - Statusbericht nach 1 Jahr der Pande            mie. Zeitschrift für Rheumatologie 2021;80: 641-646.

49  Klemm P, Pfeil A, Kleyer A, Siomn D. Virtual-Reality-basierte Konzepte in der Medizin und der Rheumatologie. Arthritis              und Rheuma 2021;41: 204-207

50  Glutig K, Pfeil A, Renz DM. Bildgebung bei Tumorprädispositionssyndromen. Radiologe 2021;61: 658-666

51  Pfeil A, Oelzner P, Hoffmann T, Renz DM, Wolf G, Böttcher J. Radiologische Progression der rheumatoiden Arthritis – ein           zeitgemäßer Parameter zur Verlaufsbeurteilung? Aktuelle Rheumatologie 2021;46: 149-154

52  Pfeil A, Renz DM, Oelzner P, Wolf G, Böttcher J, Lange U. Axiale versus periphere Osteoporose – Eine differentialdiagnosti          sche Betrachtung. Arthritis und Rheuma 2021;41: 20-22.

53  Pfeil A, Oelzner P, Hoffmann T, Renz DM, Wolf G, Böttcher J. Die periartikuläre Demineralisation bei rheumatoider Arthri            tis. Arthritis und Rheuma 2021;41: 36-40.

54  Pfeil A, Fleck M, Keyßer G. Weiterbildungssituation in der Rheumatologie aus Sicht der Weiterbilder. Zeitschrift für Rheu          matologie 2021;80: 22-26

55  Leipe J, Holle UJ, Weseloh C, Pfeil A, Krüger K. Empfehlungen der Deutsche Gesellschaft für Rheumatologie zum Manage          ment der Glukokortikoid-induzierte Osteoporose. Zeitschrift für Rheumatologie 2021;80:670-687

56  Pfeil A, Krusche M, Vossen D, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J,          Baraliakos X, Fleck M, Proft F. Mustercurriculum der Deutschen Gesellschaft für Rheumatologie für die Weiterbildung im          Fachgebiet Innere Medizin und Rheumatologie. Zeitschrift für Rheumatologie 2021;80: 688-691

57  Pfeil A. Editorial: Calcium Pyrophosphate Crystal Deposition in Gitelman Syndrome: Which joint is affected? Rheumato            logy 2021; ahead of print

58  Pfeil A, Maus U. Editorial Osteoporose. Arthritis und Rheuma 2021;41: 8-9.

59  Keinki C, Meyer H, Bozkurt G, Müller N, Römelt J, Müller UA, Hübner J. Salvation Expectations of Patients of Medicine, Com        plementary and Alternative Medicine and Religion; Journal of Religion and Health 2020; doi.org/10.1007/s1094. ahead of          print

60  Jacob VYP, Felber J, Müller N, Kloos C, Müller UA, Stallmach A. The High-Resolution Three-Dimensional Magnetic Detector        System 3D-Magma Accurately Measures Gastric and Smal Bowel Motility in People with Type 2 Diabetes with Neuropathy.        Exp Clin Endocrinol Diabetes; published online: 2020; doi.org/10.1055/a-1163-7230; ahead of print

1. Mirna M, Topf A, Wernly B, Rezar R, Paar V, Jung C, Salmhofer H, Kopp K, Hoppe UC, Schulze PC, Kretzschmar D, Schneider MP, Schultheiss UT, Sommerer C, Paul K, Wolf G, Lichtenauer M, Busch M. Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study. J Clin Med 2020 Mar 24; 9 (3): 886; doi:10.3390/jcm9030886
2. Wolf G, Haller H. Diabetische Nephropathie. Neue Therapieoptionen für ein großes klinisches Problem. Der Nephrologe 2020; 15:135
3. Wolf G. Systemerkrankungen und Niere. Dialyse aktuell 2020; 24:205
4. Wolf G. Journal Club. SGLT2-Inhibitoren. Sind die protektiven Effekte auf renale und kardiovaskuläre Endpunkte durch eine Senkung der Harnsäure bedingt? Dialyse aktuell 2020; 24:204
5. Eisfeld H, Kircher S, Rosenwald A, Anagnostopoulos I, Werner M, Gaßler N, Wolf G, Lehmkuhl L, Teichgräber U, Gühne F, Darr A, Freesmeyer M, Weschenfelder W, Hofmann G, Dalkilic R, Kalff R, Hochhaus A, Schrenk KG. Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL). Ann Hematol. 2020 https://doi.org/10.1007/s00277-020-04247-4
6. Löffler I, Wolf G. Geschlechtsunterschiede bei der diabetischen Nephropathie. Der Nephrologe 2020; 15(3): 136–144
7. Bondeva T, Schindler K, Schindler C, Wolf G. Ramipril pretreatment worsened renal injury and survival despite a reductionin renal inflammation in experimentally induced sepsis in mice. J Renin Angiotensin Aldosterone Syst 2020; 21:1-8
8. Liebisch M, Wolf G. AGE-induced suppression of EZH2 mediates injury of podocytes by reducing H3K27me3. Am J Nephrol 2020; 51:676–692
9. Ziller N, Kotolloshi R, Esmaeili M, Liebisch M, Mrowka R, Baniahmad A, Liehr T, Wolf G, Loeffler I. Sex Differences in Diabetes- and TGF-ß1-Induced Renal Damage. Cells. 2020 Oct; 9(10): 2236
10. Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Budde K, Mertens PR, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J, Moeller MJ, Weihprecht H, Budde K, Peters H, Elitok S, Bieringer M, Schindler R, Frei U, Canaan-Kühl S, Erley C, Schlieps K, Kuhlmann U, Zandvoort F, Hohenstein B, Hugo C, Palm C, Hilgers K, Haller H, Bertram A, Wolf G, Busch M, Rath T, Ziefle S, Benzing T, Grundmann F, Westphalen S, Benck U, Göttmann U, Fischereder MI, Sarkar O, Stefanidou M, Otte B, Pavenstädt H, Banas B, Boeger A, Heyne N, Artunc F, Reichel H, Mettang T, Wanner C,  Metzger T. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. Kidney Int. 2020; 98:1044-1052
11. Kache T, Mrowka R. Did you know? How Simulations May Help Us to Understand the Dynamics of COVID-19 Spread. - Visualizing Non-Intuitive Behaviours of a Pandemic (pansim.uni-jena.de). Acta Physiol (Oxf). 2020 Aug;229(4):e13520. doi: 10.1111/apha.13520. Epub 2020 Jun 21. PMID: 32497348; PMCID: PMC7300557
12. Mrowka R. Recent advances in blood pressure research. Acta Physiol (Oxf). 2020 Jan;228(1):e13412. doi: 10.1111/apha.13412. Epub 2019 Nov 26. PMID: 31721449
13. Kirchner S, Reuter S, Westphal A, Mrowka R. Decipher the complexity of cis- regulatory regions by a modified Cas9. PLoS One. 2020 Jul 2;15(7):e0235530. doi: 10.1371/journal.pone.0235530. PMID: 32614871; PMCID: PMC7332081
14. Auge I. Intracellular events in diabetes mellitus - Behind the scenes; Acta Physiol (Oxf) 2020 May;229(1):e13468. doi: 10.1111/apha.13468. Epub 2020 Mar 25
15. Mrowka R. Kidney research. Acta Physiol (Oxf). 2020 Dec;230(4):e13569. doi:10.1111/apha.13569. Epub 2020 Nov 3. PMID: 33063924
16. Ruhe J, Giszas B, Wiech T, Busch M, Wolf G. Hyperkalzämie, Kraftlosigkeit und akutes Nierenversagen. Der Nephrologe 2020 (4); 15:248-250
17. Ritter C, Hofmann U, Busch M, Wolf G. Erfolgreiche Nierentransplantation nach 11 Jahren automatisierter nächtlicher Peritonealdialyse mit nur einer Peritonitis. Nieren- und Hochdruckkrankheiten 2020; 49: 554-558
18. Busch M, Wolf G. Diabetische Nephropathie - eine aktuelle Übersicht. Dialyse aktuell 2020; 24: 212-221.
19. Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol. 2020;9(4):661-677
20. Stengel S, Quickert S, Lutz P, Ibidapo-Obe O, Steube A, Köse-Vogel N, Yarbakht M, Reuken PA, Busch M, Brandt A, Bergheim I, Deshmukh SD, Stallmach A, Bruns T. Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis. Gastroenterology 2020 May;158(6):1745-1761
21. Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? Autoimmun Rev. 2020 Nov;19(11):102671
22. Kronbichler A, Shin JI, Lee KH, Nakagomi D, Quintana LF, Busch M, Craven A, Luqmani RA, Merkel PA, Mayer G, Jayne DRW, Watts RA. Clinical associations of renal involvement in ANCA-associated vasculitis. Autoimmun Rev. 2020 Apr;19(4):102495
23. Ruhe J, Gröne HJ, Schlosser M, Kroegel C, Wolf G, Busch M. IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration. Ann of Hematol 2020; May 4; doi: 10.1007/s00277-020-04046-x. Online ahead of print
24. Busch M, Lehmann T, Wolf G, Günster C, Müller UA, Müller N. Antidiabetic Therapy and Rate of Severe Hypoglycaemia in Patients with Type 2 Diabetes and Chronic Kidney Disease of Different Stages - A Follow-up Analysis of Health Insurance Data from Germany. Exp Clin Endocrinol Diabetes. 2020 Apr 14. doi: 10.1055/a-1129-6699. Online ahead of print.
25. Hoffmann T, Mawrin C, Oelzner P, Wolf G, Pfeil A. Musculoskeletal Ultrasound Can Aid in Diagnosis and Follow-up of a Patient With Eosinophilic Fasciitis. J Clin Rheumatol. 2020 Sep 23. doi: 10.1097/RHU.0000000000001477
26. Hoffmann T, Oelzner P, Böttcher J, Wolf G, Pfeil A. Analyse der Zuweisungsdiagnose in der internistischen Rheumatologie. Z Rheumatol. 2020; 79:160-167
27. Pfeil A, Franz M, Wolf G, Freesmeyer M. Refractory giant cell arteritis: the value of clinical symptoms and imaging. BMJ 2020; Case Rep 13:e237623
28. Franz M, Renz D, Wolf G, Pfeil A. Granulomatosis with Polyangiitis Mimics ST-elevation Myocardial Infarction. BMJ 2020; Case Rep.13(5):e234728
29. Betge S, Drinda S, Neumann T, Bäz L, Pfeil A, Schulze C, Mrowka R, Jung C, Franz M. Influence of Macitentan on the Vascular Tone and Recruitment of Finger Capillaries Under Hypobaric Hypoxia in High Altitude. High Alt Med Biol. 2020 Dec;21(4):336-345. doi: 10.1089/ham.2019.0120. Epub 2020 Jul 31. PMID: 32758029
30. Pfeil A, Nussbaum A, Renz DM, Hoffmann T, Malich A, Franz M, Oelzner P, Wolf G, Böttcher J. Radiographic remission in rheumatoid arthritis quantified by computer-aided joint space analysis (CASJA): A Post-Hoc Analysis of the RAPID 1 Trial. Arthritis Res Ther 2020; 6;22(1):229. doi:10.1186/s13075-020-02322-92020
31. Oelzner P, Amann K, Wolf G. Nierenbeteiligung bei Kollagenosen – Teil 1: Lupus-Nephritis. Akt Rheumatol 2020; 45: 150-162
32. Oelzner P, Amann K, Wolf G. Nierenbeteiligung bei Kollagenosen – Teil 2: Antiphospholipid-Syndrom, primäres Sjögren-Syndrom, systemische Sklerose.  Akt Rheumatol 2020; 45: 163-172
33. Pfeil A, Busch M, Lupp A, Lehmann G, Oelzner P, Wolf G. Innovative rheumatologische und osteologische Medikation im Kontext der chronischen Niereninsuffizienz – Was ist möglich? Akt Rheumatol 2020; 45: 173-179
34. Lehmann G, Pfeil A, Oelzner P, Wolf G. Renale Osteodystrophie. Akt Rheumatol 2020; 45: 180-186
35. Lehmann G, Wolf G. Langzeitverlauf einer X-chromosomalen Hypophosphatämie (Phosphatdiabetes) bei Mutter und Sohn. Thieme Case Report 2020 (Dec), X-chromosomale Hypophosphatämie (XLH); 16-19
36. Pfeil A, Böttcher J, Oelzner P, Hoffmann T, Wolf G, Renz DM. Röntgendiagnostik in der Rheumatologie im Jahr 2020. Arthritis und Rheuma 2020; 40:153-162
37. Papageorgiou I, Dvorak J, Cosma I, Pfeil A, Teichgraeber U, Malich A. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer. Clin Transl Oncol. 2020 Aug;22(8):1321-1328
38. Ludriksone L, Pfeil A, Schliemann S, Elsner P. Eyelid edema as first manifestation of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: A case report. J Dtsch Dermatol Ges. 2020 Mar;18(3):263-265
39. Bäz L, Dannberg G, Grün K, Westphal J, Möbius-Winkler S, Jung C, Pfeil A, Schulze PC, Franz M. Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis. Int J Mol Sci. 2020 Jun 11;21(11):4174. doi: 10.3390/ijms21114174
40. Hasseli R, Mueller-Ladner U, Schmeiser T, Hoyer BF, Krause A, Lorenz HM, Regierer AC, Richter JG, Strangfeld A, Voll RE, Pfeil A, Schulze-Koops H, Specker C. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open. 2020 Sep;6(2):e001332. doi: 10.1136/rmdopen-2020-001332
41. Pfeil A, Fleck M, Keyßer G. Specialist training situation in rheumatology from a trainer's perspective. Z Rheumatol. 2020 Nov 24. doi: 10.1007/s00393-020-00922-z.
42. Teichgräber U, Ingwersen M, Mentzel HJ, Aschenbach R, Neumann R, Franiel T, Herzog AB, Böttcher J, Pfeil A, Mensel B, Kühnel C, Freesmeyer M, Fischer MR, Zottmann J. Impact of a Heutagogical, Multimedia-Based Teaching Concept to Promote Self-Determined, Cooperative Student Learning in Clinical Radiology. Rofo. 2020 Dec 16. doi: 10.1055/a-1313-7924
43. Renz DM, Dohna M, Böttcher J, Kaireit TF, Pfeil A, Streitparth F, Vogel-Claussen J. Magnetresonanztomografie der Lunge bei Zystischer Fibrose. Monatsschrift Kinderheilkunde 2020;5: 406-415
44. Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R, TULIP-2 Trial Investigators (u.a. Oelzner P). Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med 2020; 382: 211 - 221
45. Pfeil A, Baerwald DGO, Sieburg M, Boche K, Kupka TA, Linde T, Heldmann F, Unger L, Oelzner P, Aringer M, Keyßer G. Rheumatologin/Rheumatologe in spe: Wie geht es weiter? Z Rheumatol 2020; 79: 168 - 174  
46. Thiele K, Callhoff J, Eidner T, Hoese G, Karberg K, Wassenberg S, Zink A, Albrecht K. Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers. Z Rheumatol. 2020 Mar;79(2):153-159. doi: 10.1007/s00393-019-00712-2
47. Huber R, Augsten S, Kirsten H, Zell R, Stelzner A, Thude H, Eidner T, Stuhlmüller B, Ahnert P, Kinne RW. Identification of New, Functionally Relevant Mutations in the Coding Regions of the Human Fos and Jun Proto-Oncogenes in Rheumatoid Arthritis Synovial Tissue. Life (Basel). 2020 Dec 23;11(1):E5. doi: 10.3390/life11010005
48. Gerdes C, Werner C, Kloos C, Lehmann T, Wolf G, Müller UA, Müller N. Progression of diabetic complications in subgroups of people with long term diabetes Type 1 according to clinical course. Exp. Clin. Endocrinol. Diabetes 2020; 128:1-10
49. Werner C, Lupp A, Mtuka-Pardon G, Kloos C, Wolf G, Aschenbach R, Biermann A, Freesmeyer M, Seifer P. Case report of a cystic parathyroidaladenoma with rapid growth induced by cinacalcet. BMC Endocrine Disorders 2020; 20:53, https://doi.org/10.1186/s12902-020-0532-7
50. Kramer G, Kuniß N, Wolf G, Kloos C. Diabetologische Tagesklinik und Kompetenzzentrum für Diabetestechnologie am Universitätsklinikum Jena ergänzen komplementär ambulante Versorgungsstrukturen für Menschen mit Diabetes mellitus. Ärzteblatt Thüringen 2020; 34-36
51. Kronsbein P, Kuniß N. CME-Fortbildung: Strukturierte Diabetes-Schulung / Structured Diabetes Education. Diabetologie und Stoffwechsel 2020; 15(04): 287-304. DOI: 10.1055/a-0895-7607.
52. Werner C, Ritter C, Busch M. Radiopaque Coproliths in the Pelvis Minor. Dtsch Arztebl Int. 2020;117(22-23):388. DOI:10.3238/arztebl.2020.0388
53. Werner C, Dirsch O, Dahmen U, Grimm MO, Schulz S, Lupp A. Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies. Transl Oncol. 2020 Sep;13(9):100801. doi: 10.1016/j.tranon.2020.100801
54. Mertes B, Gödde S, Piorkowski M, Kramer G, Müller UA, Kuniss N. Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years. J Clin Med. 2020 Apr 17;9(4):1153. doi: 10.3390/jcm9041153.
55. Kramer G, Kuniss N, Wolf G. Technische Systeme in der Therapie des Diabetes mellitus - Welche gibt es und welcher Nutzen kann auf dem Gebiet der Nephrologie erwartet werden? Nieren- und Hochdruckkrankheiten 2020; 49, 461-468
56. Kramer G, Michalak L, Müller UA, Kloos C, Werner C, Kuniss N. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1. Exp Clin Endocrinol Diabetes. 2019 Jun 11. doi: 10.1055/a-0875-3988
57. Burghardt K, Müller UA, Müller N, Kloos C, Kramer G, Jörgens V, Kuniss N. Adequate Structured Inpatient Diabetes Intervention in People With Type 1 Diabetes Improves Metabolic Control and Frequency of Hypoglycaemia. Exp Clin Endocrinol Diabetes 2020 Dec;128(12):796-803
58. Kloos C, Burghardt K, Müller UA, Kramer G, Müller N, Wolf G, Kuniss N. Reduction of Severe Hypoglycaemia in People with Type 2 Diabetes after a Structured Inpatient Intervention. Exp Clin Endocrinol Diabetes 2019 Sep 5.doi: 10.1055/a-0983-1559
59. Müller N, Lehmann T, Klöss A, Günster C, Kloos C, Müller UA. Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication. Diabet Med. 2020 Aug;37(8):1326-1332. doi: 10.1111/dme.14294.

1. Pfeil A, Nussbaum A, Renz DM, Jung C, Oelzner P, Malich A, Wolf G, Böttcher J. Inhibition of periarticular bone loss is associated with clinical remission and ACR70-Response in rheumatoid arthritis. Rheumatol Int. 2019 Apr;39(4):637-645. doi: 10.1007/s00296-018-4226-7. Epub 2018 Dec 19.
2. Pfeil A, Oelzner P, Hellmann P. The Treatment of Giant Cell Arteritis in Different Clinical Settings. Front Immunol. 2019 Jan 24;9:3129. doi: 10.3389/fimmu.2018.03129. 
3. Keyßer G, Baerwald CGO, Sieburg M, Boche K, Pfeil A, Kupka TA, Lüthke K, Heldmann F, Oelzner P, Unger L, Aringer M. Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care. Z Rheumatol. 2019 Jun;78(5):479-485. 
4. Gadeholt O, Hausotter K, Eberle H, Klink T, Pfeil A. Differing x-ray patterns in seronegative and seropositive rheumatoid arthritis. Clin Rheumatol. 2019 Sep;38(9):2403-2410. doi: 10.1007/s10067-019-04602-5. Epub 2019 May 23. 
5. Hoffmann T, Oelzner P, Böttcher J, Wolf G, Pfeil A. Analysis of referral diagnoses to the rheumatology department. Z Rheumatol.  2020 Mar;79(2):160-167. doi: 10.1007/s00393-019-0672-1. German. 
6. Pfeil A, Baerwald CGO, Sieburg M, Boche K, Kupka TA, Linde T, Heldmann F, Unger L, Oelzner P, Aringer M, Keyßer G. Future of rheumatologists: what are the perspectives? : Survey of resident physicians in rheumatology in middle Germany. Z Rheumatol. 2020 Mar;79(2):168-174. doi: 10.1007/s00393-019-00713-1. German. 
7. Papageorgiou I, Dvorak J, Cosma I, Pfeil A, Teichgraeber U, Malich A. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer. Clin Transl Oncol. 2019 Dec 19. doi: 10.1007/s12094-019-02257-x. [Epub ahead of print]
8. Cosma I, Tennstedt-Schenk C, Winzler S, Psychogios MN, Pfeil A, Teichgraeber U, Malich A, Papageorgiou I. The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study. PLoS One. 2019 Dec 23;14(12):e0227031. 
9. Pfeil A, Busch M, Gröne HJ, Renz DM, Oelzner P, Wolf G. Mundtrockenheit und akutes Nierenversagen. Der Nephrologe 14:120-123. (2019)
10. Fiedler R, Lehmann G. Phosphat und Knochenstoffwechsel. Nieren- und Hochdruckkrankheiten 2019, 48(9);440-452
11. Galli E, Rossi J, Neumann T, Andressoo JO, Drinda S, Lindholm P. Mesencephalic Astrocyte-Derived Neurotrophic Factor is upregulated with Therapeutic Fasting in Humans and Diet Fat Withdrawal  in Obese Mice. Sci Rep. 2019 Oct 4;9(1):14318. doi: 10.1038/s41598-019-50841-6.
12. Fliser D, Eckardt KU, Erley C, Feldkamp T, Floege J, Haller H, Haubitz M, Heemann U, Hoyer J, Kleophas W, Kunzendorf U, Lutz J, Schweda F, Tönshoff B, Weber L, Witzke O, Wolf G, Wüthrich R, Zeier M, Initiative des Gesetzgebers zur Verbesserung der Struktur der Organspende. Hoffnung für viele Patienten, die auf ein Spenderorgan warten. Der Nephrologe 2019; 14:155-158.
13. Tutal AE, Wolf G. Wie valide sind Patientenratgeber in der Nephrologie? Nieren- und Hochdruckkrankheiten 2019; 48:272-287
14. Amann K, Wolf G. Einführung zum Thema: Nephropathologie. Der Nephrologe 2019; 14, 4 
15. Lehmann G, Wolf G. Knochengesundheit bei chronischen Lebererkrankungen und nach Lebertransplantation. Lebenslinien. Informationen für Lebertransplantierte 2019; 2, 6-8 
16. Reindl J, Gröne HJ, Wolf G, Busch M. Uromodulin-related autosomal-dominant tubulointerstitial kidney disease - pathogenetic insights based on a case. Clin Kidney J 2019;12(2):172-179
17. Karrasch M, Michel D, Schneider S, Baier M, Busch M. Development of a combined CMV-UL97 C592F and CMV-UL54 T503I resistance mutation during ganciclovir treatment in a kidney transplant recipient. Reviews in Medical Microbiology 2019;30:197–199
18. Schmidt IM, Hübner S, Nadal S, Titze S, Schmid M, Bärthlein B, Schlieper G, Dienemann T, Schultheiss UT, Meiselbach H, Köttgen A, Floege J, Busch M, Kreutz R, Kielstein JT, Eckardt KU; on behalf of the German Chronic Kidney Disease study investigators. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clin Kidney J. 2019 May 24;12(5):663-672. doi: 10.1093/ckj/sfz046.
19. Kielstein JT, Heisterkamp M, Jing J, Nadal J, Schmid M, Kronenberg F, Busch M, Sommerer C, Lorenzen J, Eckardt KU, Köttgen A, for the GCKD Study Investigators. Spectrum and dosing of urate lowering drugs in a large cohort of CKD patients and their effect on serum urate levels – a cross sectional analysis from the GCKD – study. Clin Kidney J 2019 sfz136, https://doi.org/10.1093/ckj/sfz136 Published: 08 November 2019
20. Werner C, Müller N, Müller UA. Agonistic autoantibodies against B2-adrenergic receptors correlating with macrovascular disease in longstanding diabetes type 2. Acta Diabetol. 2019 Jun;56(6):659-665. doi: 10.1007/s00592-019-01296-8
21. Taškova K, Fontaine JF, Mrowka R, Andrade-Navarro MALiterature optimized integration of gene expression for organ-specific evaluation of toxicogenomics datasets. PLoS One. 2019 Jan 14;14(1):e0210467. doi: 10.1371/journal.pone.0210467. eCollection 2019.
22. Reuter S, Mrowka R. Obesity, adipocytes and insulin resistance-Friends for life? Acta Physiol (Oxf). 2019 Mar;225(3):e13258. doi: 10.1111/apha.13258.
23. Dabiri Y, Gama-Brambila RA, Taškova K, Herold K, Reuter S, Adjaye J, Utikal J, Mrowka R, Wang J, Andrade-Navarro MA, Cheng X. Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs. iScience. 2019 Feb 22;12:168-181. doi: 10.1016/j.isci.2019.01.012. Epub 2019 Jan 11.
24. Ackermann S, Mrowka R. Cancer - An ongoing fight searching for reasons and therapies. Acta Physiol (Oxf). 2019 May;226(1):e13275. doi: 10.1111/apha.13275. Epub 2019 Mar 30.
25. Mrowka R. Recent advances in hypertension research. Acta Physiol (Oxf). 2019 Aug;226(4):e13295. doi: 10.1111/apha.13295. Epub 2019 Jun 5.
26. Herold K, Mrowka R. Inflammation-Dysregulated inflammatory response and strategies for treatment. Acta Physiol (Oxf). 2019 Jul;226(3):e13284. doi: 10.1111/apha.13284. Epub 2019 May 16.
27. Busch M, Wolf G. Wann sollte bei monoklonaler Gammopathie eine Nierenbiopsie erfolgen? Der Nephrologe 2019 (14) 1:5-13 
28. Lyons PA et al (The European Vasculitis Genetics Consortium [Neumann T]). Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status, Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9
29. Loeffler I. MKP2 suppresses TGF-β1-induced epithelial-to-mesenchymal transition through JNK inhibition. Clin Sci (Lond). 2019 Feb 13;133(3):545-550
30. Huber R, Kirsten H, Näkki A, Pohlers D, Thude H, Eidner T, Heinig M, Brand K, Ahnert P, Kinne RW. Association of Human FOS Promoter Variants with the Occurrence of Knee-Osteoarthritis in a Case Control Association Study. Int J Mol Sci. 2019 Mar 19;20(6). pii: E1382. doi: 10.3390/ijms20061382.
31. Masuch A, Friedrich N, Roth J, Nauck M, Müller UA, Petersmann A. Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord. 2019 Feb 12;19(1):20. doi: 10.1186/s12902-019-0338-7.
32. Kuniss N, Müller UA, Kloos C, Jörgens V, Kramer G. Diabetes-related distress is reduced in people with type 1, but not type 2 diabetes after participating in a diabetes treatment and teaching programme. Diabetes Metab. 2019 Jun;45(3):310-312. doi: 10.1016/j.diabet.2017.11.008.
33. Schübert H, Müller UA, Kramer G, Müller N, Heller T, Kloos C, Kuniss N. Snacking is Common in People with Diabetes Type 1 and Type 2 with Insulin Therapy and Is Not Associated With Metabolic Control or Quality of Life. Exp Clin Endocrinol Diabetes. 2019 Jul;127(7):461-467. doi: 10.1055/a-0631-8813.
34. Arend F, Müller UA, Schmitt A, Voigt M, Kuniss N. Overestimation of Risk and Increased Fear of Long-term Complications of Diabetes in People with Type 1 and 2 Diabetes. Exp Clin Endocrinol Diabetes. 2019 Oct;127(10):645-652. doi: 10.1055/a-0977-2667.
35. Bernard M, Müller N, Hecht L, Fabisch G, Harder A, Luck-Sikorski C. Efficacy of DiaLife, an education program for relatives of adult patients with diabetes - study protocol of a cluster randomized controlled trial. Trials. 2019 Aug 22;20(1):523. doi: 10.1186/s13063-019-3600-4.
36. Stojiljkovic MR, Quratul A, Bondeva T, Heller R, Schmeer C, Witte OW. Phenotypic and functional differences between senescent and aged murine microglia. Neurobiol Aging 2019 Feb; 74:56-69
37. Kramer G, Michalak L, Müller UA, Kloos C, Werner C, Kuniss N. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1. Exp Clin Endocrinol Diabetes. 2019 Jun 11. doi: 10.1055/a-0875-3988. [Epub ahead of print]
38. Thiele K, Callhoff J, Eidner T, Hoese G, Karberg K, Wassenberg S, Zink A, Albrecht K. Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers. Z Rheumatol. 2020 Mar;79(2):153-159. doi: 10.1007/s00393-019-00712-2. German

1. Fischer C, Deininger N, Wolf G, Loeffler I CERA attenuates kidney fibrogenesis in the db/db mouse by influencing the renal myofibroblast generation; J. Clin. Med.; 2018; 7, 15
2. Feldmann Y, Böer K, Wolf G, Busch M Complications and monitoring of percutaneous renal biopsy - a retrospective study. Clin. Nephrol; 2018; 89:260-268
3. Bondeva T, Schindler C, Schindler K, Wolf G MORG1+/- Mice are protected from histologica renal damage and inflammation in a murine model of endotoxemia; BMC Nephrology; 2018; 19: 29
4. Loeffler I, Liebisch M, Allert S, Kunisch E, Kinne RW, Wolf G FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy; Cell Tissue Res; 2018; 372:115-133
5. Burghardt K, Kaemmerer D, Michael A, Aschenbach R, Mueller UA, Kloos C, Wolf G Successful endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma in a patient with severe comorbidities not suitable for pancreatic surgery; Diabetes Metab; 2018; 44:84-86
6. Reise K, Hartung V, Mueller UA, Kloos C, Lehmann T, Wolf G, Kuniss N Prevalence and influencing factors of mild hypoglycaemia in people with diabetes type 1 and type 2 in a tertiray care centre: a cross sectional study; Curr. Res. Diabetes Obes J; 2018; 6 (3) 555689
7. Kuniss N, Mueller UA, Kloos C, Wolf G, Kramer G Reduction of HbA1c and diabetes-related distress after intervention in a diabetes day care clinic in people with type 2 diabetes but not with type 1 diabetes; Exp. Clin. Endocrinol. Diabetes; 2018; 126:242-248
8. Askitis D, Tsitlakidis D, Mueller N, Waschke A, Wolf G, Mueller UA, Kloos C Complete evaluation of pituitary tumours in a single tertiary care institution; Endocrine; 2018; 60:255-262
9. Witzke O, Nitschke M, Bartels M, Wolters H, Wolf G, Reinke P, Hauser IA, Alshuth U, Kliem U Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial; Transplantation; 2018; 102:876-882
10. Lehmann G, Wolf G Hypophosphatämie und FGF-23 Erhöhung bei normaler Nierenfunktion. Eine ungewöhnliche Konstellation; Der Nephrologe; 2018; 13: 186-188
11. Heller T, Kloos C, Lehmann T, Schiel R, Lorkowski S, Wolf G, Mueller UA, Mueller N Mortality and its Causes in a German Cohort with Diabetes Mellitus Type 1 after 20 Years of Follow-Up: The JEVIN Trial; Exp Clin Endocrinol Diabetes; 2018; 126:387-393
12. Drinda S, Franke S, Schmidt S, Stoy K, Lehmann T, Wolf G, Neumann T AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis; Complement Med Res; 2018; 25:167-172
13. Reindl J, Busch M, Wolf G Patientin mit ausgeprägter metabolischer Azidose und akutem Nierenversagen; Der Nephrologe; 2018; 13: 340-345
14. Voigt M, Schmidt S, Lehmann T, Koehler B, Kloos C, Voigt UA, Meller D, Wolf G, Mueller UA, Mueller N Prevalence and Progression Rate of Diabetic Retinopathy in Type 2 Diabetes Patients in Correlation with the Duration of Diabetes; Exp Clin Endocrinol Diabetes; 2018; 26: 570–576
15. Dorenkamp M, Müller JP, Shanmuganathan KS, Schulten H, Müller N, Löffler, I, Müller UA, Wolf G, Böhmer FD, Godfrey R, Waltenberger J Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis; Scientific Report Sci Rep; 2018; 8:14684
16. Herfurth K, Busch M, Gröne HJ, Wolf G Progressive renal insufficiency in a 55-year-old man with psoriasis; Internist; 2018; 59:1204-1207
17. Reindl J, Gröne HJ, Wolf G, Busch M Uromodulin-related autosomal-dominant tubulointerstitial kidney disease - pathogenetic insights based on a case; Clinical Kidney Journal, 2018; sfy094, https://doi.org/10.1093/ckj/sfy094 (nur elektronische Publikation)
18. Merker L, Ebert T, Guthoff M, Schlosser M, Hasslacher C, Wolf G Nephropathie bei Diabetes - Praxis-Leitlinie der DDG; Diabetologie und Stoffwechsel; 2018; 13 (Suppl.2), S217-S220
19. Werner C, Lupp A, Drescher R, Freesmeyer M, Mireskandari M, Stoykow C, Bauschke A, Mueller UA Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT; J Med Imaging Radiat Oncol; 2018; 62 (3):370-374. doi:10.1111/1754-9485.12704
20. Werner C, Mueller N, Mueller UA Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2; Acta Diabetol; 2018; 55 (3):301-303. doi:10.1007/s00592-018-1100-8
21. Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T Development and validation of a renal risk score in ANCA-associated glomerulonephritis; Kidney Int.; 2018; 94(6):1177-1188. doi: 10.1016/j.kint.2018.07.020. Epub 2018 Oct 29
22. Schneider MP, Hilgers KF, Schmid M, Hübner S, Nadal J, Seitz D, Busch M, Haller H, Köttgen A, Kronenberg F, Baid-Agrawal S, Schlieper G, Schultheiss U, Sitter T, Sommerer C, Titze S, Meiselbach H, Wanner C, Eckardt KU; GCKD Study Investigators Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study; PLoS One; 2018; Aug 20;13(8):e0202604. doi: 10.1371/journal.pone.0202604. eCollection 2018
23. Haeckel S, Stein F, Wolf G, Stein G, Busch M Quality of Blood Pressure Control in General Practice Using Ambulatory Blood Pressure Monitoring - a Retrospective Monocentric Cross-Sectional Study; Dtsch Med Wochenschr; 2018; Jul;113(13):e108-e116. doi: 10.1055/a-0589-7580. Epub 2018 Jul 4
24. Brix SR, Noriega M, Herden EM, Goldmann B, Langbehn U, Busch M, Jabs WJ, Steinmetz OM, Panzer U, Huber TB, Stahl RAK, Wiech T Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis; Histopathology; 2018; Jun;72(7):1093-1101. doi: 10.1111/his.13487. Epub 2018 Mar 25.
25. Ain Q, Schmeer C, Penndorf D, Fischer M, Bondeva T, Foerster M,  Haenol R, Witte OW, Kretz A Cell cycle-dependent and -independent telomere shortening accompanies murine brain aging; Aging (Albany NY); 2018 Nov 20;10(11):3397-3420. doi: 10.18632/aging.101655
26. Westphal A, Mrowka R New insights into the astonishing diversity of hormone functions. Acta Physiol (Oxf). 2018 Dec;224(4):e13188. doi: 10.1111/apha.13188.
27. Mrowka R Modifiers of hypertension. Acta Physiol (Oxf). 2018 Nov;224(3):e13184. doi: 10.1111/apha.13184.
28. Ackermann S, Mrowka R Nephropathy: New aspects of mechanisms, diagnosis and therapy. Acta Physiol (Oxf). 2018 Sep;224(1):e13162. doi: 10.1111/apha.13162.
29. Mrowka R, Westphal A Skeletal muscle in the fight against chronic diseases. Acta Physiol (Oxf). 2018 Aug;223(4):e13086. doi: 10.1111/apha.13086.
30. Mrowka R, Kirchner S, Reuter S How to switch on genes with CRISPR/Cas9? Acta Physiol (Oxf). 2018 Sep;224(1):e13087. doi: 10.1111/apha.13087.
31. Heger JI, Froehlich K, Pastuschek J, Schmidt A, Baer C, Mrowka R, Backsch C, Schleußner E, Markert UR, Schmidt A Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum. Exp Cell Res. 2018 Apr 1;365(1):57-65. doi: 10.1016/j.yexcr.2018.02.017. Epub 2018 Feb 21.
32. Theobald J, Cheng X, Ghanem A, Gaitantzi H, Song G, Klipp E, Wodke J, Becker H, Mrowka R, Breitkopf-Heinlein K, Dooley S, Wölfl S. Monitoring cytochrome P450 activity in living hepatocytes by chromogenic substrates in response to drug treatment or during cell maturation. Arch Toxicol. 2018 Mar;92(3):1133-1149. doi: 10.1007/s00204-017-2128-1. Epub 2017 Dec 5.
33. Taškova K, Fontaine JF, Mrowka R, Andrade-Navarro MA. Evaluation of in vivo and in vitro models of toxicity by comparison of toxicogenomics data with the literature. Methods. 2018 Jan 1;132:57-65. doi: 10.1016/j.ymeth.2017.07.010. Epub 2017 Jul 14.
34. Dawczynski C, Dittrich M, Neumann T, Goetze K, Welzel A, Oelzner P, Völker S, Schaible AM, Troisi F, Thomas L, Pace S, Koeberle A, Werz O, Schlattmann P, Lorkowski S, Jahreis G Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clin Nutr 2018;37:494-504
35. Pfeil A, Nussbaum A, Renz DM, Jung C, Oelzner P, Malich A, Wolf G, Böttcher J Inhibition of periarticular bone loss is associated with clinical remission and ACR70-Response in rheumatoid Arthritis. Rheumatol Int 2018 doi 10.1007/s00296-018-4226-7
36. Roth J, Müller N, Lehmann T, Böer K, Löbel S, Pum, J, Müller UA Comparison of HbA1c Measurements using 3 Methods in 75 Patients Referred to One Outpatient Department
37. Kuniss N, Müller UA, Kloos C, Müller R, Starrach G, Jörgens V, Kramer G Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting. Acta Diabetol. 2018 Feb;55(2):131-137
38. Kellner C, Kuniss N, Kloos C, Müller UA, Müller N No selection, but higher satisfaction of people participating in the disease management programme diabetes type 2 in Germany. Acta Diabetol. 2018 Apr;55(4):363-367
39. Petersmann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):406-410.
40. Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, Merker L, Müller UA, Müller-Wieland D, Roth J, Spannagl M, Wallaschofski H, Nauck M. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany. Horm Metab Res. 2018 Oct;50(10):728-734
41. Landgraf R, Nauck M, Freckmann G, Müller UA, Heinemann L, Kellerer M, Müller-Wieland D. Pitfalls in the Diagnosis of Diabetes: Are we too Lax with Laboratory Parameters? Dtsch Med Wochenschr. 2018 Oct;143(21):1549-1555
42. Abendroth K, Lehmann G Knochenbiopsie und histomorphometrische Befunde. Fachwissen Osteologie; 2018; 1. Auflage; S.69-73
43. Wernly B, Haumann S, Masyuk M, Muessig J, Lichtenauer M, Bäz L, Franz M, Pfeil A, Lauten A, Schulze PC, Hoppe UC, Kelm M, Westenfeld R, Jung C, Renz D Extravascular lung water index and Halperin score to predict outcome in critically ill patients. Wien Klin Wochenschr 2018, 130:505-510
44. Edlinger C, Granitz M, Paar V, Jung C, Pfeil A, Eder S, Wernly B, Kammler J, Hergan K, Hoppe UC, Steinwender C, Lichtenauer M, Kypta A Visualization and appearance of artifaxts of leadless pacemaker systems in cardiac MRI. An experimental ex vivo study. Wien Klin Wochenschr 2018,130:427-435
45. Renz DM, Kümpel S, Böttcher J, Pfeil A, Streitparth F, Waginger M, Reichenbach JR, Teichgräber UK, Mentzel HJ Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population. Investigative Radiology, 2018, Vol 53, Number 2
46. Pfeil A, Lehmann G, Lange U. Update DVO guidelines 2017 on "Prophylaxis, diagnostics and treatment of osteoporosis in postmenopausal women and men" : What is new, what remains for rheumatologists? Z Rheumatol 2018;77(9):759-763
47. Pfeil A, Oelzner P, Böttcher J, Jung C, Wolf G Essentials Rheumatologie; Elsevier; 2018.

1. Pfeil A, Thodberg HH, Renz DM, Reinhardt L, Oelzner P, Wolf G, Böttcher J: Metacarpal bone loss in patients with rheumatoid arthritis estimated by a new Digital X.ray Radiogrammetry method- initila results; BMC; Musculoskeletal Disorders; 2017; 18:6. doi 10.1186/s12891-016-1348-5

2. Pfeil A, Busch M, Oelzner P, Freesmeyer M, Renz DM, Drescher R, Hertel K, Wolf G: 42-jähriger Patient mit Harnstau unklarer Genese; Der Nephrologe; 2017; 12; 51-53

3. Pfeil A, Haugeberg G, Renz DM, Reinhardt L, Jung C, Franz M, Wolf G, Böttcher: Digital X-ray radiogrammetry and its sensitivity and specificity for the identification of rheumatoid arthritis-related cortical hand bone loss; J Bone Mineral Metab; 2017; 35; 192-198

4. Rump LC, Fliser D, Heemann U, Wolf G, Haller H: Nachruf auf Prof. Dr. Bernd Grabensee; Der Nephrologe; 2017; 12; 294-296

5. Lehmann G, Pfeil A, Wolf G: Effekte von Teriparatid auf knochenhistologische Parameter bei einer Patientin mit adynamer renaler Knochenerkrankung und Wirbelkörperfrakturen; Osteologie; 2017; 26; 147-152

6. Wolf G, Zeier M Diabetes und Niere; Der Nephrologe; 2017; 12; 384-385

7. Liebisch M, Bondeva T, Franke S, Hause S, Wolf G Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products; Nephrol Dial Transplant; 2017; 32; 641-653

8. Löffler I, Liebisch M, Daniel D, Amann K, Wolf G Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db mice; Nephrol Dial Transplant; 2017; 32; 2017-2034

9. Köhler B, Kloos C, Kißler H, Raack S, Bärthel E, Weber M, Wolf G, Settmacher U, Strauß B, Stallmach A, Müller UA Outcome nach Schlauchmagen-OP und ausschließlich konservativer Behandlung bei Adipositas WHO III-retrospektive Untersuchung am Klinikum Jena; Ärzteblatt Thüringen; 2017; 28; 272-274

10. Schlosser M, Hasslacher C, Wolf G Nephropathie bei Diabetes - Praxis-Leitlinie der DDG; Diabetologie und Stoffwechsel; 2017; 121 (Suppl 2), 115-120

11. Pfeil A, Lehmann G, Böttcher J, Reinhardt L, Oelzner P, Wolf G, Renz DM Knochenmineraldichtemessung in der klinischen Routine; Akt Rheumatol; 2017; 42; 211-216

12. Oelzner P, Wolf G Prophylaxe und Therapie der Glukokortikoid-induzierten Osteoporose; Akt Rheumatol; 2017; 42; 233-244

13. Löffler I, Wolf G Pathophysiologie der diabetischen Nephropathie; Der Nephrologe; 2017; 12; 391-399

14. Frommhold B, Wolf G Kommissar Wallanders Krankengeschichte; Der Diabetologe; 2017; 13; 253-259

15. Kolleck M, Wolf G "Fleisch für Dr. Jackson“: Organhandel in Spielfilmen und mögliche Beziehungen zur Realität; Nieren- und Hochdruckkrankheiten; 2017; 46; 259-274

16. Trivedi H a,∗, Grayb LJ, Seidua S, Daviesa MJ, Charpentierc G, Lindbladd U, Kellner Ch, Nolanf J, Pazderskag A, Ruttenh G, Trentoi M, Khuntia K Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control; Prim Care Diabetes; 2017; 11(5); 414-420. doi 10.1016/j.pcd.2017.03.011. Epub 2017 Jul 3.

17. Kölling M, Kaucsar T, Schauerte C, Hübner A, Dettling A, Park JK, Busch M, Wulff X, Meier M, Scherf K, Bukosza N, Szénási G, Godó M, Sharma A, Heuser M, Hamar P, Bang C, Haller H, Thum T, Lorenzen JM Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice; Mol Ther; 2017; Jan 4;25(1):165-180. doi: 10.1016/j.ymthe.2016.08.001. Epub 2017 Jan 4.

18. Busch M 82-jähriger multimorbider VHF-Patient mit subakutem embolischen Schlaganfall bei vorbestehender chronischer Niereninsuffizienz; Fall 1 Thieme Case Report; 2017; 9(8):1-16

19. Sekula P1,2, Li Y1, Stanescu HC3, Wuttke M1, Ekici AB4, Bockenhauer D3, Walz G1, Powis SH3, Kielstein JT5, Brenchley P6; GCKD Investigators, Eckardt KU7, Kronenberg F8, Kleta R3, Köttgen A1,2 Collaborators: Eckardt KU, Titze S, Prokosch HU, Bärthlein B, Reis A, Ekici AB, Gefeller O, Hilgers KF, Hübner S, Avendaño S, Becker-Grosspitsch D, Hauck N, Seuchter SA, Hausknecht B, Rittmeier M, Weigel A, Beck A, Ganslandt T, Knispel S, Dressel T, Malzer M, Floege J, Eitner F, Schlieper G, Findeisen K, Arweiler E, Ernst S, Unger M, Lipski S, Schaeffner E, Baid-Agrawal S, Petzold K, Schindler R, Köttgen A, Schultheiss U, Meder S, Mitsch E, Reinhard U, Walz G, Haller H, Lorenzen J, Kielstein JT, Otto P, Sommerer C, Föllinger C, Zeier M, Wolf G, Busch M, Paul K, Dittrich L, Sitter T, Hilge R, Blank C, Wanner C, Krane V, Schmiedeke D, Toncar S, Cavitt D, Schönowsky K, Börner-Klein A, Kronenberg F, Raschenberger J, Kollerits B, Forer L, Schönherr S, Weißensteiner H, Oefner P, Gronwald W, Zacharias H, Schmid M. Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies; Nephrol Dial Transplant; 2017 Feb 1;32(2):325-332. doi: 10.1093/ndt/gfw001. Epub 2016 Feb 4

20. Löffler I, Liebisch M, Allert S, Kunisch E, Kinne RW, Wolf G FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy; Cell Tiss Res; 2017; doi: 10.1007/s00441-017-2754-1

21. Dawczynski C, Dittrich M, Neumann T, Goetze K, Welzel A, Oelzner P, Völker S, Schaible AM, Troisi F, Thomas L, Pace C, Koeberle A, Schlattmann P, Lorkowski S, Jahreis G Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil; Clin Nutr; 2017. doi: 10.1016/j.clnu.2017.02.021

22. Lehmann G, Wolf G Der multimorbide geriatrisch/osteologische Patient mit Niereninsuffizienz; arthritis + rheuma; 2017; 381-385

23. Patecki M, Lehmann G, Bräsen JH, Schmitz J, Bertram A, Berthold LD, Haller H, Gwinner W. A case report of severe calciphylaxis – suggested Approach for diagnosis and treatment; BMC Nephrol; 2017; Apr 21;18(1):137. doi: 10.1186/s12882-017-0556-z

24. Kettner C, Mann J Prophylaxe und Therapie der diabetischen Nephropathie; Der Nephrologe; 2017; DOI 10.1007/s11560-017-0193-3

25. Burghardt K, Kaemmerer D, Michael A, Aschenbach R, Müller UA, Kloos C, Wolf G Successful endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma in a patient with severe comorbidities not suitable for pancreatic surgery, Diabetes Metab., 2017; doi: 10.1016/j. diabet.2016.12.012

26. Albrecht K, Huscher D, Eidner T, Kleinert S, Späthling-Mestekemper S, Bischoff S, Zink A Medical treatment of rheumatoid arthritis in 2014: Current data from the German Collaborative Arthritis Centers; Z Rheumatol; 2017; 76(1): 50-57; doi: 10.1007/s00393-016-0156-5

27. Jahn L, Rüster Ch, Winkler Y, Grimm MO, Wolf G, Busch M Factors and outcome of delayed graft function after kidney transplantation over a period of 8 years - a single center study; Nephrology Dialysis Transplantation; 2017; 32(suppl_3): iii403-iii403 (publizierter Abstract)

28. Roth J, Müller N, Lehmann T, Böer K, Lobel S, Pum J, Müller UA Comparsion of HbA1c Measurements using 3 Methods in 75 Patients Referred to One Outpatient Department; Exp Clin Endocrinol Diabetes; 2017; doi: 10.1055/s-0043-110053

29. Kuniss N, Rechtacek T, Kloos C, Müller UA, Roth J, Burghardt K, Kramer G Diabetes-related burden and distress in people with diabetes mellitus at primary care lever in Germany; Acta Diabetol; 2017; 54(5): 471-478; doi: 10.1007/s00592-017-0972-3

30. Heller T, Reise K, Roth J, Lehmann T, Schiel R, Lorkowski S, Müller UA, Müller N Changes in Quality of Diabetes Care and Morbidity over 20 years in People with Type 1 Diabetes and Long Diabetes Duration: The JEVIN Trial; Exp Clin Endocrinol Diabetes; 2017; 125(2): 122-129; doi: 10.1055/s-0042-117717

31. Müller N, Khunti K, Kuss O, Lindblad U, Nolan JJ, Rutten GE, Trento M, Porta M, Roth J, Charpentier G, Jörgens V, Müller UA Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE Study; Acta Diabetol; 2017; 54(2): 209-214; doi: 10.1007/s00592-016-0939-9

32. Carmona FD, Augusto V, Mackie SL, Hernández-Rodríguez J, Monach PA, Castaneda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated witz Giant Cell Arteritis; The American Journal of Human Genetics; 2017; 100; 64-74

33. Alberici F, Smith RM, Fonseca M, Willcocks LC, Jones RB, Holle JU, Wieczorek S, Neumann T, Martorana D, Gregorini G, Sinico RA, Bruchfeld A, Gunnarsson I, Ohlsson S, Baslund B, Tesar V, Hruskova Z, Cid MC, Vaglio A, Lyons PA, Smith KGC, Jayne DRW Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis; J Allergy Clin Immunol; May 2017; 139(5)1684-1686

34. Theobald J, Cheng X, Ghanem A, Gaitantzi H, Song G, Klipp E, Wodke J, Becker H, Mrowka R, Breitkopf-Heinlein K, Dooley S, Wölfl S Monitoring cytochrome P450 activity in living hepatocytes by chromogenic substrates in response to drug treatment or during cell maturation.Arch Toxicol. 2017 Dec 5. doi: 10.1007/s00204-017-2128-1. [Epub ahead of print

35. Westphal A, Reuter S, Mrowka R Nephropathies. Acta Physiol (Oxf). 2017 Nov;221(3):151-154. doi: 10.1111/apha.12945. Epub 2017 Sep 20. No abstract available

36. Reuter S, Mrowka R The complement system in kidney diseases.Acta Physiol (Oxf). 2017 Aug;220(4):398-401. doi: 10.1111/apha.12909. No abstract available

37. Göhring AR, Reuter S, Clement JH, Cheng X, Theobald J, Wölfl S, Mrowka R Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis.PLoS One. 2017 Apr 20;12(4):e0174912. doi: 10.1371/journal.pone.0174912. eCollection 2017

38. Mrowka R, Freytag A, Reuter S Did you know? Modelling vision: computational science for understanding human visual perception.Acta Physiol (Oxf). 2017 Dec;221(4):227-229. doi: 10.1111/apha.12875. Epub 2017 Apr 19. No abstract available

39. Mrowka R Arterial hypertension.Acta Physiol (Oxf). 2017 Apr;219(4):697-699. doi: 10.1111/apha.12855. No abstract available

40. Mrowka R Did you know? Suppression by delay.Acta Physiol (Oxf). 2017 Oct;221(2):87-89. doi: 10.1111/apha.12794. No abstract available

41. Taškova K, Fontaine JF, Mrowka R, Andrade-Navarro MA Evaluation of in vivo and in vitro models of toxicity by comparison of toxicogenomics data with the literature. Methods. 2018 Jan 1;132:57-65. doi: 10.1016/j.ymeth.2017.07.010. Epub 2017 Jul 14

42. Scholz O, Denecke T, Böttcher J, Schwarz C, Mentzel HJ, Streitparth F, Maurer MH, Pfeil A, Huppertz A, Mehl A, Staab D, Hamm B, Renz DM MRI of cystic fibrosis lung manifestations: sequence evaluation and clinical outcome analysis. Clin Radiol. 2017;72(9):754-763

43. Seifert P, Drescher R, Pfeil A, Freesmeyer M Large-vessel vasculitis in positron emission tomography and ultrasound fusion imaging. Rheumatology (Oxford) 2017;56(11):1992

44. Müller N, Lehmann T, Gerste B, Adler JB, Kloos C, Hartmann M, Kramer G, Kuniss N, Müller UA Increase in the incidence of severe hypoglycaemia in people with Type 2 diabetes in spite of new drugs: analysis based on health insurance data from Germany. Diabet Med. 2017 Sep;34(9):1212-1218

45. Boels AM, Vos RC, Hermans TGT, Zuithoff NPA, Müller N, Khunti K, Rutten GEHM; GUIDANCE study group What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. group. BMJ Open. 2017 Jul 11;7(7):e016180. doi: 10.1136/bmjopen-2017-016180

46. Schmidt J, Peters S, Sauer L, Schweitzer D, Klemm M, Augsten R, Müller N, Hammer M Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy. Acta Ophthalmol. 2017 Feb;95(1):33-40

1. Neumann T, Lodes S, Kaestner B, Lehmann T, Hans D, Lamy O, Mueller UA, Wolf G, Saemann A: Trabecular bone score in type 1 diabetes - a cross-sectional study; Osteoporos. Int.; 2016; 27:127-133
2. Neumann T, Lodes S, Kaestner B, Franke S, Kiehntopf M, Lehmann T, Mueller UA, Wolf G, Saemann A: Osteocalcin, adipokines and their associations with glucose metabolism in typ 1 diabetes; Bone; 2016; 82:50-55
3. Kloos C, Mueller N, Hartmann P, Lehmann T, Saemann A, Roth J, Wolf G, Mueller UA: High Quality of Diabetes Care Based Upon Individualised Treatment Goals - A Cross Sectional Study in 4784 Patients in Germany; Exp. Clin. Endocrinol. Diabetes; 2016; 124:294-299
4. Lehmann G, Pfeil A, Weiß JM, Kunz J, Wolf G: Inzidenz und Komplikationen osteoporotischer Frakturen in Jena/Thüringen; Osteologie; 2016; 25:7-11
5. Wolf G: Journal-Club: SPRINT-Studie zum Bluthochdruck (2): Was bringt die Blutdrucksenkung auf unter 120 mmHg im Vergleich zu 140 mmHg?; Dialyse aktuell; 2016; 20:126
6. Klein FK, Groten T, Schleußner E, Wolf G, Battefeld W: Analytische Probleme in der Diagnostik des Gestationsdiabetes - Vergleich von 6 Analytikmethoden; Diabetologie und Stoffwechsel; 2016; 11:155-162
7. Kramer G, Kuniss N, Kloos C, Lehmann T, Mueller N, Sanow B, Lorkowski S, Wolf G, Mueller UA: Principles of self-adjustment of insulin dose in people with diabetes type 2 and flexible insulin therapy; Diabetes Res. Clin. Practice; 2016; 116:165-170
8. Thodberg HH, Boettcher J, Lomholt J, Kreiborg S, Wolf G, Pfeil A: A new implementation of digital X-ray radiogrammetry and refrence curves of four indices of cortical bone for healthy European adults; Arch. Osteoporos.; 2016; 11:17-26
9. Kuniss N, Kramer G, Mueller N, Kloos C, Lehmann T, Lorkowski S, Wolf G, Mueller UA: Diabetes-Related Burden and Distress is Low in People with Diabetes at Outpatient Tertiary Care Level; Exp Clin Endocrinol Diabetes; 2016; 124:307-312
10. Herfurth K, Busch M, Forberg T, Groene HJ, Wolf G: Akutes Nierenversagen und Verdacht auf Bronchialkarzinom; Der Nephrologe; 2016; 11:213-216
11. Busch M, Nadal J, Schmidt M, Paul K, Titze S, Huebner S, Koettgen A, Schultheiss UT, Baid-Agarwal S, Lorenzen J, Schlieper G, Sommerer C, Krane V, Hilge R, Kielstein JT, Kronenberg F, Wanner C, Eckardt KU, Wolf G: Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort; BMC Nephrology; 2016; 17:59
12. Kramer G, Kuniss N, Kloos C, Lehmann T, Mueller N, Wolf G, Lorkowski S, Mueller UA: Principles and frequency of self-adjustment of insulin dose in people with diabetes mellitus type 1 and correlation with markers of metabolic control; Diabetes Res. Clin. Practice; 2016; 116:299-305
13. Schindler K, Bondeva T, Schindler C, Claus RA, Franke S, Wolf G: Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models; Nephrol Dial Transplant; 2016; 31:1100-1113
14. Kramer G, Kuniss N, Joergens V, Lehmann T, Mueller N, Lorkowski S, Wolf G, Mueller UA, Kloos C: Prospective analysis of principles and frequency of self-adjustment of insulin dose in people with diabetes type 1 before and after participation in a diabetes treatment and teaching programme; Diabetes Res. Clin. Practice; 2016; 119:65-70
15. Paul K, Franke S, Nadal J, Schmid M, Yilmaz A, Kretschmar D, Baerthlein B, Titze S, Koettgen A, Wolf G, Busch M: Inflammation, Vitamin D and dendritic cell precursors in chronic kidney disease; Clin. Exp. Immunol.; 2016; 186:86-95
16. Kuniss N, Kramer G, Mueller N, Kloos C, Wolf G, Mueller UA: History of mild hypoglycaemia does not affect the prevalence of diabetes-related distress in people with diabetes; Acta Diabetol; 2016; 53:833-838
17. Neumann T, Baertschi M, Viser W, Drinda S, Franz M, Brueckmann A, Wolf G, Jung C: Retinal vessel regulation at high altitudes; Clin. Hemorheol. Microcirc.; 2016; 63:281-292
18. Ruester C, Franke S, Reuter S, Mrowka R, Bondeva T, Wolf G: Vitamin D3 Partly Antagonizes Advanced-Glycation End Products induced NF kB Activation in Mouse Podocytes; Nephron; 2016; 134(2):105-116
19. Windisch C, Petersen I, Schulz B, Winkens T, Lopatta E, Oelzner P, Wolf G, Neumann T: Erdheim-Chester disease with vascular involvement mimics large vessel vasculitis; Postgrad Med J, 2016; 92:687-688
20. Pfeil A, Krojniak L, Renz DN, Reinhardt L, Franz M, Oelzner P, Wolf G, Boettcher J: Psoriatic arthritis is associated with bone loss of the metacarpals; Arthritis Research & Therapy; 2016; 18:248
21. Jahn I, Busch M, Ott U, Wolf G, Battefeld W: Posttransplantationsdiabetes mellitus bei Patienten nach Nierentransplantation. Inzidenz und Risikofaktoren; Dtsch. Med. Wochenschr; 2016; 141:e173-e182
22. Oelzner P, Lehmann G, Wolf G: Medikamentöse Therapie ausgewählter Formen der sekundären Osteoporose; Arzneimitteltherapie; 2016; 34:59-71
23. Ruester C, Wolf G: Diabetische Nephropathie. Hintergründe und Therapiemöglichkeiten; Dialyse aktuell; 2016; 20:128-133
24. Oelzner P, Wolf G: Lupusnephritis. Krankheitsmechanismen, Diagnostik und Behandlung; Dialyse aktuell; 2016; 20:141-150
25. Oelzner P, Wolf G: Lupus und Lupusnephritis; Kompendium Nephrologie; 2016; 8:61-66
26. Ruester C, Hasslacher C, Wolf G: Nephropathie bei Diabetes - Praxis-Leitlinie der DDG; Diabetologie und Stoffwechsel; 2016; 11 (Suppl. 2):S93-S98
27. Wolf G: Diabetes und Nierenerkrankungen; Deutscher Gesundheitsbericht Diabetes; 2016; 90-94.
28. Stuhlmueller BA, Mans K, Tandon N, Bonin MO, Smiljanovic B, Soerensen T, Schendel P, Martus P, Listing J, Detert J, Backhaus M, Neumann T, Winchester RJ, Burmester GR, Haeupl T: Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis; Clinical Immunology; 2016; 171:50-61
29. Busch, M: IgA-Nephropathie - Pathogenese, Diagnose, Therapie und mehr; Dialyse aktuell; 2016; 20(03):134-140
30. K. Albrecht, D. Huscher, T. Eidner, S. Kleinert, S. Späthling-Mestekemper, S. Bischoff, A. Zink: Versorgung der rheumatoiden Arthritis 2014; Z Rheumatol; 75: Epub 2016 Jul 5. DOI 10.1007/s00393-016-0156-5
31. Kramer G, Kuniss N, Kloos C, Lehmann T, Mueller N, Saemann A, Wolf G, Mueller UA: Metabolic control and hypoglycaemia in people with type 2 diabetes on conventional or intensified insulin therapy: a 22 year retrospective single centre survey; Diabetes Metab Res Rev.; 2016; 32(6):652-658
32. Schorr SG, Hammes HP, Mueller UA, Abholz HH, Landgraf R, Bertram B: The Prevention and Treatment of Retinal Complications in Diabetes; Dtsch Arztebl Int; 2016; 113(48):816-823
33. Heller T, Reise K, Roth J, Lehmann T, Schiel R, Lorkowski S, Mueller UA, Mueller N: Changes in Quality of Diabetes Care and Morbidity over 20 Years in People with Type 1 Diabetes and Long Diabetes Duration: The JEVIN Trial; Exp Clin Endocrinol Diabetes; 2016; Dec 22
34. Appel JE, Ift F, Kißler H, Kloos C, Lehmann T, Strauß B, Wick K: Influence of Attachment Style on the Outcome of Bariatric Surgery - A Pilot Study; Psychother Psychosom Med Psychol; 2016; 66(12):465-472
35. Renz DM, Malich A, Ulrich A, Pfeil A, Mentzel HJ, Streitparth F, Maurer MH, Teichgraeber UK, Boettcher J: Reference values for digital X-ray radiogrammetry parameters in children and adolescents in comparsion to estimates in patients wih distal radius fractures; Journal of Bone and Mineral Metabolism; 2016; 34:55-64
36. Jung C, Drummer KF, Oelzner P, Figulla HR, Boettcher J, Franz M, Betge S, Foerster M, Wolf G, Pfeil A: The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud's phenomenon as detected by functional imaging; Clinical Hemorheology and Microcirculation; 2016; 61:549-557
37. Ziffels B, Ospel J, Gruen K, Neri D, Pfeil A, Fritzenwanger M, Figulla HR, Jung C, Berndt A, Franz M: Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling; Disease Markers; 2016; 3695454
38. Ziemer M, Mueller AK, Hein G, Oelzner P, Elsner P: Incidence and classification of cutaneous manifestations in rheumatoid arthritis; J Dtsch Dermatol Ges; 2016; 14:1237-1246
39. Lehmann G: Osteoporose; Geriatrie-Report; 2016; 04:13-15

1. Heller T, Kloos C, Keßler D, Müller N, Thierbach R, Wolf G, Müller U: Use of snacks in insulin-treated people with diabetes mellitus and association with HbA1c, weight and quality of life: a cross sectional study; Diabetic Medicine; 2015; 32; 353-358.
2. Loeffler I, Wolf G: Morg1 heterozygous defiency ameliorates hypoxia-induced acute renal injury; Am J Physiol Renal Physiol; 2015; 308; F511-F521.
3. Askitis D, Kloos C, Battefeld W, Müller N, Wolf G, Dirsch O, Müller UA: Complete evaluation of adrenal tumours in a tertiary care institution in thuringia, germany; Exp. Clin. Endocrinol. Diabetes; 2015; 123; 347-352.
4. Roth J, Milke B,Müller N, Zitterbart U, Rechtacek S, Rechtacek T, Kloos C, Wolf G, Müller UA: People with type 2 diabetes on premixed insulin therapy: how is the daily insulin dose partioned and are there effects on metabolic control; Exp. Clin. Endocrinol. Diabetes; 2015; 123; 368-370.
5. Müller N, Heller T, Freitag MH, Gerste B, Haupt CM, Wolf G, Müller UA: Healthcare utilization of people with type 2 diabetes in Germany: an Analysis based on health insurance data; Diabetic Medicine; 2015; 32; 951-957.
6. Müller N, Kämmer K, Kloos C, Wolf G, Müller UA: Postprandial self-monitoring of urine glucose reflects glycaemic control in people with relatively well controlled type 2 diabetes mellitus not treated with insulin: a retrospective cohort study; Diabetic Medicine; 2015; 32; 958-962.
7. Pfeil A, Oelzner P, Renz DM, Hansch A, Wolf G, Böttcher J: Is there a role for Digital X-ray radiogrammetry as surrogate marker for radiological progression and imaging of structural integrety in rheumatoid arthritis; BMC Musculoskelet Disord.; 2015; 16; 155.
8. Pfeil A, Renz DM, Fröber R, Hansch A, Lehmann G, Sommerfeld J, Malich A, Wolf G, Böttcher J: Influence of angulation on metacarpal bone mineral density measurements using digital X-ray radiogrammetry; Int. J. Comput. Assit. Radiol. Surg.; 2015; 10; 587-592.
9. Amann K, Wolf G: Alte und neue Entwicklungen in der Nierenbiopsiediagnostik; Der Nephrologe; 2015; 10; 269-270.
10. Busch M, Wolf G: Wann sollte bei Patienten mit Diabetes mellitus eine Nierenbiopsie erfolgen?; Der Nephrologe; 2015; 10; 271-278.
11. Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA: CC Chemokine Ligand 18 in ANCA-Associated Crescentic Glomerulonephritis; J. Am. Soc. Nephrol.; 2015; 26; 2105-2117.
12. Pfeil A, Drummer KF, Böttcher J, Jung C, Oelzner P, Renz DM, Franz M, Hansch A, Wolf G: The application of fluorescence optical imaging in systemic sclerosis; Biomed Res InternID; 2015; 44; 388-395.
13. Busch M, Stein A, Lehmann G, Paul K, Stein G, Wolf G: Vitamin K1 status in chronic kidney disease; Nieren- und Hochdruckkrankheiten; 44; 388-395.
14. Schleenvoigt BT, Sprague LD, Mertens K, Moog U, Schmoock G, Wolf G, Neumann M, Pletz MW, Neubauer H: Acute Q fever infection in Thuringia, Germany, after burial of roe deer fawn cadavers (Capreolus capreolus). A case report; New Microbe and New infect; 2015; 8; 19-20.
15. Löffler I, Wolf G: The role of hypoxia and Morg1 in renal injury; Eur. J. Clin. Invest.; 2015; 45; 294-302.      
16. Rüster C, Wolf G: Prävention der diabetischen Nephropathie: Was ist praktisch machbar? Perspektiven der Diabetologie; Deutsches Ärzteblatt; 2015; 1; 4-9.
17. Lehmann G, Schütze J, Pfeil A, Wolf G: Einfluss von CKD-MBD und Diabetes auf histomorphometrische Parameter des Knochens - retrospektive Analyse von Knochenbioptaten von Diabetikern und Nicht-Diabetikern mit chronischer Niereninsuffizienz; Nieren- und Hochdruckkrankheiten; 2015; 44; 210-212.
18. Bondeva T, Wolf G: Role of neuropilin-1 in diabetic nephropathy; J Clin Med 4; 2015; 1293-1311.
19. Pfeil A, Böttcher J, Lehmann G, Wolf G: Bildgebung im Rahmen der osteologischen Diagnostik; Thüringer Ärzteblatt; 2015; 26; 420-423.
20. Wolf G: Diabetes und Nierenerkrankungen; Der Nephrologe; 2015; 10; 382-385.
21. Löffler I, Wolf G: Epithelial-to-mesenchymal transition in diabetic nephropathy: Fact or fiction; Cells; 2015;4; 631-652.
22. Rüster C, Hasslacher C, Wolf G: Nephropathie bei Diabetes - Praxis Leitlinie der DDG; Diabetologie und Stoffwechsel; 2015; 8 (Suppl.2); 113-118.
23. Wolf G: Diabetes und Nierenerkrankungen in Deutscher Gesundheitsbericht Diabetes 2016; Kirchheim-Verlag Mainz; 2015; 90-94.
24. Otto GP, Hurtado-Oliveros J, Chung HY, Knoll K, Neumann T, Müller HJ, Herbsleb M, Kohl M, Busch M, Sossdorf M & Claus RA: Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach; PLOSone; 2015;10(4).
25. Mrowka R: Evolution and physical laws. Acta Physiol (Oxf). 2015 Nov;215(3):125-6. doi: 10.1111/apha.12598.
26. Reuter S, Mrowka R: Acute kidney injury; Acta Physiol (Oxf); 2015; 215(2):73-5. doi: 10.1111/apha.12555.
27. Cheng X, Yoshida H, Raoofi D, Saleh S, Alborzinia H, Wenke F, Göhring A, Reuter S, Mah N, Fuchs H, Andrade-Navarro MA, Adjaye J, Gul S, Utikal J, Mrowka R, Wölfl S: Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and Derivatives Are Potent Inducers of Oct3/4; J Med Chem.; 2015; 58(15):5742-50. doi: 10.1021/acs.jmedchem.5b00226.
28. Reuter S, Mrowka R: The metabolic syndrome: the future is now; Acta Physiol (Oxf); 2015; 214(3):291-4. doi: 10.1111/apha.12530.
29. Cheng X, Dimou E, Alborzinia H, Wenke F, Göhring A, Reuter S, Mah N, Fuchs H, Andrade-Navarro MA, Adjaye J, Gul S, Harms C, Utikal J, Klipp E, Mrowka R, Wölfl S: Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 Inducers; J Med Chem.; 2015; 58(12):4976-83. doi: 10.1021/acs.jmedchem.5b00144.
30. Staudacher JJ, Naarmann-de Vries IS, Ujvari SJ, Klinger B, Kasim M, Benko E, Ostareck-Lederer A, Ostareck DH, Bondke Persson A, Lorenzen S, Meier JC, Blüthgen N, Persson PB, Henrion-Caude A, Mrowka R, Fähling M: Hypoxia-induced gene expression results from selective mRNA partitioning to the endoplasmic reticulum; Nucleic Acids Res.; 2015; 43(6):3219-36. doi: 10.1093/nar/gkv167.
31. Broggini T, Czabanka M, Piffko A, Harms C, Hoffmann C, Mrowka R, Wenke F, Deutsch U, Grötzinger C, Vajkoczy P: ICAM1 depletion reduces spinal metastasis formation in vivo and improves neurological outcome; Eur Spine J.; 2015; 24(10):2173-81. doi: 10.1007/s00586-015-3811-7.
32. Schweitzer D, Deutsch L, Klemm M, Jentsch S, Hammer M, Peters S, Haueisen J, Müller UA, Dawczynski J: Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy; J Biomed Opt.; 2015; 20(6); 61106. doi: 10.1117/1.JBO.20.6.061106.
33. Buhse S, Mühlhauser I, Kuniss N, Müller UA, Lehmann T, Liethmann K, Lenz M: An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial; BMC Fam Pract.; 2015; 16:43; doi: 10.1186/s12875-015-0257-2.
34. Buhse S, Mühlhauser I, Kuniss N, Müller UA, Lehmann T, Liethmann K, Lenz M: Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial; BMJ Open; 2015; 13;5(11): e009116. doi: 10.1136/bmjopen-2015-009116.
35. Kerner W, Freckmann G, Müller UA, Roth J, Schleicher E, Niederau C, Müller-Wieland D, Landgraf R, Heinemann L: Positionspapier der Kommission für Labordiagnostik in de Diabetologie der DGKL und der DDG; Diabetologie; 2015; 10; 329-333.
36. Schöfl C, Grussendorf M, Honegger J, Tönjes A, Thyroke-Gronostay D, Mayr B, Schopohl J; participants of German Acromegaly Register: Allolio B, Badenhoop K, Bender G; Biering H, Bogner U, Bornstein SR, Cissewski K, Demtröder F, Dietrich JW, Droste M, Engelbach M, Feldkamp J, Finke R, Friesenhahn-Ochs B, Führer-Sakel D, Gallwitz B, Gerhardt A, Gruber M, Grußendorf M, Haaser D, Heike M, Hering S, Honegger J, Jacobs B, Jaursch-Hancke C, Junginger S, Jungmann E, Kajdan U, Kann P, Karges W, Kasperk C, Klein H, Klingmüller D, Knauerhase A, Kornely E, Lammert F, Lehnert H, Lerch MM, Lößner C, Lübbren J, Mann A, Mertens PR, Meuser J, Meyer A, Möning H, Müller UA, Müller-Esch G, Pichl J, Plöckinger U, Ploner O, Pohlmeyer P, Quinkler M, Reincke M, Reschke K, Schäffler A, Scharf JG, Schöfl C, Schopohl J, Schott M, Seufert J, Siggelkow H, Stalla GK, Steveling A, Streetz-van C, Strasburger CJ, Stumvoll M, Teichmann J, Tönjes A, Weber MM, Wiedenmann B, Willenberg HS, Zimmermann A, Zumbusch K: Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey; Eur J Endocrinol.; 2015; 172(4); 351-356.
37. Schneider MP, Hübner S, Titze SI, Schmid M, Nadal J, Schlieper G, Busch M, Baid-Agrawal S, Krane V, Wanner C, Kronenberg F, Eckardt KU: Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates; Kidney International; 2015; 88; 1411-1418.
38. Karrasch M, Herfurth K, Kläver M, Miethke J, Mayer-Scholl A, Luge E, Straube E, Busch M: Severe leptospirosis complicated by Epstein-Barr Virus reactivation; Infection; 2015; 43; 763-769.
39. Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A:Correction: Heart failure in a cohort of patients with chronic kidney disease: the GCKD study; PLoS One; 2015; 10(6); e0131034.
40. Busch M, Paul K, Schmid M, Titze SI, Hübner S, Bärthlein B, Hilgers KF, Köttgen A, Schultheiss UT, Baid-Agrawal S, Lorenzen J, Schlieper G, Sommerer C, Krane V, Hilge R, Kielstein JT, Kronenberg F, Wanner C, Eckardt KU, Wolf G: Diabetes mellitus und chronische Nierenerkrankung - kardiovaskuläres Risikoprofil und Behandlungsstrategien in der "German Chronic Kidney Disease" (GCKD)-Studienkohorte; Nieren- und Hochdruckkrankheiten; 2015; 44; 18-20.
41. Otto GP, Grünwald B, Geis C, Köthe S, Hurtado-Oliveros J, Chung HY, Ekaney M, Bockmeyer CL, Sossdorf M, Busch M, Claus RA: Impact of Antibiotic Treatment Intensity on Long-Term Sepsis-Associated Kidney Injury in a Polymicrobial Peritoneal Contamination and Infection Model; Nephron; 2015; 129; 137-142.
42. Renz DM, Scholz O, Böttcher J, Maurer MH, Denecke T, Schwarz C, Pfeil A, Streitparth F, Huppertz A, Mehl A, Poellinger A, Staab D, Hamm B, Mentzel HJ: Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory and pulmonary functional parameters; Investigative Radiology; 2015; 50; 733-742.
43. Jung C, Drummer K, Oelzner P, Figulla HR, Böttcher J, Franz M, Betge S, Foerster M, Wolf G, Pfeil A: The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud`s phenomenon as detected by functional imaging; Clin Hemorheol Microcirc.; 2015; 61; 549-557.
44. Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A: Heart failure in a cohort of patients with chronic kidney disease: the GCKD study; PLoS One; 2015; 10(4); e0122552.
45. Titze S, Schmid M, Köttgen A, Busch M, Floege J, Wanner C, Kronenberg F, Eckardt KU: Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort; Nephrol Dial Transplant.; 2015; 30(3); 441-451.
46. Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Collaborators (120) Van den Bosch F, Nzeusseu A, de Vlam K, Geusens P, Oparanov B, Rashkov R, Batalov A, Goranov I, Kazmin I, McCarthy T, Inman R, Rahman P, Schaeverbeke T, N'Guyen M, Bertin P, Frediani B, Adami S, Foti R, Triolo G, Fusaro E, Franceschini F, Zazueta B, Maradiaga M, Avila H, Garza M, Baeten D, Bijlsma H, Berrocal A, Garro B, Gamboa R, Castaneda O, Becerra F, Stanislav M, Salnikova T, Maslyanskiy A, Ershova O, Izmozherova N, Lesniak O, Tseng JC, Wei CC, Ozdogan H, Kisacik B, Onen F, Tahir H, Ostor A, Barkham N, Kay L, Braun J, Dahmen G, Rubbert-Roth A, Wassenberg S, Oelzner P, Nuesslein H, Moericke R, Rech J, Sieper J, Deodhar A, Kivitz A, Aelion J, Kohen M, Knibbe W, LaSalle S, Zang S, Cohen S, Brooks M, Graninger W, Jorg R, Zamani O, Bessette L, Cohen M, McCarthy T, Beaulieu A, Pavelka K, Galatikova D, Dokoupilova E, Leirisalo-Repo M, Paimela L, Järvinen P, Sokka-Isler T, Rouhe E, keskussairaala S, Foti R, Pellerito R, Adami S, Baeten D, Bijlsma J, Trofimov V, Izmozherova N, Vezikova N, Zotkin E, Stanislav M, Ershova O, Mosesova N, Lee LN, Cheung P, Balsa A, Blanco R, Blanco FJ, Gonzalez C, Bannert B, Daniela B, Dudler J, Ciurea A, Tahir H, Marzo-Ortega H, Gaffney K, Mackay K, Codding C, Dorman W, Legerton C 3rd, Kivitz A, Khan M, Lee E, Caldron P, Wolfe J, Swarup A, Singhal A, Braun J, Sieper J, Tony HP: Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis; N Engl J Med.; 2015; 373; 2534-48.
47. Schack S, Weber M, Oelzner P, Mireskandari M, Antonov D, Stallmach A: Morbus Behçet or inflammatory bowel disease - a diagnostic and therapeutic dilemma; Z Gastroenterol.; 2015; 53;1187-92.

1. Leucht L, Wolf G. Dr.House as a nephrologist: renal diagnosis and treatments in the TV-series House, ER and Scrubs. Nieren- und Hochdruckkrankheiten; 2014; 43; 6-16.
2. Kronbichler A, Oelzner P, Lopatta E, Wolf G, Neumann T. Bilateral pulmonary embolism in twins with PAI-1 4G/5G gene polymorphism: a case report. Wien. Klin. Wochenschr.; 2014; 126; 53-56.
3. Nobis R, Ansorge-Wolf G, Bär KJ, Wolf G. Therapie mit Psychopharmaka bei internistischen Patienten einer Universitätsklinik; Dtsch. Med. Wochenschr.; 2014; 139; 417-422.
4. Heller T, Blum M, Spraul M, Wolf G, Müller UA. Folgerkrankungen des Diabetes mellitus: Prävalenzen in der Bundesrepublik Deutschland; Dtsch. Med. Wochenschr.; 2014; 139; 786-791.
5. Pfeil A, Oelzner P, Renz DM, Lehmann G, Wolf G, Böttcher J. Visualisation of structural damage as a surrogate marker of radiographic progression in patients with rheumatoid arthritis; Ann. Rheum. Dis; 2014; 73:e24.
6. Neumann T, Hofbauer LC, Rauner M, Lodes S, Kästner B, Franke S, Kiehntopf M, Lehmann T, Müller UA, Wolf G, Hamann C, Sämann A. Clinical and endocrine correlates of circulating sclerostin levels in patient with type 1 diabetes mellitus; Clin. Endocrin.; 2014; 80; 649-655.
7. Neumann T, Lodes S, Kästner B, Franke S, Kiehntopf M, Lehmann T, Müller UA, Wolf G, Sämann A. High serum pentosidine, but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control; Osteoporosis Int.; 2014; 25; 1527-1533.
8. Pfeil A, Drummer KF, Oelzner P, Böttcher J, Jung C, Wolf G. Fluorescence optical imaging as a novel technique for the visualisation of inflammation in patients with systemic sclerosis with Raynaud´s phenomenon: a pilot study; Ann Rheum. Dis: 2014; 73; 1279-1280.
9. Liebisch M, Bondeva T, Franke S, Daniel C, Amann K, Wolf G. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 supppression; Kidney Int.; 2014; 86; 103-117.
10. Windisch C, Merz H, Winkens T, Rüster C, Oelzner P, Neumann T, Gröne HJ, Wolf G. Gelenkschwellung, reversible Armparase und erhöhtes Serum-IgG4 bei einem 55-jährigen Patienten; Internist; 2014; 55; 842-846.
11. Herfurth K, Busch M, Schinköthe C, Keller P, Pfeifer R, Gröne HJ, Wolf G. Akutes Nierenversagen bei einer 71-jährigen Diabetikerin; Nephrologe; 2014; 9; 382-386.
12. Oelzner P, Petrow PK, Wolf G, Bräuer R. 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption; BMC Musculoskelet Disord.; 2014; 15; (1):345.
13. Stubendorff B, Finke S, Walter M, Kniemeyer O, Eggeling von F, Gruschwitz T, Steiner T, Ott U, Wolf G, Wunderlich H, Junker K. Urine protein profiling indentified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation; World J. Urol.; 2014; 32; 1619-1624.
14. Pfeil A, Renz DM, Oelzner P, Hansch A, Lehmann G, Malich A, Wolf G, Böttcher J. Die Knochenmasse der Hand als Indikator für die strukturelle Destruktion bei Patienten mit einer rheumatoiden Arthritis - welche Messmethoden sind geeignet? Akt. Rheumatol; 2014; 39; 393-398.
15. Loeffler I, Wolf G. Transforming growth factor-b and the progression of renal disease; Nephrol. Dialy. Transplant; 2014; 29; i37-i45.
16. Oelzner P, Wolf G. Nierenbeteiligung bei Kollagenosen: Klinische und therapeutische Aspekte; Dialyse aktuell; 2014; 6; 296-303.
17. Meier F, Wolf G. ANCA-assozierte Vaskulitiden-Grundlagen und Wichtiges zur renalen Beteiligung; Dialyse aktuell; 2014; 6; 304-308.
18. Hasslacher C, Wolf G, Kempe P, Ritz E. Diabetic Kidney Disease; Exp. Clin.- Endocrinol.Diabetes; 2014; 122; 391-394.
19. Löffler I, Wolf G. Die Pathogenese der diabetischen Nephropathie; Mitteilungen der deutschen Gesellschaft für Nephrologie; 2014; 1; 3-8.
20. Lehmann G, Wolf G. Medikamentöse Therapie von Knochenstoffwechselstörungen bei CKD-MBD („chronic kidney disease-mineral bone disorders“) unter besonderer Berücksichtigung antiresorptiver Wirkstoffe; Z.Rheumatol; 2014; 73; 329-334.
21. Bondeva T, Wolf G. Reactive oxygen species in diabetic nephropathy: friend or foe? Nephrol. Dial. Transplant.; 2014; 29; 1998-2003. 
22. Löffler I, Wolf G. Rolle von Kollagen Typ VIII bei der diabetischen Nephropathie; Nieren- und Hochdruckkrankheiten; 2014; 43; 501-506.
23. Hasslacher C, Wolf G, Kempe P, Ritz E. Praxis Leitlinie der DDG: Nephropathie bei Diabetes 2014; Diabetologie und Stoffwechsel; 2014; 9; 111-114.
24. Pfeil A, Renz DM, Fröber R, Hansch A, Lehmann G, Sommerfeld J, Malich A, Wolf G, Böttcher J. Influence of angulation on metacarpal bone mineral density measurements using digital X-ray radiogrammetry; Int J Comput Assist Radiol Surg; 2014; Jul 3.
25. Böttcher J, Renz DM, Zahm DM, Pfeil A, Fallenberg EM, Streitparth F, Maurer MH, Hamm B, Engelken FJ. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation; Acta Oncologica; 2014; 53; 759-768. 
26. Renz DM, Durmus T, Böttcher J, Taupitz M, Diekmann F, Huppertz A, Pfeil A, Maurer MH, Streitparth F, Bick U, Hamm B, Fallenberg EM. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging; Investigative Radiology; 2014; 49; 474-484.
27. Franz M, Matusiak-Brückner M, Richter R, Grün K, Ziffels B, Neri D, Maschek H, Schulz U, Pfeil A, Jung C, Figulla HR, Gummert J, Berndt A, Renner A. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection. Journal of Molecular Histology; 2014; 45; 519-532.
28. Jung C, Quitter F, Lichtenauer M, Fritzenwanger M, Pfeil A, Shemyakin A, Franz M, Figulla HR, Pfeifer R, Pernow J. Increased arginase levels contribute to impaired perfusion after cardiopulmonary resuscitation; European Journal of Clinical Investigations; 2014; 44; 965-971.
29. Winkens T, Pfeil A, Theis B, Jung C. Cryofibrinogenemia associated with cryoglobulinemia - a severe case with amputation of four extremities; Japanese Journal of Clinical Oncology; 2014; 44; 1013-1014.
30. Oelzner P, Franke S, Wolf G. Advanced glycation end products (AGEs) und Vitamin D – antagonistische Prinzipien im Knochenstoffwechsel; Akt Rheumatol; 2014; 39; 384-392.    
31. Mahr A, Moosig F, Neumann T, Szczeklik W, Taille C, Vaglio A, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): evolutions in classification, etiopathogenesis, assessment and management; Curr Opin Rheumatol; 2014; 26; 16-23.
32. Frietsch J, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, Sayer HG, Hochhaus A, La Rosee P. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review; Eur J Haematol; 2014; 93(3); 247-59.
33. Kronbichler A, Kerschbaum J, Fernandez-Fresnedo G, Hoxha E, Kurschat CE, Busch M, Bruchfeld A, Mayer G, Rudnicki M. Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review; Am J Nephrol; 2014; 39(4); 322-30. doi: 10.01159/000360908. Epub 2014 Apr 15. Review.
34. Otto GP, Sossdorf M, Breuel H, Schlattmann P, Bayer O, Claus RA, Riedemann NC, Busch M. Renal outcome after vancomycin treatment and renal replaxement therapie in patients with svere sepsis and septic shock: a retrospective study; J Crit Care; 2014; 29(4); 656-61. doi: 10.1016/j.jcrc.2014.03.015. Epub 2014 Mar 21.
35. Busch M. Alte und neue kardiovaskuläre Risikofaktoren bei diabetischer Nephropathie – Ein Update; Diabetes aktuell; 2014; 12(5); 226-231.
36. Nauck MA, Haastert B, Trautner C, Müller UA, Nauck MA, Heinemann L. Clinical Trials Study Group of the German Association for the Study of Diabetes (Deutsche Diabetes-Gesellschaft): A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment; Diabetologia; 2014; 57(5); 868-77.
37. Kasim M, Benko E, Winkelmann A, Mrowka R, Staudacher JJ, Persson PB, Scholz H, Meier JC, Fähling M. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia; J Biol Chem; 2014; 26; 289(39):26973-88. doi: 10.1074/jbc.M114.579391. Epub 2014 Aug 14.
38. Gebhardt ML, Reuter S, Mrowka R, Andrade-Navarro MA. Similarity in targets with REST points to neural and glioblastoma related miRNAs; Nucleic Acids Res; 2014; May; 42(9); 5436-46. doi: 10.1093/nar/gku231. Epub 2014 Apr 11.
39. Reuter S, Patzak A, Mrowka R. Hypertension; Acta Physiol (Oxf); 2014; 211(1); 1-4. doi: 10.1111/apha.12277. Epub 2014 Apr 2.
40. Dathe C, Daigeler AL, Seifert W, Jankowski V, Mrowka R, Kalis R, Wanker E, Mutig K, Bachmann S, Paliege A. Annexin A2 mediates apical trafficking of renal Na⁺-K⁺-2Cl⁻ cotransporter; J Biol Chem; 2014; Apr 4; 289(14); 9983-97. doi: 10.1074/jbc.M113.540948. Epub 2014 Feb 13.
41. Neumann T. Knochenstoffwechsel, Umbaumarker und Diabetes; Osteologie; 2014; 23; 73-160.
42. Lehmann G. Chronische Therapie mit nichtsteroidalen Antirheumatika - wie groß ist der Einfluss der Nierenfunktion bei Patienten mit rheumatoider Arthritis? Dialyse aktuell; 2014; 18(6):250.

1. Amann K, Wolf G. Neue Klassifikationsysteme in der Nierenpathologie. Der Nephrologe 6 (2013) 465-466
2. Apel M, Maia V, Zeidan M, Schinkoethe C, Wolf G, Reinhart K, Sakr Y. End-stage renal disease and outcome in a surgical intensive care unit. Critical Care 17 (2013) R298
3. Beltran-Alvarez P, Espejo A, Schmauder R, Beltran C, Mrowka R, Linke T, Batlle M, Pérez-Villa F, Pérez GJ, Scornik FS, Benndorf K, Pagans S, Zimmer T, Brugada R. Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel. FEBS Lett 587 (2013) 3159-65
4. Beluchin E, Bäz L, Müller N, Lehmann T, Kloos C, Wolf G, Müller UA. Frequency of self adjustment of insulin dose and metabolic control in patients with diabetes mellitus type 2- is there an association? Diabet Med 30 (2013) e91-e94
5. Boettcher J, Pfeil A, Wolf G, Hansch A. Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T!-weighted sequences. Clin Imag 17 (2013) 245-250
6. Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Mauerer MH, Streitparth F, Teichgräber UK, Renz DM. Detection and classification of different liver lesions: Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. European Journal of Radiology 82 (2013) 1860-1869
7. Bondeva T, Heinzig J, Ruhe C, Wolf G. Advanced glycated end products affect HIF- transcriptional activity in renal cells. Mol Endocrinol 27 (2013) 1918-1933
8. Brezinova P, Englbrecht M, Lovric S, Sämann A, Strauss B, Wolf G, Schett G, Haubitz M, Neumann T, Zwerina J. Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52 (2013) 1856-1864
9. Busch M, Wolf G. Was bringen nephropathologische Klassifikationen  für den klinisch tätigen Nephrologen? Der Nephrologe 6 (2013) 468-473
10. Busch M, Rüster C, Schinköthe C, Gerth J, Wolf G. Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy. Clinical Nephrology 80 (2013) 105-113
11. Busch M. Alte und neue kardiovaskuläre Risikofaktoren bei chronischer Nierenerkrankung. Nieren- und Hochdruckkrankheiten 42 (2013) 273-284
12. Busch M. Diabetische Nephropathie - Kardiovaskuläre Risikofaktoren und ihre Behandlung. Ärzteblatt Thüringen 24 (2013) 599-604
13. Busch M. Kardiovaskuläre Begleiterkrankungen und Komplikationen bei Diabetes mellitus. Medizinische Welt 64 (2013) 86-90
14. Dietrich A, Mathia S, Kaminski H, Mutig K, Rosenberger C, Mrowka R, Bachmann S, Paliege A. Chronic activation of vasopressin V2 receptor signalling lowers renal medullary oxygen levels in rats. Acta Physiol (Oxf) 207 (2013) 721-31
15. Fähling M, Mathia S, Paliege A, Koesters R, Mrowka R, Peters H, Persson PB, Neumayer HH, Bachmann S, Rosenberger C.    Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. J Am Soc Nephrol 24 (2013) 1806-19
16. Fujita B, Strodthoff D, Fritzenwanger M, Pfeil A, Ferrari M, Goebel B, Figulla HR, Gerdes N, Jung C. Altered red blood cell distribution width in overweight adolescents and its association with markers of inflammation. Pediatric Obesity 8 (2013) 385-391
17. Gerth J, Sigusch H, Illner N, Busch M, Muegge LO, Lehmann T, Wolf G. Renale Manifestationen von Leichtkettenerkrankungen – Epidemiologie und Diagnose. Deutsche Medizinische Wochenschrift 138 (2013) 305-312
18. Hasslacher C, Wolf G, Kempe P, Ritz E. Nephropathie bei Diabetes -Praxis Leitlinie der DDG  Diabetologie und Stoffwechsel 8 (2013) S110-S122  
19. Hermann R, Rau M, Marx C, Wolf G. Arterielle Hypertonie: Leitlinienakzeptanz und -implementierung im Thüringer Praxisalltag von Internisten und Allgemeinmedizinern. Dtsch Med Wochenschr 138 (2013) 1347-1352
20. Hunger-Battefeld W. Schilddrüsendysfunktion und Diabetes mellitus Typ 1. Der  n i e d e r g e l a s s e n e  A r z t  8 (2013) 2-4
21. Huscher D, Sengler C, Gromnica-Ihle E, Bischoff S, Eidner T, Ochs W, Richter J, Zink A. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account. Clin Exp Rheumatol 31 (2013) 256-62
22. Jehle P, Lehmann G. Moderne Differentialtherapie des sekundären Hyperparathyreoidismus. DGfN 2 (2013) 31
23. Kellner C, Kloos C, Busch M, Wolf G, Müller UA. Das adrenogenitale Syndrom
    Thüringer Ärzteblatt 24 (2013) 473-475
24. Krebs CF, Kapffer S, Paust HJ, Schmidt T, Bennstein SB, Peters A, Stege G, Brix SR, Meyere-Schwesinger C, Müller RU, Turner JE, Steinmetz OM, Wolf G, Stahl RAK, Panzer U. Micro-RNA-155 drives Th17 immune response and tissue injury in experimental crescentic GN. JASN 24 (2013) 1955-1965
25. Kronbichler A, König P, Busch M, Wolf G, Mayer G, Rudnicki M. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases. Wiener Klinische Wochenschrift 125 (2013) 328-333
26. Lehmann G, Wolf G. Renale Osteodystrophie-wieviel Knochenumsatz braucht der nierenkranke Mensch? DGfN 2 (2013) 19-23
27. Lehmann G, Wolf G. CJD MBD – was ist diagnostisch sinnvoll und wann ist eine Knochenbiopsie bei CKD-Patienten indiziert. Nieren- und Hochdruckkrankheiten 41 (2013) 25-25
28. Löffler I, Rüster C, Franke S, Liebisch M, Wolf G. Erythropoetin ameliorates podoycte injury in advanced diabetic nephropathy in the db/db mouse. Am J Physiol: Renal Physiol 305 (2013) F911-F918
29. Löffler I, Wolf G. Neue Aspekte der Pathogenese der diabetischen Nephropathie. Ärzteblatt Thüringen 24 (2013) 542-544
30. Meier F, Neumann T. Vaskulitiden-eine klinische Herausforderung. Ärzteblatt Thüringen 24 (2013) 277-280
31. Müller N, Kloos C, Sämann A, Wolf G, Müller UA. Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes. Patient Education and Counselling 93 (2013) 108-113 
32. Müller N, Frank T, Kloos C, Lehmann T, Wolf G, Müller UA. Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes mellitus and human insulin. Diabetes Care 36 (2013) 1865-1860
33. Otto GP, Busch M, Sossdorf M, Claus RA. Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis. Critical Care 17 (2013) 417:419
34.  Otto GP, Kropf M, Rödel J, Lösche W, Rüster C, Claus RA, Sossdorf M, Busch M. Novel approach for bacteraemia detection in patients with end-stage renal failure undergoing hemodialysis. International Journal of Artificial Organs 36 (2013) 742-743
35.  Otto GP, Kropf M, Sossdorf M, Recknagel P, Lösche W, Rödel J, Claus RA, Busch M. Screening for bacteremia in sepsis and renal failure using hemofilters for renal replacement therapy. Infection 41 (2013) 387-390
36. Paul K, Kretzschmar D, Yilmaz A, Bärthlein B, Titze S, Wolf G, Busch M. Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study. BMC Nephrology 14 (2013) 274
37. Pfeil A, Lehmann G, Böttcher J, Wolf G, Hansch A. The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis. Rheumatol Intern 33 (2013) 29-35
38. Pfeil A, Oelzner P, Bornholdt K, Hansch A, Lehmann G, Renz DM, Wolf G, Böttcher J. Joint damage in rheumatoid arthritis: assessment of a new scoring method. Arthritis Research & Therapy 15 (2013) R27  
39. Pfeil A, Renz DM, Hansch A, Kainberger F, Lehmann G, Malich A, Wolf G, Böttcher J. The usefulness of computer-aided joint space analysis in the assessment of rheumatoid arthritis. Joint Bone Spine 80 (2013) 380-5
40. Roth A, Lehmann G, Wolf G. Osteoporose-Diagnostik und Therapie. Orthopädische und Unfallchirurgische Praxis 3 (2013) 122-128
41. Rüster C, Wolf G. Adipokines promote chronic kidney disease. Nephrol Dial Transplant 28 (2013) iv8-iv14
42. Rüster C, Wolf G. The role of the Renin-Angiotensin-Aldosterone System in obesity-related renal disease. Sem  Nephrol 33 (2013) 44-53  
43. Sämann A, Lehmann T, Heller T, Müller N, Hartmann P, Wolf G, Müller UA. A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care. Family Medicine 30 (2013) 290-293
44. Schrenk KG, Krokowski M, Feller AC, Bernhard V, Mügge LO, Oelzner P, Wolf G, Hochhaus A, Neumann T. Clonal T-LGL-population mimicking leukemia in Felty’s-Syndrome- part of a continuous spectrum of T-LGL proliferations? Ann Hematol 92 (2013) 985-7
45. Seeliger B, Foerster M, Neumann T, Moeser A, Happe J, Kehler N, Kroegel C. Interferon-α induced remission in three patients with eosinophilic granulomatosis and polyangiitis (Churg-Strauss Syndrome). A case study. Respiratory Medicine Case Reports 10 (2013) 60-63
46. Stolarczyk Y, Eisfeldt C. Brinkman O, Lehmann G. Vollbild eines Mb. Paget im 21. Jahrhundert. Osteologie 22 (2013) 298-301                        
47. Vogel K, Opfermann T, Wiegand S, Biermann J, Busch M, Winkens T, Freesmeyer M. Relationship between estimated glomerular filtration rate and biological half-life of 131I. Retrospective analysis in patients with differentiated thyroid carcinoma. Nuklearmedizin 52 (2013) 164-169
48. Wolf G. Obesity and renal disease: introduction. Sem Nephrol 33 (2013) 1
49. Zipfel PE, Skerk C, Hallström T, Wolf G. 14 th European Meeting on Complement in Human Disease, Jena, Germany, August 17-21, 2013. Mol Immunol 56 (2013) 151

1. Bäz L, Müller N, Beluchin E, Kloos C, Lehmann T, Wolf G, Müller UA. Differences in the quality of diabetes care caused by social inequalities disappear after treatment and education in a tertiary care centre. Diabetic Medicine 29 (2012) 640-645
2. Bondeva T, Heinzig J, Franke S, Wolf G. Angiotensin II differentially regulates Morg1 expression in kidney cells. Am J Nephrol 35 (2012) 442-455
3. Busch M, Schwenzky A, Franke S, Stein G, Wolf G. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients. Blood Purif 34 (2012) 3-9
4. Busch M, Stein A, Stein G. How to manage functional vitamin K deficiency in CKD. Am J Kidney Dis 60 (2012) 168
5. Busch M, Stein G, Wolf G.Reply to H.Schiffl: Carpal Tunnel Syndrome in patients on intermittent hemodialysis. Blood Purific. 34 (2012) 332-333
6. Busch M, Schinköthe C, Eigendorff E, Gröne HJ, Wolf G.Progrediente Niereninsuffizienz und Proteinurie bei einem 74-jährigen Patienten. Der Nephrologe 7 (2102) 52-55
7. Cheng X, Alborzinia H, Merz KH, Steinbeisser H, Mrowka R, Scholl C, Kitanovic I, Eisenbrand G, Wölfl S. Indirubin derivatives modulate TGFβ/BMP signaling at different levels and trigger ubiquitin-mediated depletion of nonactivated R-Smads. Chem Biol 19 (2012) 1423-1436
8. Eckardt KU, Bärthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, Ekici AB, Floege J, Gefeller O, Haller H, Hilge R, Hilgers KF, Kielstein JT, Krane V, Köttgen A, Kronenberg F, Oefner P, Prokosch HU, Reis A, Schmid M, Schaeffner E, Schultheiss UT, Seuchter SA, Sitter T, Sommerer C, Walz G, Wanner C, Wolf G, Zeier M, Titze S. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant 27 (2012) 1454-1460
9. Fähling M, Bondke-Persson A, Klingere B, Benko E, Steege A, Kasim M, Patzak A, Persson PB, G, Blüthgen N, Mrowka R. Multi-level refgulation of HIF-1 signalling by TTP. Mol Biol Cell 23 (2012) 4129-4141
10. Gerth J, Sachse A, Busch M, Illner N, Muegge LO, Gröne HJ, Wolf G. Screening and differential diagnosis of renal light chain-associated diseases. Kidney Blood Press Res 35 (2012) 120-128
11. Hamadanchi A, Bothe W, Pfeil A, Rad AA, Brehm BR, Figulla HR, Doenst T, Franz M, Jung C. Left atrial endocarditis as a rare complication of mitral valve endocarditis: a clinical case. BMC Cardiovascular Disorders (2012) doi: 10.1186/1471-2261-12-103
12. Hammer M, Heller T, Jentsch S, Dawczynski J, Schweitzer D, Peters S, Schmidtke KU, Müller UA. Retinal Vessel Oxygen Saturation under Flicker Light Stimulation in Patients with Non-Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science 53 (2012) 4063-4068
13. Hansch A, Betge S, Poehlmann G, Neumann S, Baltzer P, Pfeil A, Waginger M, Boettcher J, Kaiser WA, Wolf G, Mentzel HJ. Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol 21 (2102) 318-325
14. Hansch A, Heyne JP, Jung C, Wolf G, Pfeil A. Quantitative first pass perfusion in cardiovascular magnetic resonance for determination of peak ventricular transit time--a technique for evaluation of heart function. European Journal of Radiology (2012) 996-1001
15. Hansch A, Kohlmann P, Hinneburg U, Boettcher J, Malich A, Wolf G, Laue H, Pfeil A. Quantitative evaluation of MR perfusion imaging using blood pool contrast agent in subjects without pulmonary diseases and in patients with pulmonary embolism. European Radiology (2012) 1748-1756
16. Hasslacher C, Wolf G, Kempe P, Ritz E. Diabetische Nephropathie - Praxis Leitlinie der DDG. Diabetologie und Stoffwechsel 7 (2012) 99-102
17. HellerT, Müller N, Kloos C, Wolf G, Müller UA. Self medication and use of dietary supplements in adult patients with endocrine and metabolic disorders. Exp Clin Endocr Diab 120 (2012) 540-546
18. Hunger-Battefeld W, Groten T. Gestationsdiabetes - praktische Umsetzung der neuen Leitlinie. Frauenheilkunde up2date 6 (2012) 285-303
19. Hunger-Battefeld W, Kiehntopf M, Wolf G. Autoimmunthyreopathie bei Patienten mit Typ 1 Diabetes mellitus. Diabetologie und Stoffwechsel 7 (2012) 442-449
20. Hunger-Battefeld W. Schilddrüse und Schwangerschaft. Gynäkologische Endokrinologie 10 (2012) 168-175
21. Kaemmerer D, Schmidt B, Lehmann G, Wolf G, Hommann M, Settmacher U. Monthly Ibandronate for the prevention of bone loss in patients after liver transplantation. Transplant Proceed 44 (2012) 1362-1367
22. Kaemmerer D, Schmidt B, Lehmann G, Wolf G, Settmacher U, Hommann M. Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation. Transplantation Research 1 (2012) 7
23. Kronbichler A, Wolf G.Ein ernster Fall von Exercise-assoziierter Hyponatriämie. Nieren- und Hochdruckkrankheiten 41 (2012) 177-181
24. Lambeck S, Weber M, Gonnert FA, Mrowka R, Bauer M. Comparison of sepsis-induced transcriptomic changes in a murine model to clinical blood samples identifies common response patterns. Front Microbiol 284 (2012)
25. Loeffler I, Liebisch M, Wolf G.Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy. Am J Physiol: Renal Physiol 303 (2012) F733-F745
26. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med  367 (2012) 214-23 
27. Mandecka A, Kloos C, Hunger-Battefeld W, Hochstetter A, Gajda M, Wolf G, Müller UA. Seltene Differentialdiagnose bei einem 40-jährigen Patienten mit Schlafapnoesyndrom. HNO 60 (2012)120-125 
28. MüllerN, Stengel D, Kloos C, Ristow M, Wolf G, MüllerUA. Improvement of HbA1c and stable weight loss two years after an outpatient treatment and teaching programme for patients with type 2 diabetes without insulin therapy based on urine glucose self monitoring. Int J Gen Med 5 (2012) 241-7
29. Oelzner P, Franke S, Lehmann G, Eidner T, Hein G, Wolf G. The balance between soluble receptors regulating IL-6-trans-signaling is predictive fort the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. Rheumatol Int 32 (2012) 199-206
30. Oelzner P, Wolf G. Evidenz von Bisphosphonaten bei entzündlich-rheumatischen Erkrankungen. Akt Rheumatol 37 (2012) 228-237
31. Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R Krumbholz A. Serological response to influenza A H1N1 vaccine (Pandemrix) and seasonal influenca 2009/2010 in renal transplant recepient and in hemodialysis patients. Medicl Microbiol Immunol. 202 (2012) 297-302
32. Otto GP, Wissuwa B, Mehnert A, Marx S, Raessler M, Lösche W, Claus RA, Sossdorf M. A method for detection and quantification of hydroxyethyl starch in plasma. Crit Care 16 (2012) 426
33. Otto GP, Neugebauer S, Claus RA, Sossdorf M. Arginine metabolism is markedly impaired in polymicrobial infected mice. Crit Care 16 (2012) 412
34. Paliege A, Roeschel T, Neymeyer H, Seidel S, Kahl T, Daigeler AL, Mutig K, Mrowka R, Ferreri NR, Wilson BS, Himmerkus N, Bleich M, Bachmann S. Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limb. Am J Physiol Renal Physiol. 2012 Apr 1;302(7):F865-874
35. Pfeil A,  Hansch A, Sommerfeld J, Fröber R, Renz DM, Lehmann G, Malich A, Wolf G, Böttcher J. Reproducibility and the influence of hand rotation on computer-aided joint space analysis. Joint, Bone, Spine 29 (2012) 384-388
36. Pfeil A, Betge S, Poehlmann G, Boettcher J, Drescher R, Malich A, Wolf G, Mentzel HJ, Hansch A. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study. European Journal of Radiology (2012) 547-552
37. Pfeil A, Drobnik S, Rzanny R, Aboud A, Böttcher J, Schmidt P, Ortmann C, Mall G, Hekmat K, Brehm B, Reichenbach J, Mayer TE, Wolf G, Hansch A. Compatibility of temporary pacemaker myocardial pacing leads with magnetic resonance imaging: an ex vivo tissue study. International Journal of Cardiovascular Imaging (2012) 317-326
38. Pfeil A, Hansch A, Busch M, Axer H, Wolf G. Unklares Koma bei einem 69-jährigen Patienten mit mikroskopischer Polyangiitis. Nephrologe 7 (2012) 505-507
39. Pfeil A, Hansch A, Renz DM, Malich A, Wolf G, Böttcher J. Die periartikuläre Demineralisation bei Patienten mit Rheumatoider Arthritis - Klinischer Stellenwert der Digitalen Radiogrammetrie als neues Diagnoseverfahren. Aktuelle Rheumatologie (2012) 284-253
40. Pfeil A, Jung C, Ferrari M, Figulla HR, Wolf G, Hansch A. Rezidivierende Synkopen bei einem 19-Jährigen-(Kein) Fall für den Kinderkardiologen. Münchner Medizinische Wochenschrift 154 (2012) 5
41. Prochnau D, Lauten A, Busch M, Kuehnert H, Figulla HR, Surber R. Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with end-stage renal disease. Int J Cardiol. 154 (2012) e29-30
42. Renz DM, Böttcher J, Diekmann F, Poellinger A, Maurer MH, Pfeil A, Streitparth F, Collettini F, Bick U, Hamm B, Fallenberg EM. Detection and classification of contrast-enhancing masses by a fully automatic computer-assisted diagnosis system for breast MRI. Journal Magnetic Resonance Imaging (2012) 1077-1088
43. Roth A, Abendroth K, Lehmann G. Indikationen und Voraussetzungen zur Knochenbiopsie. Z Orthop Unfall (2012) 495-498
44. Sämann A, Pofahl S, Lehmann T, Voigt B, Victor S, Möller F, Müller UA, Wolf G. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocr Diab 120 (2012) 335-339
45. Sämann A, Wolf G. CME -Zertifizierte  Fortbildung: Diabetische Nephropathie. Der Internist 53 (2012) 1195-1206
46. Schäfer ML, Böttcher J, Pfeil A, Hansch A, Malich A, Maurer MH, Streitparth F, Röttgen R, Renz DM. Comparison between amputation-induced demineralization and age-related bone loss using digital X-ray radiogrammetry. Journal of Clinical Densitometry (2012) 135-145
47. Stahr A, Frahm C, Kretz A, Bondeva T, Witte O, Wolf G. Morg1 +/- heterozygous mice are protected from experimentally induced focal cerebral ischemia. Brain Res 1482 (2012) 22-31
48. Velden J, Paust HJ, Hoxha E, Turner JE, Steinmetz OM, Wolf G, Jabs WJ, Özcan F, Beige F, Heering PJ, Schröder S, Kneißler U, Disteldorf E, Mittrücker HW, Stahl RAK, Helmchen U,  Panzer U. Renal IL-17 expression in human ANCA-associated Glomerulonephritis. Am J Physiol: Renal 302 (2012) F1603-F1673
49. Witzke O, Hauser IA, Bartels M, Wolf G, Wolters H, Nitschke M for The VIPP Study Group. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial. Transplantation 93 (2012) 61-68

1. Bäz I, Müller N, Beluchin E, Kloos C, Wolf G, Müller UA. Differences in the quality of diabetes care caused by social inequalities in Germany disappear after treatment in a tertiary care center. Diabetic Medicine 28 (2011) 1-6
   
   
2. Blum M, Sämann A, Wolf G. The eye, the kidney and microcirculation. Nephrology, Dialysis, Transplantation 26 (2011) 4-6
   
   
3. Bondeva T, Wojciech S, Wolf G. Advanced glycation end-products inhibit adhesion ability of differentiated podocytes in a Neuropilin 1 dependent manner.
   Am J Physiol Renal 301 (2011) F852-F870
   
   
4. Doerr R, Hoffmann U, Otter W, Heinemann L, Hunger-Battefeld W, Kulzer B, Klinge A, Lodwig V, Amann-Zalan I, Sturm D, Tschoepe D, Spitzer SG, Stumpf J, Lohmann T, Schnell O. Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 54 (2011) 2923-2930
   
   
5. Franke S, Rüster C, Pester J, Hofmann G, Oelzner P, Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 29 (2011): 650-660
   
   
6. Gerth J, Sachse A, Busch M, Illner N, Muegge LO, Gröne HJ, Wolf G. Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases. Kidney Blood Pressure Research 35 (2011) 120-128
   
   
7. Hansch A, Pfeil A, Neumann R, Neumann S, Mayer TE, Wolf G. Renal ablation in patients with end-stage renal disease. Vasa 40 (2011) 308-14
   
   
8. Hein G, Eidner T, Oelzner P, Rose M, Wilke A, Wolf G, Franke S. Influence of Rituximab on markers of bone remodeling inpatient with rheumatoid arthritis- a prospective open label pilot study. Rheumatol International 31 (2011)269-272
   
   
9. Hermann R, Ott U, Pfeil A, Maiwald J, Gajda M, Wolf G. Nephrogene systemische Fibrose: Verbesserung des Krankheitsverlaufs durch eine Nierentransplantation? Nieren- und Hochdruckkrankheiten (40)2011 29-34
   
   
10. Jung C, Pfeil A, Hamadanchi A, Hansch A. Cysts and trabecula. What is wrong with this liver?  Polycystic degeneration of the liver and kidneys. MMW Fortschr Med 153 (2011) 5
    
    
11. Jung C, Pfeil A, Hansch A. An unusual finding in thoracic CT. MMW Fortschr Med 153 (2011) 5
    
    
12. Kloos C, Müller N, Wolf G, Hartmann P, Lehmann T, Müller UA. Better HbA1c and blood pressure control in patients with diabetes mellitus treated at a primary health care level ten years after initiation of a diabetes qulaity improvement program. Exp Clin Endocrin & Diabetes 119 (2011) 459-462
    
    
13. Lehmann G, Pfeil A, Wolf G. Multiple Wirbelkörperfrakturen bei einer Primipara mit Hajdu-Cheney-Syndrom. Osteologie 4 (2011) 342-343
    
    
14. Lehmann G, Wolf G. Renale Osteodystrophie - Pathogenese, Diagnostik und Therapie. Medizinisch Orthopädische Technik 6 (2011) 46-53
    
    
15. Lehmann G, Wolf G. Skelettale Komplikationen bei chronischer Niereninsuffizienz und nach Nierentransplantation. Akt Rheumatol 36 (2011) 291-296
    
    
16. Lehmann G. Systemische  Osteopathien in Pathologie des Bewegungsapparates. Veith Krenn, Wolfgang Rüther (Hrsg.) De Gruyter. 253-275 ISBN 978-3-11-022189-3
    
    
17. Loeffler I, Hopfer U, Koczan D, Wolf G. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. J Am Soc Nephrol 22 (2011) 649-663
    
    
18. Mah N, Wang Y, Liao MC, Prigione A, Jozefczuk J, Lichtner B, Wolfrum K, Haltmeier M, Flöttmann M, Schaefer M, Hahn A, Mrowka R, Klipp E, Andrade-Navarro MA, Adjaye J. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network. PLoS One. 2011;6(8):e24351.
    
    
19. Müller N, Kloos C, Frank T, Ristow M, Wolf G, Müller UA. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes. Diabet Med 28 (2011) 223-226
    
    
20. Müller UA. The key to managing diabetes without tears - the treatment and teaching programme for flexible insulin therapy in Germany. Diabetes Voice 56 (2011) Special Issue 2, 16-18 http://www.idf.org/sites/default/files/attachments/DV_56-SI2.pdf
    
    
21. Müller UA. Werden DPP4-Hemmer Sulfonylharnstoffe in der Therapie des Typ-2-Diabetes ersetzen? Contra. Dtsch Med Wochenschr 136 (2011) 547
    
    
22. Neuman T, Wolf G. Nierenbeteiligung bei systemischen Vaskulitiden. Aktuelle Rheumatologie 36 (2011) 297 - 306
    
    
23. Neumann T, Sämann A, Lodes S, Kästner B, Franke S, Kiehntopf M, Hemmelmann C, Lehmann T, Müller UA, Hein G, Wolf G. Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabet Med 28 (2011) 872-875
    
    
24. Oelzner P, Wolf G. Nierenbeteiligung bei Kollagenosen. Aktuelle Rheumatologie 36 (2011) 307-317
    
    
25. Ott U, Wolf G. Nierenbiopsie - die Rolle in der nephrologischen Diagnostik. Dialyse aktuell 15 (2011) 506-510
    
    
26. Pfeil A, Betge S, Poehlmann G, Boettcher J, Drescher R, Malich A, Wolf G, Mentzel HJ, Hansch A. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium-An interrater reliability study. Eur J Radiol (2011) Epub ahead of print
    
    
27. Pfeil A, Busch M, Böttcher J, Hansch A, Freesmeyer M, Wolf G. Nichtinvasive bildgebende Verfahren - Technische Innovationen und Wertigkeit in der Nephrologie. Dialyse aktuell 15 (2011) 512-22
    
    
28. Pfeil A, Drobnik S, Rzanny R, Aboud A, Böttcher J, Schmidt P, Ortmann C, Mall G, Hekmat K, Brehm B, Reichenbach J, Mayer TE, Wolf G, Hansch A. Compatibility of temporary pacemaker myocardial pacing leads with magnetic resonance imaging: an ex vivo tissue study. Int J Cardiovasc Imaging (2011) Epub ahead of print
    
    
29. Pfeil A, Hansch A, Sommerfeld J, Fröber R, Renz DM, Lehmann G, Malich A, Wolf G, Böttcher J. Reproducibility and influence of hand rotation on computer-aided joint space analysis. Joint Bone Spine (2011) Epub ahead of print
    
    
30. Pfeil A, Haugeberg G, Hansch A, Renz DM, Lehmann G, Malich A, Wolf G, Böttcher J. Value of digital X-ray radiogrammetry in the assessment of inflammatory bone loss in rheumatoid arthritis. Arthritis Care Res (Hoboken) 63 (2011) 666-74
    
    
31. Pfeil A, Jung C, Boettcher J, Wolf G, Hansch A. Erdheim-Chester-Erkrankung - eine selten Erkrankung mit typischen Zeichen einer Knochenmanifestation. MMW Fortschr med 153 (2011) 24-25
    
    
32. Pfeil A, Jung C, Boettcher J, Wolf G, Hansch A. Which organs are involved here? Erdheim-Chester disease. MMW Fortschr Med 153 (2011) 5
    
    
33. Pfeil A, Sommerfeld J, Fröber R, Lehmann G, Malich A, Hansch A, Wolf G, Böttcher J. Feasibility study of semi-automated measurements of finger joint space widths. Rheumatol Int 31 (2011)1349-54
    
    
34. Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, Dietz R, Kivelitz D, Elgeti T. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. Rofo 183 (2011) 834-41
    
    
35. Ruester C, Franke S, Bondeva T, Wolf G. Erythropoetin protects podocytes from damage by advanced glycation end-products. Nephron: Experimental Nephrology 117 (2011) e21-e30
    
    
36. Ruester C, Franke S, Wenzel U, Schmidthaupt R, Fraune C, Krebs C, Wolf G. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction. Am J Nephrol 34 (2011) 309-317
    
    
37. Ruester C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. Journal of the American Society of Nephrology 22 (2011) 1189-1199
    
    
38. Ruester C, Wolf G. Diabetische Nephropathie- Neues zur Pathogenese. Der Nephrologe 6 (2011)390-299
     
39. Schmidt P, Boettcher J, Ragoschke-Schumm J, Mentzel HJ, Wolf G, Müller UA, Kaiser WA, Mayer TE, Sämann A. Continuous monitoring of the human brain during severe insulin-induced hypoglycemia by diffusion-weighted MR imaging. Am J Neuroradiology 32 (2011)1321-1327
    
    
40. Wolf G, Busch M, Müller N, Müller UA. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary center. Nephrol Dial Transplant 26 (2011) 4017-4023
    
    
41. Wolf G, Witzke O. Nieren- und Diabeteserkrankungen. Der Nephrologe 6 (2011) 389
    
    
42. Wolf G. Journal Club: Entwicklung einer terminalen Niereninsuffizienz besser voraussagen? Dialyse aktuell 15 (2011) 492
    
    
43. Wolf G. The suffering of the Grail King in Wagner´s Parsifal: was it amyloidosis? Nieren- Hochdruckkrankheiten 40 (2011) 355-359
    
    
44. Wolf G. Wie wirksam ist Aspirin bei Typ2-Diabetikern mit unterschiedlicher GFR? Diabetologie und Stoffwechsel 6 (2011) 148
    
    
45. Wolf G. Zum Thema: Diagnostik in der Nephrologie. Dialyse aktuell 15 (2011), 494
    
    
46. Zipfel PF, Wolf G, John U, Kentouche K, Skerka C. Novel Developments in Thrombotic Microangiopathies: Report From the 4th International Workshop on Thrombotic Microangiopathies. Pediatric Nephrology 26 (2011) 1947-1956
    
    
47. Zwerina J, Bach C, Martorana D, Jatzwauk M, Hegasy G, Moosig F, Bremer J, Wieczorek S, Moschen A, Tilg H, Neumann T, Spriewald B, Schett G and Vaglio A. Eotaxin-3 in Churg-Strauss Syndrome: A clinical and immunogenetic study. Rheumatology (Oxford) 50 (2011) 1823-7

1. Bahrmann A, Zieschang T, Neumann T, Hein G, Oster P.: Das Karpaltunnelsyndrom bei Diabetes mellitus. Med Klinik 105 (2010) 150-4
2. Böttcher J, Pfeil A, Wolf G.: Radiologische Progression bei rheumatoider Arthritis. Evaluation mittels der Digitalen Radiogrammetrie. Orthopädie und Rheuma 6 (2010) 46-50
3. Busch M, Pfeil A, Traut M, Joachimski F, Mückley T, Romeike B, Wolf G.: Akutes Nierenversagen bei einer 70-jährigen Frau. Der Nephrologe 5 (2010) 58-61
4. Busch M, Göbert A, Franke S, Ott U, Gerth J, Müller A, Stein G, Bitsch R, Wolf G.: Vitamin B 6 Metabolism in Chronic Kidney Disease - Relation to Transsulfuration, Advanced Glycation and Cardiovascular Disease; Nephron Clinical Practice 114 (2010) c38-c46
5. Busch M, Franke S, Rüster Ch, Wolf G.: Advanced glycation end-products and the kidney; European Journal of Clinical Investigation 40 (2010) 742-755
6. Eidner T.: Leitliniengerechte Osteoporose-Diagnostik: von der Risikostratifizierung zur Therapieentscheidung. DBI. Der Bay Int. 30 (2010) 120-125
7. Fischle EM, P.Oelzner, G.Hein, G.Wolf.: Erst Hypokalzämie, dann Kalziummangel - Eine Expedition durch die Fallstricke des Kalziumstoffwechsel anhand eines Fallbeispiels. Nieren- und Hochdruckkrankheiten 39 (2010)  110-114
8. Fischle EM, Pfeil A, Odparlik A, Neumann T, Zanow J, Hansch A, Oelzner P,  Freesmeyer M, Wolf G.: Darstellung einer infizierten Gefäßprothese der Arteria iliaca mittels 18F-Fluorodeoxyglukose Ganzkörper -Positronenemissionstomographie Computertomographie bei einem Patienten nach Nierentransplantation. Nieren und Hochdruckkrankheiten 39 (2010) 484-487
9. Gerth J, Busch M, Illner N, Traut M, Gröne HJ, Wolf G.: Are tissue samples from two different anatomical areas of the kidney necessary for adequate diagnosis?; Clinical Nephrology 74 (2010) 258-65
10. Gerth J, Busch M, Ott U, Gröne HJ, Wolf G.: Verlauf einer Light Chain Deposition Disease (LCDD) über 8 Jahre; Nieren- und Hochdruckkrankheiten 39 (2010) 338-343
11. Hallbauer J, Kreusch S, Kleem A, Wolf G, Rhode H.: Long-term Serum proteomes are quite similar under high- and low-flux hemodialysis treatment. Proteomics Clinical application 4 (2010) 953-961
12. Hansch A, Betge S, Pfeil A, Mayer TE, Wolf G, Brehm B.: Spontaneous rupture of the right coronary atery. Circulation 121 (2010) 2692-2693
13. Hansch A, Neumann R, Gajda M, Marintchev I, Pfeil A, Mayer TE.: Transarterial catheter embolization of a sarcoma for preoperative conditioning. Vasa 39 (2010) 185-188
14. Hasslacher C, Wolf G, Kempe P, Ritz E: Diabetische Nephropathie-Praxis Leitlinie der DDG. Diabetologie und Stoffwechsel 5 (2010) 113-116
15. Häuser K, Ott U, Gerth J, Busch M, Stein G.: Einfluss des Urinvolumens auf die Progression einer chronischen Nierenerkrankung; Nieren- und Hochdruckkrankheiten 39  (2010) 8-16
16. Hermann R, A Pfeil, M Busch, C Kettner, D Kretzschmar, A Hansch, P La Rosée, G Wolf.: Schwerste thrombotisch-thrombozytopenische Purpura (TTP) nach H1N1-Vakzinierung; Medizinische Klinik 105 (2010) 663-668
17. Hunger-Battefeld W, Mandecka A, Gajda M, Hansch A, Müller UA, Wolf G.: Diagnostische Fallstricke beim Cushing-Syndrom. Internist 51 (2010) 293-302
18. Illner N, Wolf G.: Rituximab als effektive Therapie bei schwerster thrombotisch-thrombozytopenischer Purpura. Deutsche Med Wschr 135 (2010) 71-74
19. Kaemmerer D, Lehmann G, Wolf G, Settmacher U, Hommann M.: Treatment of osteoporosis after liver transplantation with ibandronate. Transplant Int 23 (2010) 753-759
20. Kellner H, Bornholdt K, Hein G.: Leflunomide in the treatment of patients with early rheumatoid-arthritis - results of a prospective non-interventional study. Clin Rheumatol 29 (2010) 913-20
21. Lehmann G, Wolf G.: Histomorphometrie des Knochens-Methode und Indikation. Der bayrische Internist 30 (2010) 136-140
22. Lehmann G, Wolf G.: Teriparatid-ein Überblick. Arzneimitteltherapie 28 (2010) 277-282
23. Marx C, Busch M, Ott U, Wolf G.: Sekundärer Hyperparathyreoidismus bei Patienten nach Nierentransplantation. Nieren und Hochdruckkrankheiten 93 (2010) 95-101
24. Marx C, Busch M, Ott U, Gerth J, Wolf G.: Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin receptor antagonists; Clinical Transplantation 24 (2010) 626-630
25. Oelzner P, Fleissner-Richter S, Bräuer R, Hein G, Wolf G, Neumann T.: Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat. Inflamm Res 59 (2010)731-741  
26. Ott U, Wolf G.: Indikation zur Nierenbiopsie nach Nierentransplantation. Der Nephrologe 6 (2010) 466-472
27. Ott U, Busch M, Steiner T, Wolf G.: Presence of Cardiovascular Disease in Patients on a Waiting List for Renal Transplantation and in Patients After Kidney Transplantation in a Single Center; Transplantation Proceedings 42 (2010) 3450-3454
28. Quick C, Kliem A, Berger S, Hocke M, Tancer M, Juckel G, Yeragani VK, Bär KJ.: Gastric dysmotility in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):92-7
29. Pfeil A, Neumann T, Römhild U, Fischle EM, Odparlik A, Steiner G, Mandecka A, Oelzner P, Freesmeyer M, Wolf G.: Inflammatory Obstruction of the Ureter Caused by Infrarenal Aortitis. Circulation 121 (2010) 453-454
30. Pfeil A, Pfeifer R, Böttcher J, Neumann R, Axer H, Schmidt P, Herzog A, Kaiser WA, Wolf G, Hansch A.: Cerebral hypoxia or cyanide intoxication? MMW Fortschr Med 152 (2010) 38-39
31. Pfeil A, Pfeifer R, Böttcher J, Neumann R, Axer H, Schmidt P, Herzog A, Kaiser WA, Wolf G, Hansch A.: Potential einer Differenzierung zwischen hypoxischer Hirnschädigung und Zyanidintoxikation in der MRT- und CT- Bildgebung des Gehirns. Münchner Medizinische Wochenschrift 43: (2010) 38-39
32. Pfeil A, Reissig A, Heyne JP, Wolf G, Kaiser WA, Kroegel C, Hansch A.: Transthoracic sonography in comparison to multislice computed tomography in detection of peripheral pulmonary embolism. Lung 188 (2010) 43-50
33. Pfeil A, Schmidt P, Hermann R, Böttcher J, Wolf G, Hansch A.: Parenchymal and pleural findings in pulmonary embolism visualized by multichannel detector computed tomography. Acta radiological 51(2010) 75-81
34. Ruester C, S.Franke, T.Bondeva, G.Wolf.: Erythropoetin protects podocytes from damage by advanced glycation end-products. Nephron: Experimental Nephrology 117 (2011) e21-e30
35. Rüster C, Wolf G.: Models of diabetic nephropathy. Drug Discovery Today 7 (2010) 35-41
36. Schiel R, Kaps A, Kamer G, Chudaske C, König K, Müller UA: Wie erleben Kinder und Jugendliche mit Diabetes mellitus Typ 1 und ihre Bezugspersonen Hypoglykämien? Diabetologie 175 (2010)169:175
37. Stone MA, Wilkinson JC, Charpentier G, Clochard N, Lindblad U, Müller UA, Nolan J, Rutten GE, Trento M, Kamlesh Khunti K, on behalf of the GUIDANCE Study Group: Evaluation  and comparison of guidelines for the management of people with type 2 diabetes from eight European countries; Diabetes Res Clin Pract 87 (2010) 252-60
38. Thude, H, Weißenborn S, Vilser C, Müller UA, Kloos C, Wolf G, Beck J, Barz D.: No association between transmembrane protein-tyrosine in a German population. Hum Immunol 71 (2010) 220-3
39. Wolf G, Amann K: Nierenbiopsie. Der Nephrologe 5 (2010) 463-465
40. Wolf G.: Darbopoetin: weniger kardiovaskuläre Komplikationen? Diabetologie und Stoffwechsel 3 (2010) 150
41. Wolf G.: Diabetische Nephropathie. Eine Langzeitkomplikation des Diabetes mellitus. Diabetes aktuell 2 (2010) 6-13
42. Wolf G.: Kann die stationäre Tätigkeit in der Nephrologie einem ärztlichen “burn-out” vorbeugen? Nieren- Hochdruckkrankheiten 93 (2010) 102-109

1. Bondeva T, Rüster C, Franke S, Hammerschmidt E, Klagsbrun M, Cohen CD, Wolf G: Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Kidney Int 75 (2009) 605-616
2. Bondeva T, Wolf G: Advanced glycation end-products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity. Am J Nephrol 30 (2009) 336-345
3. Braun AK, Kubiak T, Kuntsche J, Meier-Höfig M, Müller UA, Feucht I, Zeyfang A. SGS: A structured treatment and teaching programme for older patients with diabetes mellitus--a prospective randomised controlled multi-centre trial. Age Ageing 38 (2009) 390-6
4. Dawczynski C, Schubert R, Hein G, Müller A, Eidner T, Vogelsang H, Basu S, Jahreis G: Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br J Nutr  101 (2009)1517-1526
5. Dost A, Hofer S, Herbst A, Stachow R, Schober E, Müller UA, Holl RW: Factors Contributing to Terminal Digital Preference in 91398 Patients with Diabetes mellitus in Germany and Austria: Possible Impact on Therapeutic decisions. Diabet Med. 26 (2009) 947-8
6. Drinda S, Franke S, Eidner T, Schmidt C, Rüster C, Bondeva T, Hein G, Wolf G: Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Clin Exp Rheumatol 27 (2009) 483-490
7. Franck H, Braun J, Buttgereit F, Demary W, Hein G, Kekow J, Schett G, Kern PM: Knochendichtemessungen bei entzündlich-rheumatischen Erkrankungen. Z. Rheumatol 68 (2009) 845-850
8. Franke S, Sommer M, Rüster C, Bondeva T, Marticke J, Hofmann G, Hein G, Wolf G: Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells. Arthritis Res Ther 11 (2009) R136
9. Fünfstück R, Wolf G: Hypertonie bei Diabetes mellitus. Thüringer Ärzteblatt 20 (2009), 176-180
10. Gajda M, Schulze E, Reichelt O, Wunderlich H, Gerth J, Ott U, Junker K, Wolf G, Katenkamp D: Urine cytology after kidney transplantation. Lekarz  Wojskowy 87 (2009): 84-88
11. Gerth J, Busch M, Ott U, Groene HJ, Wolf G: Evolution of light chain deposition disease over 8 years. Clin Nephrol 72 (2009) 397-401
12. Gerth J, Busch M, Ott U, Seifert M, Gröne HJ, Wolf G: Akutes Nierenversagen bei einer 36-jährigen Patientin mit hebephrener Schizophrenie. Der Nephrologe 4 (2009) 148-151
13. Gerth J, Busch M, Oyen F, Schneppenheim R, Keller T, Budde U, Groene HJ, Wolf G: Thrombotische Mikroangiopathie bei einem 17.jährigen Patienten: TTP, HUS oder etwas von beidem? Nieren- und Hochdruckkrankheiten 38 (2009) 117-124
14. Gerth J, Schleussner E, Kentouche K, Busch M, Seifert M, Wolf G: Pregnancy-associated thrombotic thrombocytopenic purpura Thromb Haemost 101(2009) 248-251
15. Gerth J, Wolf G: Physiologische Adaptationen während der normalen Schwangerschaft. Der Nephrologe 4 (2009) 301-305
16. Haase D, Keiner S, Mawrin C, Wolf G: Reduced Morg1 expression in ischemic human brain. Neuroscience Lett 455 (2009) 46-50
17. Hammerschmidt E, Loeffler I, Wolf G: Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297 (2009) F1273-F1287
18. Hansch A, Gajda M, Pfeil A, Kaiser WA, Böttcher J: Intracardiac metastases of hepatocellular carcinoma. Rofo 181 (2009) 595-596
19. Hansch A, Neumann R, Pfeil A, Marintchev I, Pfleiderer S, Gajda M, Kaiser WA: Embolization of an unusual metastatic site of hepatocellular carcinoma in the humerus. World J Gastroenterol 15 (2009) 2280-2282
20. Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA: First-pass myocardial perfusion abnormalities in Churg-Strauss syndrome with cardiac involvement. Int J Cardiovasc Imaging 25 (2009) 501-510
21. Hasslacher C, Wolf G, Kempe P, Ritz E: Diabetische Nephropathie. Diabetologie Stoffwechsel 4 (Suppl.2) (2009) S127-S130
22. Hopfer U, Hopfer H, Meyer-Schwesinger C, Löffler I, Fukai N, Olsen BJ, Stahl RAK, Wolf G: Lack of type VIII collagen in mice ameliorates diabetic nephropathy. Diabetes 58 (2009) 1672-1681
23. Hunger-Battefeld W: Gestationsdiabetes - Eine häufige Schwangerschaftskomplikation: Diabetes aktuell (2009) 6: 272-276
24. Hunger-Battefeld W, Fath K, Mandecka A, Kiehntopf M, Kloos C, Müller UA, Wolf G: Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1. Med Klin 104 (2009) 183-91
25. Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhhart K,  Wolf G, Amann KU, Marx G: Hydroxyethylstarch impairs renal function and induces interstitila proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13 (2009) R23-R31
26. Illner N, Gerth J, Pfeiffer R, Bruns T, Wolf G: Nearly a stairway to heaven”-severe dichromate intoxication in a young man. Clin Nephrol 71(2009) 338-341
27. Kloos C, Hagen F, Lindloh C, Braun A, Leppert K, Müller N, Wolf G, Müller UA: Cognitive function is not associated with recurrent foot ulcers in patients with diabetes and neuropathy. Diabetes Care 32 (2009) 1355
28. Kornberg A, Küpper B, Bärthel E, Tannapfel A, Müller U, Thrum K, Kloos C, Wolf G: Combined en bloc liver-pancreas transplantation in patients with liver cirrhosis and insulin-dependent type 2 diabetes mellitus. Transplantation 87 (2009) 542-545
29. Krizanic F, Traut M, Gerth J, Wolf G: Case Report: a diabetic patient with acute renal failure and cardiac hypertrophy. J Nephrol Renal Transplant 2 (2009) 54-65
30. Kunisch E, Jansen A, Kojima F, Löffler I, Kapoor M, Kawai S, Rubio I, Crofford LJ, and Kinne RW: Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-a on synovial fibroblasts via specific E prostanoid receptors/cAMP. J Immunol. 183 (2009) 1328-1336 
31. Lehmann G, Ott U, Maiwald J, Wolf G: Bone-histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic renal bone disease subsequent to parathyreodectomy. Nephro Dial Transplant Plus  2 (2009) 49-51
32. Lehmann G, Pfeil A, Böttcher J, Kaiser WA, Füller J, Hein G, Wolf G: Benefit of a 17 years long-term bisphosphonate therapy in a patient with Gorham Stout Syndrome. Archiv Othop Trauma Surgery 129 (2009) 967-972
33. Lehmann G, Wolf G: Biochemische Marker des Knochenumbaus bei Dialysepatienten. Nephrologie im Dialog 2 (2009) 9-12
34. Lehmann G, Wolf G: Renale Osteodystrophie: Knochenhistologie bei Niereninsuffizienz und nach Nierentransplantation. Osteologie forum 15 (2009) 26-29
35. Mandecka A, Dawczynski J, Blum M, Vilser W, Kloos C, Müller N, Wolf G, Müller UA: Abnormal retinal autoregulation is detected by provoked stimulation with flicker light in well-controlled type 1 diabetes without retinopathy. Diab Res Clin Pract 86 (2009) 51-55
36. Materne C, Gerth J, Ott U, Gröne HJ, Wolf G: Wechsel zwischen BK-Virus-Nephropathie und Abstoßung-der frustrane Verlauf einer Lebendnierenspende. Med Klinik 104 (2009) 644-648
37. Neumann T, Manger B, Kern P, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J: Cardiac involvement in Churg-Strauss syndrome: impact of endomycarditis. Medicine 88 (2009) 236-243
38. Neumann T, Oelzner P, Freesmeyer M, Hansch A, Opfermann T, Hein G, Wolf G: Diagnosis of large vessel vasculitis by  [18F]fluorodeoxyglucose-positron emission tomography. Circulation 119 (2009) 338-339
39. Ott U, Wolf G: Schwangerschaft bei Nierenersatztherapie und Nierentransplantation. Der Nephrologe 4 (2009) 326-333
40. Otto S, Figulla HR, Goebel B, Oelzner P, Poerner TC: Churg-strauss syndrome presenting with cardiac mass and right ventricular obstruction. Clin Cardiol 32 (2009) E77-79
41. Panzer U, Steinmetz OM, Turner JE, Meyer-Schwesinger C, von Ruffer C, Meyer TN, Zahner G, Gomez-Guerro C, Schmid RM, Helmchen U, Moeckel GW, Wolf G, Stahl RAK, Thaiss F: Resolution of renal inflammation: a new role for NF-kB1 (p50) in inflammatory kidney disease. Am J Physiol:Renal 297 (2009) F429-F439
42. Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F, Hölscher C, Wolf G, Kurts C, Mittrücker HW, Stahl RAK, Panzer U: The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 20 (2009) 969-979
43. Peupelmann J, Boettger MK, Ruhland C, Berger S, Ramachandraiah CT, Yeragani VK, Bär KJ: Cardio-respiratory coupling indicates suppression of vagal activity in acute schizophrenia. Schizophr Res 112 (2009) 153-157
44. Pfeil A, Brehm B, Lopatta E, Neumann T, Schmidt P, Wolf G, Kaiser WA, Hansch A: Acute chest pain, heart failure and eosinophilia in a women without coronary disease. Cardiovasc Intervent Radiol 32 (2009) 1272-1274
45. Pfeil A, Hansch A, Lehmann G, Eidner T, Schäfer ML, Oelzner P, Renz DM, Wolf G, Hein G, Kaiser WA, Böttcher J: Impact of sex, age, body mass index and handedness on finger joint space width in patients  with prologed rheumatoid arthritis using computer-aided joint space analysis. Rheumatol Int 29 (2009) 517-524
46. Pfeil A, Lippold J, Eidner T, Lehmann G, Oelzner P, Renz DM, Hansch A, Wolf G, Hein G, Kaiser WA, Böttcher J: Effects of leflunomide and methotrexate in rheumatoid arthritis detected by digital X-ray radiogrammetry and computer-aided joint space analysis. Rheumatol Int 29 (2009) 287-295
47. Pfeil A, Schäfer ML, Lehmann G, Seidl BE, Eidner T, Malich A, Renz DM, Oelzner P, Hansch A, Wolf G, Hein G, Kaiser WA, Böttcher J: Implementation of Z-scores as an age- and sex-independent parameter for estimating joint space widths in rheumatoid arthritis. J Rheumatol 36 (2009) 717-723
48. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G: TGF-b and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792 (2009), 746-756
49. Preul C, Gerth J, Lang S, Bergmeier C, Witte OW, Wolf G, Terborg C: Cerebral involvement in a case of Goodpasture syndrome due to shortened induction therapy: a acse report. J Med Case Reports 3 (2009) 120-125
50. Rüster C, Bondeva T, Franke S, Tanaka N, Yamamoto H, Wolf G: Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors. Am J Nephrol 29 (2009) 538-550
51. Sämann A, Lehmann T, Seelinger S, Kaiser J, Wolf G, Müller UA: HbA1c-Kartographierung-Evaluation eines neuartigen versorgungsepidemiologischen Verfahrens zum Monitoring der Stoffwechselkontrolle von Patienten mit Diabetes mellitus. Das Gesundheitswesen 71 (2009) 476-480
52. Schiel R, Netzer C, Junghänel J, Müller UA: Die Behandlungsqualität von Patienten mit Typ-1- und Typ-2-Diabetes mellitus in der hausärztlichen Betreuung: Ergebnisse einer vergleichenden Untersuchung in Ostvorpommern und Thüringen. Z Evid Fortbild Qual Gesundhwes 103 (2009) 453-60
53. Steiner T, Boehme C, Wolf G, Schubert J, Ott U:
    
54. Impact of immunologic and non-immunologic variables on long-term outcome after kidney transplantation. Transplant Proc 41 (2009) 2521-2523
55. Steiner T, Wunderlich H, Ott U: Sexualität nach Nierentransplantation. Urologe 48 (2009) 1438-1442
56. Wähnert D, Hoffmeier KL, Lehmann G, Fröber R, Hofmann GO, Mückley T:
57. Temperature influence on DXA measurements: bone mineral density acquisition in frozen and thawed human femora. BMC Musculoskelet Disord. 24 (2009) 25
58. Wolf G: Diabetes und Niere-Update 2009. Der Diabetologe 5 (2009) 190-199
59. Wolf G: Possible mythological meanings of kidney excision to Jack the Ripper. The Ripperologist 99 (2009) 1-7
60. Wolf G, Misselwitz J: Proteinurie und Progression von Nierenerkrankungen. PÄD Praktische Pädiatrie 15 (2009) 80-84
61. Wolf G, Müller N, Busch M, Eidner G, Kloos C, Hunger-Battefeld W, Müller UA: Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association.Nephrol Dial Transplant 24 (2009) 1896-1901
62. Wolf G, Ziyadeh F: Transforming growth factor-b and diabetic nephropathy. J Organ Dysfunction 5 (2009) 130-139
63. Wolf G, Schleussenr E: Schwangerschaft und Niere. Nephrologe 4 (2009) 299-300

1. Blum M, Kloos C, Günther S, Hunger-Battefeld W, Müller UA. Improved Metabolic Control Results in Better Myogenic Response of Retinal Arterioles in Patients with Diabetes Mellitus Type 1. Ophthalmologica 2008 222:373-377.
   
2. Bondeva T, Scholl S, Liu Y, Clement JH, Höffken K, Wetzker R. Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma. J Cancer Res Clin Oncol. 2008 Aug;134(8):861-72.
3. Braun A, Oelzner P, Neumann T, Hein G, Gröne HJ, Ziemer M, Wolf G. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Rheumatol Int. 2008 Mar; 28(5):503-6.Braun A, Sämann A, Kubiak T, Zieschang T, Kloos Ch,
   
4. Müller UA, Oster P, Wolf G, Schiel R. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes- mellitus. Running title: Impact of diabetes treatment on quality of life. Patient Educ Consult. 2008 73, 50-59.
5. Busch M, Franke S, Wolf G, Rohde RD, Stein G. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine  and pentosidine are not influenced by treatment with the angiotensin II receptor type 1 blocker irbesartan in patients with type 2 diabetes and hypertension. Nephron Clin Pract. 2008; 108:c291-7.
   
6. Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G. Behandlung der idiopathischen membranösen Glomerulonephritis. Ist der Anti-CD20 Antikörper Rituximab eine sinnvolle Therapieoption? Med Klinik 2008; 103: 519-24.
   
7. Gerth J, Busch M, Ott U, Seifert M, Traut M, Heyne J-P, Wolf G. Rechtsseitiger Pleuraerguss bei einer jungen CAPD-Patientin. Nephrologe 2008; 3: 128-133.
8. Hartmann M, Gundermann C, Richter A, Eidner T, Hein G. Is the guideline, „Management of early rheumatoid arthritis,“ being followed in a rheumatismcenter? Dtsch Med Wochenschr. 2008; 35: 1721-4.
   
9. Hein GE, Meister M, Oelzner P, Franke S. sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis. Rheumatol Int. 2008 Jun;28(8):765-9.
   
10. Hunger-Battefeld W, Wolf G.Lebenszeichen: Die Frau litt unter lebensbedrohlichen Kaliummangel. Süddeutsche Zeitung Wissen 2008; 7/8: 43.
11. Kirchoff F, Krebs C, Abdulhag U, Meyer-Schwesinger C, Maas R, Helmchen U, Hilgers K, Wolf G, Stahl R, Wenzel U. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney Int. 2008; 73:643-50.
12. Lange U, Oelzner P, Uhlemann C. Dercum`s disease (Lipomatosis dolorosa): successful therapy with pregabalin and manual lymphatic drainage and a current overview. Rheumatol Int. 2008 Nov; 29(1):17-22.
    
13. Lehmann G, Ott U, Kämmerer D, Schütze J, Wolf G. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney diseases stages 3-5. Clin Nephrol. 2008; 70:296-305.
14. Linde B, Hein G. DISH-Syndrom und Diabetes mellitus. Arthritis + rheuma 2008; 4:219-222.
15. Lynemann JD, Frey O, Eidner T, Baier M, Roberts S, Sahihara J, Volkmer R, Cohen JI, Hein G, Kamradt T, Münz C. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008; 181(2): 991-1000.
    
16. Mandecka A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, Vilser W, Hoyer H, Müller UA. Influence of Flickering Light on the Retinal Vessels in Diabetic Patients: Response to Nguyen, Cheung, and Wong. Diabetes Care 2008; 31(6): e52.
    
17. Müller N, Schiel R, Osterbrink B, Holl RW, Kerner W, Hauner H, Beyer P, Hoyer H, Krug J, Müller UA. Care and Outcome in Patients with Diabetes Mellitus Type 1 and Type 2 in Specialized Practice, Diabetes Specialized Hospital and Diabetes Department of a Regional General Hospital in Germany. Diabetologie 2008; 3: 41-50.
    
18. Oelzner P, Schwabe A,  Lehmann G, Eidner T, Franke S, Wolf G, Hein G. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int. 2008 Sep;28(11):1143-50.
19. Ott U, Busch M, Steiner M, Schubert J, Wolf G. Renal retransplantation: a retrospective monocentric study. Transplant Proc. 2008; 40(5): 1345-1348.
    
20. Ott U, Busch M, Steiner T, Schubert J, Gröne E, Gröne HJ, Wolf G. Renal failure, sepsis, and bilateral kidney tumors. Xanthogranulomatous Pyelonephritis. Kidney Int. 2008; 73(6): 787-788.
    
21. Ott U, Busch M, Steiner T, Wolf G. Anemia after renal transplantation - an underestimated problem. Transplant Proc. 2008 Dec; 40(10): 3481-3484.
    
22. Ott U, Gerth J, Gröne HJ, Gröne E, Wolf G. Cholesterol embolization in a renal graft. Clin Transplant. 2008 Sep-Oct; 22(5): 677-680.
    
23. Ott U, Steiner T, Busch M, Gerth J, Wolf G. A single-center experience with BK virus nephropathy. Clin Nephrol. 2008; 69 (4): 244-250.
    
24. Panzer U, Zahner G, Wienberg U, Steinmetz OM, Peters A,  Turner JE, Paust H, Wolf G, Stahl RAK, Schneider A.15-deoxy-Δ12,14-prostglandin J2 inhibits INF-α-induced SJAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrol Dial Transplant. 2008; 23:3776-85.
25. Pfeil A, Böttcher J, Schäfer ML, Seidl BE, Schmidt M, Petrovitch A, Heyne JP, Lehmann G, Oelzner P, Hein G, Wolf G, Kaiser WA. Normative reference values of joint space width estimated by computer-aided joint space analysis (CAJSA): the distal interphalangeal joint. J Digital Imaging 2008; 21:104-12 .
26. Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, Hellmich B, Csernok E, Distler J, Manger B, Redlich K, Schett G, Zwerina J. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008 Jun;47(6):804-8.
27. Rousseau JC, Sumer EU, Hein G, Sondergaard BC, Madsen S, Pedersen C, Neumann T, Mueller A, Quist P, Delmas P, Karsdal MA. Patients with Rheumatoid Arthritis have an altered circulatory Aggrecan Profile BMC Musculoskelet Disord. 2008 May 28;9(1):74.
28. Rüster C, Bondeva T, Franke S, Förster M, Wolf G. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant. 2008 Jul;23(7):2179-91.
29. Sämann A , Tajiyeva O, Müller N, Tschauner T, Hoyer H, Wolf G, Müller UA. Prevalence of diabetic foot syndrome at primary care level in Germany: a cross-sectional study. Diab Med. 2008; 25:557-63.
30. Sämann A, Lehmann T, Kloos C, Braun A, Hunger-Battefeld W, Wolf G, Müller UA. Flexible, intensive insulin therapy and dietary freedom in adolescents and young adults with Type 1 diabetes: a prospective implementation study. Diabet Med. 2008 May;25 (5):592-6.
31. Schäfer ML, Pfeil A, Renz DM, Lehmann G, Schmidt M, Hansch A, Hein G, Wolf G, Kaiser WA, Böttcher J. Effects of long-term immobilisation on cortical bone mass after traumatic amputation of the phalanges estimated by digital X-ray radiogrammetry. Osteoporos Int. 2008; 19 (9), 1291-9.
32. Seifert M, Gerth J, Gajda M, Pester F, Pfeifer R, Wolf G. Eosinophilie - eine differentialdiagnostische Herausforderung. Med Klin 2008; 103 (8): 591-597.
33. Siegmund R, Boer K, Pöschel K, Wolf G, Deufel T, Kiehntopf M. Comparison of  the ecarin chromogenic assay and different aPTTT assays for the measurements of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients. Throm Res 2008; 123:159-65.
34. Siegmund R, Boer K, Pöschel K, Wolf G, Deufel T, Kiehntopf M. Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation and patients with liver dysfunction. Blood Coagul Fibrin 2008; 9:288-93.
35. Steiner T, Schubert J, Wolf G, Giessing M. 15. Jahrestagung des Arbeitskreises Nierentransplantation der Akademie der Deutschen Urologen. Der Urologe 2008; 47:486-8.
36. Wernicke D, Voigt A, Müller A, Schmidt WA, Stiehl P, Hein G. Association between histopathologic type II synovitis and increased amounts of pyridinoline in synovial tissue samples in rheumatoid arthritis. Z Rheumatol. 2008; 67 (3), 225-31.
    
37. Wolf G, Müller N, Hunger-Battefeld W, Kloos C, Müller UA. Hemoglobin concentrations are closely linked to renal function in patients with type 1 and 2 diabetes mellitus. Kidney Blood Pressure Res. 2008; 31: 313-21.
38. Wolf G. A kidney from hell?- A nephrological view of the Whitechapel murders in 1888. Nephrol Dial Transplant. 2008; 23:3343-9.
39. Wolf G. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis. Nat Clin Nephrol. 2008; 4:474-5.

Originalarbeiten

1. Böttcher J, Pfeil A, Kaiser WA, Hein G, Wolf G. New CAD techniques based on digital hand radiographs for early diagnosis of rheumatoid arthritis. Hosp Imag Radiol 2007  2: 15-19.
2. Blum M, Kloos C, Mueller N, Mandecka A, Berner R, Bertram B, Mueller UA. Prevalence of diabetic retinopathy: Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 2007 104 :499-500.
   
3. Busch M, Franke S, Stein G, Wolf G. Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease? Deutsche Medizinische Wochenschrift 2007  132: 1810-1814.
4. Dawczynski J, Mandecka A, Blum M, Müller UA, Ach T, Strobel J. Endothelial Dysfunction of Central Retinal Vessels: A Prognostic Parameter for Diabetic Retinopathy? Klin Monatsbl Augenheilkd 2007 224 : 827-831.
5. Franke S, Siggelkow H, Wolf G, Hein G. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 2007 113: 154-161.
   
6. Gerth J, Busch M, Oyen F, Schneppenheim R, Keller T, Budde U, Gröne HJ, Wolf G. Thrombotic microangiopathy in a 17 year old patient: TTP, HUS, or a bit of both? Clinical Nephrology 2007 68: 405-411.
7. Gerth J, Cohen CD, Hopfer U, Lindenmeyer MT, Sommer M, Gröne HJ, Wolf G. Collagen type VIII expression in human diabetic nephropathy. Eur J Clin Invest 2007 37: 767-773.
8. Gerth J, Ott U, Busch M, Heyne JP, Baier M, Wolf G. Leistungsknick ein Jahr nach Nierentransplantation-unspezifisches Symptom einer seltenen Infektion. Der Nephrologe 2007 2:124-127.
9. Harscher S, Rummler S, Oelzner P, Mentzel HJ, Brodhun M, Witte OW, Terborg C, Isenmann S. Selective immunoabsorption in neurologic complications of systemic lupus erythematosus. Nervenarzt 2007 78: 441-444.
10. Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W,  Wolf G,  Settmacher U. Prevention of Early loss of Bone Mineral Density After Liver Transplantation  by Prostaglandin E1. Transplant Proc 2007 39:540-543.
11. Hunger-Dathe W, Hocke M, Sämann A, Müller UA, Wolf G, Gajda M. 64-jährige Patientin mit rezidivierenden Hypoglykämien. Schwierige Diagnosestellung. Der Internist 2007 48:1020-1028.
12. Kloos Ch, Sämann A, Lehmann T, Braun A, Heckmann B, Müller UA. Flexible intensive versus conventional insulin therapy in insulin-naive adults with type 2 diabetes: an open-label, randomized, controlled, crossover clinical trial of metabolic control and patient preference. Diabetes Care 2007 30 : 3031-3032.
13. Lehmann G, Becker K, Wolf G, Hein G. Schwere gemischte Osteopathie bei einer in Deutschland lebenden Türkin. Akt Rheumatol 2007 32:49-51.
14. Lehmann G, Ott U, Stein G, Steiner T, Wolf G. Renal osteodystrophy after successful renal transplantation-A histomorphometric analysis in 57 patients.
    Transplant Proc 2007 39: 3153-3158.
15. Linde B, Oelzner P, Katenkamp K, Hein G, Wolf G. Fulminantes Leberversagen bei einer 39-jährigen Patientin mit Leukozytose, unklaren Fieberschüben und Arthralgien. Med Klinik 2007 102: 846-851.
16. Mandecka A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, Vilser W, Hoyer H, Müller UA. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007 30 : 3048-3052
17. Materne C, Porubsky S, Gerth J, Gröne HJ, Wolf G. Histiocytosis X and renal insufficiency. Nephrol Dial Transplant 2007 22: 3664-3667.
18. Müller A, Bölzner C, Eidner T, Smolenski UC, Hein GE. Factors modifying collagen catabolism in patients with ankylosing spondylitis. Eur J Med Res 2007 12: 568-572.
19. Müller UA, Hunger-Dathe W, Müller N, Lodwig V, Langen L, Arnolds S und das Advisory Board Insulinpumpentherapie für Erwachsene (2007). Langzeitglykämie und Hypoglykämien nach Teilnahme am strukturierten Behandlungs- und Schulungsprogramm „Insulinpumpen-Therapie für erwachsene Patienten mit Diabetes mellitus Typ 1” von Roche Diagnostics GmbH. Diabetologie und Stoffwechsel 2007 2:161-168.
20. Netzel M, Netzel G, Ott U, Bitsch I, Bitsch R, Frank T. Biological antioxidant activity of a beverage containing polyphenols and ascorbic acid. Ernährung 2007 3: 102 - 109.
21. Oelzner P, Buttgereit F, Demary W, Franck H, Kern P, Hein G. The mechanism of bone loss in rheumatoid arthritis: Description based on a case report. Z Rheumatol 2007 66: 337-340.
22. Oelzner P, Franke S, Lehmann G, Eidner T, Müller A, Wolf G, Hein G. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis-relationship with bone mineral density, disease activity and bone turnover. Clin Rheumatol 2007 26: 2127-2135.
23. Olsen AK, Sondergaard BC, Byrjalsen I, Tanko LB, Christiansen C, Müller A, Hein GE, Karsdal MA, Qvist P. Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen. OsteoArthritis and Cartilage 2007 15: 335-342.
24. Ott U, Aschoff A, Fünfstück R, Jirikowski G, Wolf G. DNA-fragmentation in acute and chronic rejection after renal transplantation. Transplant Proc 2007 39: 73-77.
25. Ott U, Aschoff A, Pocok J, Fünfstück R, Jirikowski G, Stein G, Wolf G. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis. Nephron Clinical Practice 2007 105: c18 - c28.
26. Pfeil A, Böttcher J, Seidl BE, Heyne JP, Petrovitch A, Eidner T, Mentzel HJ, Wolf G, Hein G, Kaiser WA. Computer-aided joint space analysis of the metacarpal-phalangeal and proximal-interphalangeal finger joint: normative age-related and gender-specific data. Skeletal Radiol 2007 36: 853-864.
27. Pfeil A, Böttcher J, Seidl BE, Schäfer ML, Hansch A, Eidner T, Wolf G, Hein G, Kaiser WA. Computer-Aided Joint Space Analysis (CAJSA) of the Proximal-Interphalangeal Joint-Normative Age-Related and Gender Specific Data. Acad Radiol 2007 14: 594-602.
28. Reichelt O, Pilchowski R, Müller J, von Eggeling F, Schubert J, Gröne HJ, Ott U, Junker K. Identifizierung von Rejektionsmarkern nach Nierentransplantation mit Hilfe der Proteinchiptechnologie. Der Urologe A. 2007 46:1161
29. Renders L, Frisman M, Ufer M, Mosyagin I, Haenisch S, Ott U, Caliebe A, Dechant M, Braun F, Kunzendorf U, Cascorbi I. CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients. Clin Pharmacol Ther 2007 81: 228 - 234.
30. Schiel R, Müller UA. Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study. Exp Clin Endocrinol Diabetes 2007 115 : 627-633
31. Schweitzer D, Lasch A, van der Vorst S, Wildner K, Hammer M, Voigt U, Jutte M, Muller UA. Change of retinal oxygen saturation in healthy subjects and in early stages of diabetic retinopathy during breathing of 100% oxygen. Klin Monatsbl Augenheilkd 2007 224: 402-410.
32. Schnell O, Heinemann L, Hunger-Dathe W, Kulzer B, Lodwig V, Klinge A, Sturm D. Blutzuckermessung bei Typ-2-Diabetes ohne Insulintherapie: A never-ending Story. Diabetes, Stoffwechsel und Herz 2007 5: 345-346.
33. Sommer M, Wolf G. Rosiglitazone increasess PPAR γ in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Am J Nephrol 2007 27: 425-434.
34. Traut M, Haufe C, Eismann U, Deppisch R, Stein G, Wolf G. Increased binding of ß2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced ß2-microglobulin concentrations: results of a cross-over study. Blood Purification 2007 25: 432-440.
35. Wolf G, Müller N, Mandecka A, Müller UA. Association of diabetic retinopathy and renal function in patients with type 1 and 2 diabetes mellitus. Clinical Nephrol 2007 68: 81-86.

Übersichtsarbeiten

1. Hasslacher C, Kempe P, Ritz E, Wolf G. Praxisleitlinie-Diabetische Nephropathie. Diabetol Stoffwechsel 2007 2(Suppl. 2): S159-S162.
2. Hein GE. Particular features of steroid-induced osteoporosis. Orthopäde 2007 36: 708-713.
3. Hunger-Dathe W. Gestationsdiabetes - Ein unterschätztes Problem für Mutter und Kind im späteren Leben. MedReview 2007 6: 4-5.
4. Kleinwechter H, Bührer C, Hunger-Dathe W, Kainer F, Kautzky-Willer A, Pawlowski B, Reiher H, Schäfer-Graf U, Sorger M. Praxisleitlinie DDG - Diabetes und Schwangerschaft. Diabetologie und Stoffwechsel 2007 2 (suppl 2): 1-7.
5. Lehmann G, Ott U, Mikolayzak F, Stein G, Schütze J, Wolf G. Evaluation der Knochenmineraldichte bei Patienten mit renaler Osteodystrophie (ROD). Nieren- und Hochdruckkrankheiten 2007 36: 299-302.
6. Ott U, Steiner T, Schubert J, Wolf G. Update Nephrologie: Nierentransplantation. Medizinische Klinik 2007 102: 219 - 229.
7. Ott U, Werner T, Wolf G. Harnwegsinfektionen nach Nierentransplantation. Nieren- und Hochdruckkrankheiten 2007 36: 489 - 495.
8. Rüster C, Wolf G. Pathophysiologie der diabetischen Nephropathie. Der Nephrologe 2007 2: 325-332.
9. Rüster C, Wolf G. Update diabetische Nephropathie. Spektrum der Nephrologie 2007 20: 3-14.
10. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 2007 18: 2439-2446.
11. Sämann A, Müller UA, Wolf G. Sicherheitsaspekte oraler Antidiabetika. Der Diabetologe 2007 3: 31-36.
12. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007 106: 26-31.

Originalarbeiten

1. Oelzner P, Lehmann G, Eidner T, Franke S, Müller A, Wolf G, Hein G.
   Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism. Rheumatol Int 2006, 26: 908-915.
2. Neumann T, Oelzner P, Petrow PK, Thoss K, Hein G, Stein G.
   Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis. Inflamm Res 2006, 55:32-39.
3. Rapp A, Grohmann G, Oelzner P, Uehleke B, Uhlemann C.
   Does garlic influence rheologic properties and blood flow in progressive systemic sclerosis? Forsch Komplementarmed 2006, 13:141-146.
4. Drinda St, Oelzner P, Canet CC, Kaatz M, Wolf G, Hein G.
   Fatal outcome of Pyoderma gangrenosum with multiple organ involvement and partially responding to Infliximab. CEJMed 2006, 1: 306-312.
5. Neumann T, Bornkessel A, Pfleiderer SO, Hein G, Isenmann S, Wolf G, Terborg C.
   Images in cardiovascular medicine. A swelling of the right neck and sudden death. Circulation 2006, 113:e768-769.
6. Busch M, Fleck C, Wolf G, Stein G.
   Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease. Amino Acids 2006, 30: 225-232.
7. Busch M, Franke S, Wolf G, Brandstädt A, Gerth J, Ott U, Hunsicker LG, Stein G.
   The advanced glycation end product (AGE) Nε-carboxymethyllysine (CML) is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am J Kidn Dis 2006, 48: 571-579.
8. Ulbricht K, Bucha E, Poeschel KA, Stein G, Wolf G, Nowak G.
   The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters. Clin Nephrol 2006 65: 180-90.
9. Ulbricht K, Schmidt D, Ott U, Gerth J, Stein G, Wolf G.
   Vergleich klinisch angewandter Clearancemethoden zur Einschätzung der Nierenfunktion bei Niereninsuffizienz. Nieren- und Hochdruckkrankheiten 2006, 35: 305-315.
10. Hunger-Dathe W, Mosebach N, Sämann A, Schulz J, Müller UA, Wolf G.
    Prevalence of impaired glucose tolerance 6 years after gestational diabetes. Exp Clin Endocrinol Diabetes 2006; 114: 11-17.
11. Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA.
    Flexible, intensive Insulintherapy in adults with type 1 Diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care 2006, 29: 2196-2199.
12. Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RAK, Thaiss F.
    Compartment specific expression and function of the chemokine IP 10/CXL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 2006, 17: 454-464.
13. Hopfer U, Hopfer H, Jablonski K, Stahl RAK, Wolf G.
    The novel WD-repeat protein Morg1 acts as a molecular scaffold for HIF prolyl-hydroxylase 3 (PHD3). J Biol Chem 2006, 281: 8645-8655.
14. Böttcher J, Pfeil A, Rosholm A, Sörös P, Petrovitch A, Schaefer ML, Seidl BE, Malich A, Hansch A, Wolf G, Kaiser WA.
    Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital X-ray radiogrammetry. Invest Radiol 2006, 41: 36-44.
15. Wolf G, Bohlender J, Roger T, Wenzel U.
    Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 2006, 17: 1585-1693.
16. Zahner G, Wolf G, Schroeder S, Stahl RAK.
    Inhibition of platelet-derived growth factor induced mesangial cell proliferation by cyclooxygenase-2 overexpression is abolished through reactive oxygene species. FEBS Letters 2006, 580: 2523-2528.
17. Dreihaupt M, Ott U, Wolf G, Schubert J, Steiner T.
    Realization of the sixth modification of guidelines for organ placement in renal transplantation-a single-center experience. Transplant Proceed 2006, 38: 682.
18. Wolf G, Müller N, Tschauner T, Müller UA.
    Prävalenz von Nierenfunktionsstörungen im Diabetes TÜV der Deutschen BKK 2000 - 2004. Med Klinik 2006, 101: 441-447.
19. Rüster M, Sommer M, Stein G, Wolf G, Bauer K, Walter B, Bauer R.
    Upregulation of renal angiotensin receptor type 1 and 2 expression in naturally occurring intrauterine growth restriction of newborn piglets. Cell Tissues Organs 2006, 182: 106-114.
20. von Öhsen J, Ott U, Frícke HJ, Wolf G.
    Seltene Ursache einer Anämie bei einer nierentransplantierten Patientin. Med Klinik 2006, 101: 577-582.
21. Böttcher J, Pfeil A, Rosholm A, Schäfer ML, Malich A, Petrovitch A, Seidel B, Lehmann G, Mentzel HJ, Hein G, Wolf G, Kaiser WA.
    Computerized digital imaging techniques provided by digital radiogrammetry as new diagnostic tool in rheumatoid arthritis. J Digital Imaging 2006,19: 279-288.
22. Rüster C, Gerth J, Ott U, Pfeiffer R, Wolf G.
    Visusverlust und akutes Nierenversagen bei einer 28jährigen Reiterin. Der Internist 2006, 47: 857-860.
23. Pfeil A, Böttcher J, Mentzel HJ, Lehmann G, Schäfer ML, Kramer A, Petrovitch A, Seidl BE, Malich A, Hein G, Wolf G, Kaiser WA
    Multi-site quantitative ultrasound compared to dual energy X-ray absorptiometry in rheumatoid arthritis: effects of body mass index and inflamed soft tissue on reproducibility. Rheumatol Int 2006, 26: 1084-1090.
24. Böttcher J, Pfeil A, Schäfer ML, Petrovitch A, Seidl BE, Menzel HJ, Lehmann G, Malich A, Heyne JP, Hein G, Wolf G, Kaiser WA.
    Normative data for digital X-ray radiogammetry from a female and male German cohorts. J Clin Densitometry 2006, 9: 341-350.
25. Rüster M, Kiehntopf M, Gröne HJ, Wolf G.
    A Friday afternoon case of apparent anti-glomerular basement nephritis. Nephrol Dial Transplant 2006, 21: 2328-2330.
26. Wenzel U, Stahl R, Adam G, Wolf G.
    Schwellung des Shuntarms bei einem Dialysepatienten. Der Nephrologe 2006, 1: 103-105.
27. Wolf G.
    Portrayal of negative qualities in a doctor as a potential teaching tool in medical ethics and humanism: “Journey to the End of Night” by Louis-Ferdinand Céline. Postgraduate Medical J 2006, 82: 154-156.
28. Böttcher J, Pfeil A, Petrovitch A, Schmidt M, Kramer A, Schäfer ML, Gajda M, Hein G, Wolf G, Kaiser WA.
    Metacarpal index estimated by digital X-ray radiogrammetry as a tool for differentiating rheumatoid arthritis related periarticular osteopenia. Int J Biomed Science 2006, 2: 241-245.
29. Lehmann G, Stein A, Müller A, Hein G, Stein G, Wolf G.
    Vitamin K-Serumspiegel bei Patienten mit renaler Osteodystrophie. Nieren- und Hochdruckkrankheiten 2006, 35: 448-453.
30. Schiekofer S, Franke S, Andrassy M, Chen J, Rudowsky G, Schneider JG, von Eynatten M, Wendt T, Morcos M,Kientsch-Engel R, Stein G, Schleicher E, Nawroth PP, Bierhaus A.
    Postprandial mononuclear NF-kappa B activation is independent of the AGE-content of a single meal. Exp Clin Endocrinol Diabetes 2006, 14: 160-167.
31. Dawczynski J, Vater C, Kasper M, Franke S, Augsten R, Jurkutat S, Strobel J, Königsdörffer E.
    Advanced glycation end products and pseudoexfoliation - correlation between clinical outcome and histological findings. Klin Monatsbl Augenheilkd 2006, 223: 748-751.
32. Dawczynski J, Janz S, Kasper M, Franke S, Königsdörffer E, Augsten R, Strobel J.
    Histological and immunohistological investigations in human epiretinal membranes.  Klin Monatsbl Augenheilkd 2006, 223: 687-690.
33. Mentzel HJ, Blume J, Boettcher J, Lehmann G, Tucjscherer D, Pfeil A, Kramer A, Malich A, Kauf E, Hein G, Kaiser WA.
    The potential of digital X-ray radio-grammetry (DXR) in the assessment of osteopenia in children with chronic inflammatory bowel disease. Pediatr Radiol 2006, 36: 415-420.
34. Blum M, Pils C, Müller UA, Strobel J.
    The myogenic response of retinal arterioles in diabetic retinopathy. Ophthalmologe 2006, 103:209-13.
35. Gensischen J, Muth C, Butzlaff M, Rosemann T, Raspe H, Müller de Comejo G, Beyer M, Härter M, Müller UA, Angermann CE, Gerlach FM, Wagner ED.
    Die Zukunft ist chronisch: das Chronic Care-Modell in der deutschen Primärversorgung. Übergreifende Behandlungsprinzipien einer proaktiven Versorgung für chronische Kranke. Z ärztl Fortbild Qual Gesundh wes 2006, 100: 365-374.
36. Schiel R, Müller UA, Beltschikow W, Stein G.
    Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial. J Diabetes Complications 2006, 20: 273-279.
37. Reichelt O, Müller J, von Eggeling F, Driesch D, Wunderlich H, Schubert J, Gröne HJ, Stein G, Ott U, Junker K.
    Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology 2006, 67:472-5.
38. Keller T, Lehmann G, Sperschneider H.
    Effekt des Bisphosphonats Ibandronat bei der Behandlung der Osteoporose nach Nierentransplantation. Nieren- und Hochdruckkrankheiten 2006, 35:1-9.
39. Schiel R, Voigt U, Ross IS, Braun A, Rillig A, Hunger-Dathe W, Stein G, Muller U A.
    Structured Diabetes Therapy and Education Improves the Outcome of Patients with Insulin Treated Diabetes Mellitus - The 10 Year Follow-Up of a Prospective, Population-Based Survey on the Quality of Diabetes Care (The JEVIN Trial). Exp Clin Endocrinol Diabetes 2006, 114: 18-27.

Übersichtsarbeiten

1. Hunger-Dathe W, Wolf G.
   Albuminurie beim Diabetes mellitus - Marker und Motor der diabetischen Nephropathie und vaskulärer Komplikationen. Der Diabetologe 2006, 2: 400-409.
2. Gerth J, Ott U, Busch M, Poeschl K, Kroegel CC, Heyne JP, Wolf G.
   Therapierefraktäre pulmonale Infiltrate nach Nierentransplantation. Der Nephrologe 2006, 1: 56-58.
3. Gerth J.
   Niereninsuffizienz und Schwangerschaft, Teil 1. Diatra 2006, 2: 14-19.
4. Gerth J.
   Niereninsuffizienz und Schwangerschaft, Teil 2. Diatra 2006, 3: 15-18.
5. Panzer U, Steinmetz O, Stahl RAK, Wolf G.
   Kidney diseases and chemokines. Current Drug Targets 2006, 7: 65-80.
6. Wolf G.
   Are oral contraceptives associated with increased renin-angiotensin activity and risk of nephropathy in diabetic women? Nature Clinical Practice Nephrology 2006, 2: 78-79.
7. Ott U, Wolf G.
   Posttransplantationsdiabetes-Achillesferse der Transplantationsmedizin? NephroNews 2006, 8: 1-5.
8. Wolf G.
   Neue Aspekte der Hochdrucktherapie bei diabetischer Nephropathie. Med Report 2006, 30: 6.
9. Wolf G.
   Antihypertensiva und Niere-Pleiotrope Wirkungen. Diabetes News 2006, 5: 12.
10. Wolf G.
    Prophylaxe und Therapie der diabetischen Nephropathie. Nephrologie im Dialog 2006, 2: 4-8.
11. Hunger-Dathe W, Wolf G, Müller UA.
    Betreuung von Frauen mit Diabetes mellitus Typ 1 und Typ 2 präkonzeptionell und während der Schwangerschaft. Diabetes aktuell für die Hausarztpraxis 2006, 4: 7-10.
12. Wolf G.
    Zeit als vernachlässigte Krankheitsdimension: Patienten mit chronischer Niereninsuffizienz als Beispiel. Nieren- und Hochdruckkrankheiten 2006, 35: 185-190.
13. Hunger-Dathe W, Wolf G, Müller UA.
    Gestationsdiabetes-eine häufige Schwangerschaftskomplikation. Diabetes aktuell für die Hausarztpraxis 2006, 4: 11-16.
14. Rüster C, Wolf G.
    The renin-angiotensin-aldosterone-system and progression of renal disease. J Am Soc Nephrol 2006, 17: 2985-2991.
15. Pöschel KA, Wolf G.
    Diabetiker an der Dialyse. Diabetes, Stoffwechsel und Herz 2006, 15: 67-76.
16. Schubert J, Dreikorn K, Seiter H, Huland H, Jonas D, Kälble T, Wolf G, Steiner Th.
    Nierentransplantation in der Urologie: Vergangenheit-Gegenwart-Zukunft. Der Urologe 2006, 45: 85-89.
17. Wolf G.
    Renal injury due to renin-angiotensin-aldosterone system activation of the TGF-ß pathway. Kidney Int 2006, 70: 1914-1919.
18. Pöschel KA, Wolf G.
    Das Renin-Angiotensin-Aldosterone System als zentraler Mediator der Progression der Niereninsuffizienz. Der Nephrologe 2006, 1: 233-240.
19. Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S,
    Advanced glycation endproduct (AGE)-modification of bone proteins and bone remodelling - hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 2006, 65: 101-104.
20. Dreher R, Buttgereit F, Demary W, Görtz B, Hein G, Kern P, Schulz A,
    Insuffizienzfrakturen in der Rheumatologie - Fallbeschreibung und Übersicht. Z Rheumatol 2006, 65:417-424.
21. Hein G.
    Glycation endproducts in osteoporosis - is there a pathophysiologic importance? Clinica Chimica Acta 2006, 371: 32-36.
22. Lehmann G, Hein G, Wolf G.
    Der niereninsuffiziente Osteoporosepatient: Was ist bei der osteoprotektiven Medikation zu beachten? Z Rheumatol 2006, 65:378-382.
23. Kaiser R, Kaatz M, Oelzner P.
    Lyme-Borreliose - Klinik und Therapie. Ärtzebl Thüring 2006, 17:263ff
24. Fünfstück R, Ott U, Naber KG.
    The interaction of urinary tract infection and renal insufficiency. Intern J Antimicrob Agents 2006, 28: 71-77.